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ABSTRACT
When pulmonary hypertension occurs in the face o f hypoxia there is remodelling o f all 3 
layers o f the pulmonary vessels, but in particular, there is an increase in number o f 
adventitial fibroblasts. Hypoxia causes vasoconstriction in the pulmonary circulation and 
vasodilation in the systemic. We hypothesised that the remodelling process might be 
circulation specific and that there are fundamental differences in oxygen sensing and cell 
signalling between systemic and pulmonary artery cells in response to hypoxia. Both the 
mitogen-activated protein kinases (MAP kinase) and the stress-activated protein kinases 
(SAPK) have been shown to play an important role in cellular growth and proliferation in a 
number o f  cell systems. The aim o f  this present study was to examine the effects o f acute 
and chronic hypoxia on proliferation and determine a role for MAP/SAP kinases in 
response to both G-protein linked receptor agonists and growth factors in fibroblasts fi*om 
the pulmonary and systemic arteries o f cows and rats.
In bovine pulmonary artery fibroblast (BPAF) cells short-term exposure (24h) to 2% 
oxygen (hypoxia) increased proliferation. In the presence of certain agonists hypoxia 
augmented this proliferation. This enhanced proliferation was not seen in fibroblasts from 
the mesenteric artery (BMAF). Hypoxia also gave rise to increases in the second 
messenger, inositol 1,4,5-trisphosphate (IP3) mass in conjunction with the agonists 
responsible for increased proliferation in the BPAF cells. There was no increase in IP3 
mass in the BMAF cells. The effect o f acute hypoxia on activity o f MAP kinase isoforms 
was also studied. Hypoxia was found to increase the SAP kinase isoforms, p38 MAP 
kinase and c-jun N-terminal kinase (JNK) without effecting MAP kinase in BPAF cells. In 
contrast, hypoxia had no effect on the MAP kinase family o f enzymes in BMAF cells. 
Pulmonaiy artery fibroblasts from chronically hypoxic rats (HRPAF) displayed increased 
proliferation to serum and constitutive increases in p38 and MAP kinase, with no increase 
in JNK when compared to control cells even when maintained in normoxic conditions. 
This increase in proliferation was not observed in aortic fibroblasts fiom chronically 
hypoxic rats (HRAF). 5-HT, with the addition o f low serum levels, increased proliferation 
in the rat cells and could fiirther enhance the phosphorylation o f p38 and MAP kinase in 
HRPAF cells. Specific 5-HT agonists and antagonists showed the 5 -HT2a receptor to be 
the relevant receptor responsible for these observations.
The results reported in this thesis show for the first time that hypoxia can increase 
fibroblast proliferation in cells from pulmonary arteries whilst having so such effect in 
those from the systemic arteries. In addition, specific signalling pathways have been 
highlighted which are activated in the pulmonary cells to hypoxia but not in those of the 
systemic arteries.
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Chapter 1
Introduction
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1 General Introduction
The acceleration o f pulmonary artery fibroblast cell proliferation and the resultant 
remodelling is thought to be a primary event in the development o f pulmonary 
hypertension (Reid and Davies, 1989). At present, no underlying mechanism for 
remodelling has been found. One question is the link between vasoconstriction and 
remodelling. Does vasoconstriction lead to remodelling? It is tempting to say that this 
is the case because many vasoconstrictors, including hypoxia, are also growth factors, 
that is, thei e is a hnk between cell replication and vascular control (“cell growth- 
vasomotor coupling”) (Scott and Peacock, 1995). Understanding the cell signalling 
events involved in the regulation of normal and abnormal fibroblast cell proliferation 
due to hypoxia may provide an important insight into the degeneration o f growth 
control during pulmonary hypertension. In some instances irregular proliferation may 
be the result o f over activity or dysfunction o f component(s) o f the growth regulating, 
intracellular signalling pathway(s). Investigation o f these pathways may point to 
possible sites o f pharmacological intervention for the prevention o f pulmonary 
hypertension.
1,1 Pulmonary Hypertension.
Pulmonary Hypertension is a condition of abnormally high pressure within the 
pulmonary circulation and develops in many species, including humans. It i.s 
important because it contributes to the morbidity of most heart and lung diseases. One 
cause o f pulmonary hypertension is chronic exposure to normobaric and hypubaric 
hypoxia (Janssens et al, 1991). Exposure to hypoxia results in an acute increase in 
pulmonary arterial pressure (PAP), as a result o f vasoconstriction which can be 
followed by sustained pulmonary hypertension resulting from a combination of
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polycythemia and morphological alterations of the pulmonary vascular bed. This late 
increase in PAP is not immediately or totally correctable upon improvements in 
oxygen concentrations to normal values (Vender, 1994).
1.1.1 Epidemiology o f pulmonary hypertension 
There are several causes o f pulmonary hypertension
Left to right shunt. This means that blood at high pressure (systemic circulation) 
passes directly to the pulmonary circulation (low pressure).
Pulmonary Thrombo-Embolism. A condition in which pulmonary arteries are blocked 
by a clot formed in situ or carried in the bloodstream from the site of remote 
formation.
Primary pulmonary hypertension. This is a rare disorder of unknown cause. 
Histological examination o f the lung shows an increase in smooth muscle and 
fibroblast deposition in the small pulmonary arteries.
Chronic hypoxic lung disease. This includes:- Kyphoscoloiosis, chronic bronchitis 
and emphysema, cystic fibrosis and interstitial lung disease and is thought to cause 
pulmonary hypertension in two ways: alveolar hypoxia causes pulmonary 
vasoconstriction and structural damage in the lung reduces pulmonary vascular 
compliance.
1.1.2 Pathological processes seen in pulmonary hypertension 
These fall in to three categories: -
Hypoxic pulmonary vasoconstriction.
Hypoxic pulmonary vasoconstriction has been known to exist since 1946 (von Euler 
and Liljestrand, 1946) but the mechanism is not yet fully understood. It is turned on
27
within 1-2 minutes after a sudden decrease in alveolar PO2, is fully developed after 3- 
5 minutes, remains more or less stable thereafter according to the experimental 
conditions, and is generally reversed in less than 1 minute. Hypoxic vasoconstriction 
is observed in isolated lungs devoid o f nervous connections. It is located mostly in 
small order arterioles but may extend to large branches o f the pulmonary artery or to 
pulmonary capillaries. The biological mechanism o f hypoxic pulmonary 
vasoconstriction remains unknown (Grovner, 1983).
Destruction o f  the pulmonary vascular bed.
Examples of this are loss o f lung parenchyma- e.g. emphysema, and pulmonary 
vascular arteritis- e.g. polyarteritis nodosa.
Pulmonary vascular remodelling.
In addition to short-term autoregulatory changes in vascular tone, vessels can undergo 
profound fibrocellular changes. This is an active process termed vascular remodelling 
which results in an increase in the medial coat o f the normally muscular arteries and 
an extension o f muscle into smaller and more peripheral vessels than is normal. There 
are various clinical conditions in which these features are found. Hypoxia is one cause 
and is a useful model because it can be tested in the laboratory. These include 
Kyphoscoliosis (Naeije, 1961), chronic bronchitis and emphysema (Semmons and 
Reid, 1974) and cystic fibrosis (Ryland and Reid, 1975). Pulmonary vascular 
remodelling is important clinically because it renders the vessels relatively 
unresponsive to vasodilators.
28
1.2 Pulmonary Vascular Remodelling.
1.2.1 Pathological pulmonary vascular remodelling.
Pathologically, pulmonary vascular remodelling represents increased muscularisation 
o f both the large and small pulmonary arteries, which results in a reduction of the area 
o f the pulmonary arterial bed (Reid and Meyrick, 1982). One of the main causes of 
remodelling in humans is hypoxia.
Thickening of the muscular coat o f small pulmonary arteries begins a few days after 
exposure to hypoxia (Hunter ei al, 1974). Furthermore, fibroblasts migrate into 
arterioles and in some studies appear to undergo transformation into smooth muscle 
cells (Sobin et al, 1983) that reduce the size o f the vessel lumen. In addition to this, 
the proximal pulmonary arteries respond to the rise in blood pressure by an increase in 
the thickness of the media and adventitia. Proliferation of adventitial fibroblasts 
occurs before the other cell types (Reid and Davies, 1989). High blood flow can also 
contribute to the remodelling process by increasing the wall shear stress which may 
directly damage endothelial cells (Esterly et al, 1968), and activate platelets to release 
growth factors leading to smooth muscle cell proliferation There may also be release 
o f endothelial-derived growth factors. There is experimental evidence that mechanical 
forces (e.g. stretch) directly stimulate the vascular wall to undergo remodelling in the 
absence of endothelial cell damage (Archer et al, 1988).
1.2.2 Morphological features of pulmonary vascular remodelling.
One of the main features o f pulmonary vascular remodelling is the proliferation of 
fibroblast and smooth muscle cells in the pulmonary arteries. When this occurs, the 
proliferation of intima and media will encroach on the lumen of the vessel, which in
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turn will alter the relationship between flow and pressure in the vessel (Owens and 
Schwartz, 1983; Murphy et a/, 1981). Structural changes within the vessel can also 
occur in the larger of the pulmonary arteries. Thickening o f the vessel walls also 
involves an increase in the number of fibroblast cells, which may be a consequence of 
chemotaxis from a distant site, mitogenesis or both (Harris and Heath, 1986).
1.2.3 Mechanisms o f pulmonary vascular remodelling.
The process of pulmonary vascular remodelling consists o f some or all of the 
following events:-
1/ Altered physical and haemodynamic forces.
These include shear stress and transmural pressure. Endothelial cells are subjected to 
shear stress caused by the movement o f blood over their surface. Transmural pressure 
is the increased atrial pressure causing an increase in stress and strain on all cell types 
across the vessel wall (Sumpio et al, 1988).
2/ Relay o f signals to cells.
This may consist of signals / substances (Sharkey et al, 2000; Santilli et al 1991) 
secreted from one cell type or in the form of stress which either stimulates or 
suppresses the growth or activity of another cell type within the vessel.
3/ Alteration o f vessel wall and extracellular matrix.
Marked increases in extracellular matrix protein synthesis by fibroblast and smooth 
muscle cells in vivo under conditions o f chronic hypoxia have been well established 
(Saed et al, 1999; Crouch et al, 1989). Studies in chronically hypoxic adult and 
neonatal animals from several species demonstrate increases in the production and 
accumulation of collagen and e last in in the media o f  conducting pulmonary arteries 
(Novotna and Her get, 1998; Xu et al, 1995). In the adult rat, substantial and rapid
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increases in the relative rates o f connective tissue protein synthesis in the explants o f 
main pulmonary arteries have been demonstrated (Poiani et al, 1990)
4/ Growth promoting substances.
There has been much work done on growth factors, which stimulate all forms of cells 
from within the pulmonary artery to proliferate. Several peptide growth factors are 
known to cause smooth muscle cells to proliferate (Schwartz and Reidy, 1987) and 
indeed the same is true for fibroblasts (Welsh et al, 1996). The response o f cells to 
these factors may also be enhanced by the addition o f environmental change, such as 
hypoxia (Welsh et al, 1996).
1.2.4 Cells and extracellular matrix in remodelling in response to hypoxia
Little is known of the mechanisms by which hypoxia mediates vascular remodelling. 
It is unclear whether abnormal cell proliferation and connective tissue deposition in 
pulmonary arteries is a direct effect o f hypoxia itself or secondary to the rise in 
pulmonary artery pressure and blood flow caused by hypoxic vasoconstriction.
1.2.5 In vivo studies o f pulmonary vascular remodelling
Ultrastructural and morphometric analysis o f pulmonary arteries o f animals exposed 
to clironic hypobaric hypoxia show a significant thickening o f each of the three vessel 
wall layers and a narrowing o f the vessel lumen. The nature o f the hypoxic response 
in the media varies with distal progression along the vessel. Medial thickening in 
large diameter muscular pulmonary arteries seen in the rat (Rabinovitch et al, 1979, 
Walker et al, 1984), dog (Rorie et al, 1988), newborn domestic calf (Stenmark et al,
1988) and humans native to high altitudes (Heath et al, 1988) is caused principally by 
hypertrophy o f pre-existing smooth muscle cells (SMCs). This, due mainly to an
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increase in the organelles o f protein synthesis, the rough sarcoplasmic reticulum and 
golgi apparatus (Meyrick & Reid, 1980). There is also an increase both in the 
thickness of the elastic laminae separating SMCs from endothelial cells and 
extracellular connective tissue deposition including elastin and collagen. Fibroblasts 
too are able to migrate into the media in response to hypoxia (Sobin et al, 1983) and 
express a dramatic change in phenotype, acquiring structural characteristics of 
contractile cells.
Adventitial thickening during the development o f chronic pulmonary hypertension in 
rats (Meryick & Reid, 1980) and neonatal calves (Stenmark et al, 1988) has been 
shown to be caused by both an early and a prolonged intense fibroblast proliferative 
response greater than either the endothelial cell or SMCs (Meryick & Reid, 1979). In 
addition to an increase in the number of fibroblasts observed in the adventitia of 
hypoxic pulmonary arteries, marked increases in matrix protein deposition has been 
noted, especially that o f collagen and elastin, as described in human and animal 
studies of pulmonary hypertension.
1.2.6 In vitro studies o f pulmonary vascular remodelling
Smooth muscle cells isolated from muscular pulmonary arteries o f newborn calves 
exposed to hypoxia produce more elastin than cell from normal calves (Mecham et al, 
1987). Cultured human fibroblasts have been shown to exhibit a proliferative response 
to hypoxia (2.5% O2) (Storch & Talley, 1988). Although there is compelling 
evidence that there is SMC replicatb/e response to hypoxia in vivo, this observation 
has not been extended to cultured SMCs. In fact, authors have shown that hypoxia 
actually inhibits proliferation of cultured bovine foetal, neonatal and adult pulmonary 
artery SMCs (Benitz et al, 1990; Stenmark et al, 1991; Dempsey et al, 1991)
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suggesting that reducing oxygen tension, at least by itself, is unlikely to be a direct 
stimulus accounting for the increased quantity of smooth muscle found in the 
pulmonary arteries in association with hypoxemia. However, a homogenous 
population o f pulmonary arterial SMCs in a cultured cell system may not accurately 
reflect their behaviour in situ. They are removed from the influence of pressure flow 
and physical interactions with matrix components and other cell types usually found 
in close proximity within the vessel wall, which may influence their response to 
hypoxia. Other vascular cells including endothelial cells, fibroblasts and 
macrophages, or blood-borne cells such as the platelet or monocyte may be oxygen 
sensors themselves and facilitate SMC proliferation in response to hypoxia by their 
generation of extracellular growth-promoting factors that act in a paracrine manner. 
The stimulatory effect o f reducing oxygen on cultured fibroblast proliferation may 
also be partially explained by the enhanced synthesis and secretion o f autocrinic 
peptide mitogens. Several groups have used conditioned media from cultured ceils 
exposed to hypoxic conditions to look at its effect on growth o f cells and to identify 
and quantify the factors released (Ankoma-Sey et al, 2000).
1.2.7 Growth factors in remodelling
Hypoxia increases the expression of growth factors in whole lung and isolated 
vascular cells (Sodhi et al, 2000; Ankoma-Sey et al, 2000). It is not clear which are 
critical to the remodelling process, although endothelin-l (ET-1), platelet-derived 
growth factor fPDGF), Angiotensin II (AH), Thrombin and 5-hydroxytryptamine (5- 
HT) are probably important.
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EndotheIin-1: Vender and colleagues (1987) first described a SMC macromolecular 
mitogen released from hypoxic pulmonary artery endothelial cells (PA ECs). Since 
then, ET-1 has been identified as an EC-derived G protein-coupled receptor agonist 
peptide shown to be mitogenic for cultured SMCs and fibroblasts from the systemic 
vasculature (Suzuki et al, 1999). Production o f ET-1 by cultured human umbilical 
vein ECs is elevated by hypoxic exposure (Peacock et al, 1992). However, cultured 
bovine SMCs from the pulmonary artery exhibit only a modest increase in growth in 
response to maximal ET-1 concentrations. Indeed, bovine pulmonary artery 
fibroblasts as measured by cell counts and [^H]thymidine incorporation, a reflecfion 
o f DNA synthesis show no increase in proliferation to ET-1 (Hassoun et al, 1992, 
Welsh et al, 1996). Furthermore, bovine PA ECs show either no change (Hassoun et 
al, 1992) or a decrease (Wiebke et al, 1992) in ET-1 release in response to hypoxia o f 
48h duration. These discrepant and contradictory results have made it difficult to 
interpret the role o f ET-1 as a factor regulating SMC and fibroblast proliferation and 
in how hypoxia modifies ET-1 production by ECs in the pulmonary cfrculation.
Platelet-derived growth factor: Platelets contain a mitogenic protein factor referred 
to as PDGF (Deuel, 1987). This protein is present in platelet a  granules (Gerrard et al, 
1980) and is released when platelets are stimulated to aggregate (Ross et al, 1986). It 
is a major mitogen in serum for many types o f cells, including fibroblasts, glial cells, 
and vascular smooth muscle cells, (Heldin and Westermark, 1984; Deuel et al, 1983; 
Ross et al 1986) but not in endothelial cells (Davies et al, 1978). PDGF is a dimeric 
molecule that occurs as a homodimer (AA and BB) and a heterodimer (AB) o f related 
polypeptide chains; PDGF -A  and PDGF -B  (Heldin and Westermark, 1984).
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Platelets contain mainly PDGF-AB and some PDGF-BB. On the other hand, VSMC 
secretes PDGF-AA in a growth and differentiation-dependant manner, which may 
contribute to the growth-stimulating mechanisms of blood vessels. In contrast to 
fibroblasts, which show an equal growth response to PDGF-AA and -B B  (Mehmet et 
al, 1990), the mitogenic responses o f VSMC to the three PDGF isoforms are not 
uniform, e.g. PDGF -AA is a far weaker mitogen than PDGF -A B  and -BB 
(Sachinidis et al, 1990). In fibroblast and smooth muscle cells, PDGF has been shown 
to increase the cellular replicative responses to hypoxia (Welsh et al, 1996; Stenmark 
et al, 1991).
5-Hydro xytryptamine (5-HT): 5-HT, also known as serotonin, is one o f the best 
known examples o f  a neurotransmitter that mediates a wide variety o f  physiological 
effects, including peripheral and central actions, through the binding to multiple 
receptor subtypes (Wilkinson and Dourish, 1991). The large diversity of 5-HT 
functions is paralleled by the pharmacological complexity o f 5-HT receptors. At least 
four classes o f 5-HT receptors have been distinguished pharmacologically, based on 
the second messenger systems to which the receptor is coupled. The family including 
5-HT] and 5-HTs subtypes o f receptors interacts negatively with adenylyl cyclase, the 
5 -HT2 subfamily o f receptors is coupled to the activation o f the phospholipase C-p, 
the 5-HT] receptor is a ligand-gated ion channel, and the family, including 5 -HT4, 5- 
HT&, and 5-HT? subtypes o f  receptors, activates adenylyl cyclase (Peroutka, 1995).
O f the receptor classes distinguished, the 5-HTi receptor is the most likel> to be 
involved in the hypoxic responses seen in the pulmonary vessels. It mediates many of 
the central and peripheral physiological functions o f 5-HT, including contraction of 
blood vessels and cell growth and development (Tecott et al, 1995).
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Angiotensin II (All): All stimulates a variety o f physiological responses related to 
the regulation o f blood pressure, salt and fluid homeostasis (Raizada et al, 1993). In 
addition, AH promotes growth responses in many cells, including cardiomyocytes, 
fibroblasts (Marshall et al, 2000), and vascular smooth muscle cells (Aceto and 
Baker, 1990; Sadoshima and Izumo, 1993). AH exerts effects through specific G- 
protein coupled receptors, predominantly the AT| receptor subtype. ATi receptors 
couple to intracellular calcium mobilisation, activation o f tyrosine kinases such as 
p i25^^*  ^ and induction o f serine/threonine kinases, including protein kinase C (PKC) 
and mitogen-activated protein kinases (MAP kinases) (Lindpainter and Ganten, 1994; 
Sadoshima and Izumo, 1993). AH may act directly through these pathways or 
indirectly via the release o f growth factors such as PDGF and TGF-p, as demonstrated 
for rat vascular smooth muscle cells (Sadoshima and Izumo, 1993). Like other growth 
factors, AH induces a rapid increase in the growth associated nuclear proto-oncogenes 
c-myc, c-fos and c-jun and several cellular genes including tenascin, fibronectin and 
collagen (Naftilan et al, 1990; Taubman et al, 1989). These studies indicate that AH 
caii induce rapid changes in gene expression and function that may ultimately lead to 
increased cell growth (Dosai et al, 1991)
Thrombin: Thrombin may have a role in the pathogenesis o f pulmonary vascular 
disease. It is well documented as causing pulmonary vasoconstriction (Horgan et al, 
1987) and has been implicated in the development o f intimai thickening after balloon 
angioplasty (Sarembock et al, 1991). The action of tlirombin on vascular cells 
involves the proteolytic activation o f G protein-coupled receptors that are subjected to 
rapid and iireversible de-sensitisation. Tlirombin is mitogenic in neonatal rat vascular
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smooth muscle (Huang and Ives, 1987) as well as various fibroblast cell lines 
(Vouret-Craviari et al, 1992; Carney et al, 1985). Furthermore, the mitogenic effects 
o f thrombin can be mimicked by thrombin receptor-derived peptides that activate the 
thrombin receptor (McNamara et al, 1993).
Growth factors mediate their effect in general by binding to the cell surface via 
specific receptors and initiating a cascade o f intracellular signalling events (Chapter 
1.8 ).
1.3 Hypoxia.
1.3.1 Definition
Hypoxia is a physiological term for the condition in which the oxygen supply to 
tissue, organs or whole animals is insufficient to maintain a normal function. The 
effect o f hypoxia on an animal is characterised by tachycardia, hypertension, 
peripheral vasoconstriction, and mental confusion.
1.3.2 Causes o f hypoxia
1.3.2.1 Altitude
The first clue that altitude adversely affected the lung circulation of the altitude 
resident was the recognition of 'brisket disease’ in cattle. In 1913, ranchers in 
Colorado (10,000 feet) asked veterinary scientists at Colorado State University to 
investigate why theii' herds were dying with swelling ventral to the sternum in the area
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of the brisket of beef, hence the name ‘brisket disease’ (Glover & Newsom, 1915). At 
the turn of the century when cattle from Kansas and Texas were being introduced into 
Colorado high pastures, mortality approached 40%. Investigations, which began then, 
revealed that the swelling was due to accumulation o f heart failure fluid and that cattle 
recovered when taken to lower altitude.
After von Euler and Liljestrand (1946) reported that acute hypoxia induced 
pulmonary vasoconstriction, investigators in Colorado confirmed that pulmonary 
hypertension in the cattle was the result o f sustained vasoconstriction from chronic 
hypoxia (Alexander & Jenson, 1959).
1.3.2.2 Lung disease
Many lung diseases are associated with hypoxia which stimulate pulmonary 
vasoconstriction and cause pulmonary vascular remodelling. Examples o f these are 
clironic bronchitis, emphysema and interstitial lung disease. Chronic bronchitis leads 
to airway narrowing and obstruction and in some cases polycythemia results from 
chronic hypoxemia (Hasleton et al, 1968). Emphysema is the result o f destructive 
changes in the alveolar wall resulting in loss of lung elasticity and gas exchange. 
Interstitial lung disease may be idiopathic but may also follow industrial exposure to 
inorganic dusts, such as asbestos or silica. There is scarring o f the lung tissue and 
hence reduction o f the lungs ability to allow oxygen transport to the blood.
1.3.3 Effects of hypoxia
In response to hypoxia, mammals exhibit systemic responses that decrease cellular 
oxygen need and dependence and increase tissue oxygen supply. Alterations in 
oxygen tension elicit important responses at the organ and tissue level. Exposure to
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chronic hypoxia causes pulmonary hypertension in most mammalian species. The 
pulmonary hypertension is associated with changes in vascular tone and is nearly 
always associated with significant structural changes within the pulmonary vascular 
bed (pulmonary vascular remodelling) (Stenmark and Mecham, 1997). There are also 
marked changes in the phenotype o f endothelial, smooth muscle and fibroblast cell 
populations. Over the last few years it has become clear that the vascular responses to 
hypoxia involve extremely complicated cell-cell interactions mediated by growth 
factors, cytokines and biological messengers. For the purpose o f this thesis, the most 
relevant effect of hypoxia in the body is its effect on the lungs where hypoxia leads to 
pulmonary vasoconstriction and pulmonary vascular remodelling.
1.3.3.1 Endothelial cells
Large amounts of work have been carried out in endothelial cells. PA ECs are 
continually exposed to low levels o f oxygen due to the low oxygen content of mixed 
venous blood. This level o f oxygen can become even lower during hypoxic exposure. 
In response to hypoxia, a number o f genes have been shown to be induced. These 
include vascular endothelial growth factor (VEGF) and transforming growth factor-(3 
(TGF“P). Current evidence suggests that most o f the presumably essential adaptive 
responses to hypoxia exhibited by endothelial cells are mediated through the 
transcription factor called hypoxia inducible factor (HIF) (Bunn and Poyton, 19^6, 
Bunn ct al, 1998). Changes in endothelial gene expression regulated by the HIF 
transcription factor include gene glycolytic enzyme, the glucose transporter GLUT-1, 
VEGF-receptor expression, hemeoxygenase (HO), endothelin and PDGF (Ankoma- 
Sey et al, 2000; Sodhi et al, 2000; Blanc her et al, 2000; Richard et al, 2000). Yan et 
al (1998) demonstrated that in contrast to hypoxia-induced adaptive responses that
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appear to be the subject mostly to regulation by HÏF-1, those responses that could be 
considered maladaptive (inflammation) appear to be under the control of other 
transcription factors, most notably early growth response gene product (Egr-1). Thus 
hypoxia appears to activate several distinct types o f host response mechanisms in 
endothelial cells.
1.3.3.2 Smooth muscle cells
Research into the effect o f hypoxia on smooth muscle cells has led to a substantial 
body o f evidence which suggests that there are specific subsets o f smooth muscle 
cells which display unique differences depending on the location o f the cell along the 
axis o f  the arterial tree, as well as in distinct layers. These differences would appear to 
play an important role in the cells reaction to hypoxia (Frid et al, 1994). Cells 
exhibiting unique morphological and biochemical characteristics also differ 
significantly with respect to their proliferative responses to growth promoting stimuli. 
In general the ‘non-muscle-like’ cell sub-populations exhibit markedly enhanced 
growth capabilities under serum-stimulated conditions compared to ‘differentiated’ 
SMC populations (Frid et al, 1997a; Frid et al, 1997b).
1.3.3.3 Fibroblasts
In. animal models, the earliest and most dramatic structural changes following hypoxic 
exposure are found in the adventitial compartment o f the vessel wall (Jones and Reid, 
1995). Fibroblast cells from the adventitia exhibit increases in proliferation that 
exceed those observed in other cell types (Belknap et al, 1997). The fibroproliferative 
changes in the adventitia are ultimately associated with luminal narrowing and
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progressive decreases in the ability o f the vessel wall to respond to vasodilating 
stimuli (Durmowicz et al, 1993).
1.3.3.4 Intracellular targets o f hypoxia
As noted previously, the activity of several different transcription factors are known 
to be influenced by low oxygen tensions. Protein phosphorylation appears to be 
crucial for expression of many hypoxic-inducible genes. Inhibition o f tyrosine kinase 
pathways has been shown to inhibit many HIF-inducible genes. One important target 
is the mitogen-activated protein kinase (MAPK) family o f enzymes. Many studies 
have demonstrated that the MAPK’s p44 (Erk 1) and p42 (Erk 2) are crucial to 
proliferation in response to growth factors in a variety o f cell types (Chapter 1.16; 
Segal and Greenberg, 1996)
In addition to the “classic” forms o f MAP kinase, families o f related protein 
serine/threonine kinases exist in cells, and are referred to as the stress-activated 
protein (SAP) kinases (Chapter 1.17). These consist o f p38 MAP kinase and JNK 
homologues and have also been shown to be activated in adventitial fibroblasts to 
acute hypoxia (Scott et al, 1998).
1.4 Fibroblast physiology
Within the developing vasculature, fibroblasts influence the growth and development 
o f blood vessels. The normal arterial wall is predominantly composed o f tliree layers; 
intima, media and adventitia. Smooth muscle cells are the principle cells found within 
the media in association with a matrix of connective tissue components (collagen and 
elastin) and provide mechanical and structural support to the vessel. The intima 
consists of a single layer o f endothelial cells resting on a thin basal lamina. The
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adventitia is comprised of connective tissue proteins secreted by locally resident 
fibroblasts. These fibroblasts play a significant role in arterial repair.
Recent insights into arterial remodelling have implicated the adventitial layer as an 
important modulator o f remodelling through its interactions with the media and 
intima. In pulmonary hypertension, adventitial thickening with increased cellular it y 
and extra cellular matrix (ECM) deposition are most prominent in the small, muscular 
pulmonary arteries (Stenmark and Mecham, 1997; Riley et al, 1986), which typically 
share a number o f structural features in common with systemic muscular arteries. 
There are several factors that contribute to significant structui'ai changes in both the 
adventitia and media. These include fibroblast proliferation, fibroblast apoptosis, and 
fibroblast migration into the intima, adventitial fibrosis and expression of matrix 
metalloproteinases (MMPs). It is important to assess evidence for these activities in 
the pathogenesis o f remodelling in the pulmonary and systemic circulation because 
hypoxia has opposite and contrasting effects in the 2 populations.
1.4.1 Fibroblasts from the pulmonary and systemic circulations 
As mentioned previously, whereas hypoxia causes vasoconstriction in the pulmonary 
arteries, it has a vasodilatory effect in the systemic arteries (Heisted and Abbound, 
1980; Wagner and Mitzner, 1988). Teleologically, this vasodilation increases oxygen 
delivery to hypoxic tissues; this can be problematic when treating pulmonary 
hypertension as pulmonary vasodilators can give rise to systemic hypotension. 
Although metabolic intermediaries such as ATP depletion or the formation of 
adenosine have been suggested as likely mechanisms, how systemic vasodilation is 
effected remains obscure. There has been further evidence o f this tantalising 
discrepancy between the pulmonary and systemic circulations by the observations that
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administration of ET-1 to intact-chest cats constricts pulmonary vessels and dilates 
systemic vessels (Lippton et al, 1989a; Lippton et al, 1989b). The role played by 
endothelium-derived mediator(s) in the opposite effects o f hypoxia on the pulmonary 
and systemic circulation awaits clarification.
Although many properties are shared between adventitial fibroblasts in the muscular 
arteries o f the pulmonary and systemic circulation, differences also exist that need 
further elucidation, particularly in response to hypoxia. It is possible that fibroblasts 
fiom the pulmonary artery exhibit increases in intracellular signalling pathways when 
exposed to hypoxia that are not seen in those from the systemic circulation. By 
studying the intracellular mechanisms from normal and hypoxic fibroblasts from both 
the pulmonary and systemic arteries, possible targets may be found for treating 
hypoxic pulmonary hypertension without causing adverse effects in the systemic 
circulation.
1,5 Signalling events controlling cell proliferation
1.5.1 The Cell Cycle
The cell cycle is a chain o f r;vents which is necessary for successful cell division; this 
period varies depending on the type o f cell but generally takes fiom between 24-30 
hours. The cell cycle contains a number o f phases; G| (the first gap before DNA 
replication). S phase (when chromosomes are replicated), Gi (the gap after DNA 
replication) and M phase (the period when the replicated chromosomes are split into 
two daughter cells (Figure 1.1). Many non-dividing cells in tissues (e.g. all quiescent 
fibroblasts) suspend the cycle after mitosis and just prior to DNA synthesis; such 
“resting” cells are said to have exited from the cell cycle and to be in the Go state. It is
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possible to identify cells when they are in one o f the three interphase stages o f the cell 
cycle, by using a fluorescence-activated cell sorter (FACS) to measure their relative 
DNA content: a cell that is in Gi (before DNA synthesis) has a defined x amount of 
DNA; during S (DNA replication), it has between x and 2x; and when in Gz (or M), it 
has 2x of DNA. Extracellular stimuli in the form of growth factors, mitogens or stress 
determine whether a quiescent cell will begin to proliferate and also whether a normal 
proliferating cell in Gi will continue to traverse the cell cycle or revert to quiescence 
(reviewed in Pardee, 1989). Once the S phase is entered, mainly intracellular triggers 
compose regulatory events. In fact, the control regulating the onset o f the M phase is 
now believed to be via levels o f various eye lins and their partner cyclin-dependent 
kinases (cdks) as well as cdk inhibitors such as pi 6 and P27'^‘'’’. The use o f clonal cell 
lines has greatly facilitated the analysis o f the early events induced by growth factors. 
These cell lines can be made quiescent by either withdrawing serum growth factors 
from the culture medium or by allowing the cells to reach confluency so that all o f the 
available growth factors aie depleted and the cells contact inliibited. By re-adding 
serum or defined growth factors, quiescent cells are stimulated to re-enter the cell 
cycle and thus early biochemical events in response to the growth factor can be 
investigated.
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Figure 1.1
M -phase 
1-2 hrs
‘S’-phase 
7-12 hrs
Gl-phase
variable
GO-phase
variable
Figure 1.1 The cell cycle
Cell growth can be conceptualised as occmTing in distinct phases; the mitotic M phase 
and the synthetic S phase, each separated by a Gap phase (Gi or G2). Cells may 
temporarily occupy an additional Go, or “resting phase”.
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1.5.2 Transcriptional regulation o f cell cycle dependent genes.
In order for a cell to respond to extracellular signals and progress through the cell 
cycle, the co-ordinate regulation of the transcription of cell cycle dependent genes is 
essential. To activate or repress transcription, transcription factors must be activated 
in the nucleus, bind to specific regions o f DNA (palindromic response elements) and 
interact with the transcription apparatus (e.g. RNA polymerase). Regulation o f 
transcription is achieved at a number o f levels:
(1) Nuclear translocation, where the location o f transcriptional factors is 
determined by the activity o f either nuclear localisation signals or cytoplasmic 
retention signals. For example, translocation o f NFkB to the nucleus is prevented by 
its association with an inhibitory subunit, IkB, in the cytoplasm (Beg and Baldwin,
1993).
(2) Transcriptional activation, where phosphorylation and acétylation events 
directly facilitate interaction with transcription machinery. For example, cAMP/Ca^^ 
response element binding protein (CREB) activity is dependent on regulated 
phosphorylation o f Ser'^^ (Gonzales, 1991).
(3) Alteration of DNA binding properties. For example, some 
phosphosphorylation events directly regulate transcription factor binding to response 
elements, as is the case for serum response factor (SRF) (Rivera et al, 1993). These 
mechanisms have been reviewed by Hill and Treisman (1995).
Transcriptional regulation in response to extracellular signals is both cell type and 
developraentally specific. This level o f control is determined by a number of 
interacting factors. Principally, the specificity o f transcriptional activation is due to 
the presence o f a host o f transcription factors that specifically bind to response 
elements (Table 1.1) by two mechanisms (Hill and Treisman, 1995):
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(a) Promoter activity is dependent upon the binding o f a specific set o f transcription 
factors at multiple response elements immediately on the 5' side o f the promoter. 
Transcription factor binding is specific for both the agonist and signal 
transduction pathway activated.
(b) The activity o f certain promoters is dependent on the binding o f ternary 
complexes composed o f different families o f transcription factors that, in some 
cases, require the activation of a number o f different specific signalling pathways.
In addition, the level o f  transcriptional activation or ‘promoter strength’ may also be 
regulated by both the duration and magnitude o f signal. For example, the ability o f the 
response element(s) to induce the same promoter with different activities may be 
dependent on the number o f activated transcription factors bound to the response 
elements, which will ultimately be dependent upon the activity o f  the signalling 
pathway.
1,6 Early growth factor-stimulated events
Since the initiation o f DNA synthesis is a late event in the cell cycle attention has 
focused on the initial cellular responses associated with a mitogenic stimulus and their 
importance in the later proliferative response. As discussed previously there is an 
increasing list o f growth promoting agents acting on different types of cells that elicit 
a common pleiotypic response. These initial cellular responses to mitogens include an 
intrinsic rise in intracellular pH, a transient rise in cytoplasmic Ca^^, the 
phosphorylation o f a common set o f proteins and an increase in c-fos and c-myc 
mRNA.
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Stimulation o f a rise in cytoplasmic pH has been reported to be a common response in 
the activation o f many quiescent cell types. Growth promoting agents such as serum, 
endothelin, EOF, a-thrombin, insulin, bombesin, PDGF and vasopressin have all been 
shown to induce a rapid rise in pH by controlling Na^/HT exchange. The Na^/H^ 
exchanger is a cell membrane protein that exchanges Na^ ions for H^ ions in an 
electorneural fashion. (Hesketh et al, 1985; Simonson et al, 1989; Grinstein et al,
1989).
In addition to pH changes a characteristic feature o f many growth stimuli is that they 
induce increases in the intracellular free Ca^^ concentrations ([Ca^^ji). Hormone- 
receptor-mediated increases in the cytosolic [Ca^^], often result from both 
mobilisation of Ca^^ fi*om intracellular stores and transmembrane Ca^ "^  influx (Tsien 
and Tsein, 1990; Benddge, 1993a). In individual cells, the hormone-stimulated 
elevation o f intracellular Ca^^ has a complex temporal and spatial regulation, as the 
rise in intracellular Ca^^ is often observed as a series of repetitive oscillations, or 
spikes (Berridge and Galione, 1988; Meyer and Stryer, 1991). The spatial counterpart 
o f a [Ca^^Ji spike is a wave, where an initial local [Ca^^]i elevation ultimately spreads 
throughout the cell in a regenerative manner (Roony et al, 1991; Lechleiter et al,
1991). The link between hormone-receptor activation and Ca^^ release is the 
intracellular messenger inositol 1, 4, 5-trisphosphate (IP3) which mobilises Ca^^ by 
binding to specific intracellular receptors. These receptors also form the channels 
through which stored Ca^^ is released (Taylor and Richardson ,1991; Ferris and 
Snyder, 1992). In non-excitable cells the Ca^^ spikes and waves, described above, are 
due to the cyclical and co-ordinated activation o f IP3 receptors (IP3R).
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[Ca^^ji is clearly very important for the control of many essential cellular responses 
and therefore the increase in [Ca^’^ Ji observed with many growth factors and mitogenic 
peptides may play a role in their mechanism of action.
In addition to the events in the membrane and cytosol, as described above, growth 
factors rapidly and transiently induce the expression o f the cellular oncogenes c-fos 
and c~myc in quiescent fibroblasts (Kelly et al, 1983). The enhanced expression of c~ 
fos messenger RNA (niRNA) occurs within minutes of, for example, PDGF addition 
followed by increased expression of c-myc. The induction o f c-fos mRNA is one o f 
the earliest nuclear events that follow the addition of PDGF. Since these cellular 
oncogenes encode nuclear proteins (Abrams et al, 1982) their transient expression 
may play a role in the transduction of the mitogenic signal in the nucleus.
One o f the best characterised pathways, the Ras—> Raf—> MEK~» ERK cascade 
(where ERK is extracellular-signal-regulated kinase and MEK is mitogen-activated 
protein (MAP) kinase (ERK) kinase) is stimulated by many mitogens and growth 
factors. MAP kinase is phosphorylated by a unique dual-specificity kinase on both 
tyrosine and threonine in one o f three motifs (Thr-Glu-Tyr, Thr-Phe-Tyr or Thr-Gly- 
Tyr), depending on the pathway. In addition to activating one or more protein 
cascades, the initiating sfimulus may also mobilise a variety o f other signalling 
molecules (e.g. PKC iso forms, phosphatidylinositol-3 kinase (PI3K), phospholipid 
kinases, G-protein a  and subunits, phospholipases, intracellular Ca^^). These 
various signals impact to a greater or lesser extent on multiple downstream effectors. 
Important concepts are that signal transmission often entails the targeted relocation o f 
specific proteins in the cell, and the reversible formation of protein complexes by 
means o f regulated protein phosphorylation. The signalling circuits may be completed
50
by the phosphorylation o f upstream effectors by downstream kinases, resulting in a 
modulation o f the signal.
1.7 Protein phosphorylation
Protein phosphorylation is a regulatory covalent modification o f a protein, in which 
the phosphate group is transferred from ATP to a side chain o f the protein, catalysed 
by a protein kinase. A particularly large amplification is possible if two or more 
protein kinases are arranged in series -  a system known as a protein kinase cascade. 
There are at least two purposes o f phosphorylation cycles in cells:
1. They are the major mechanism by which extracellular signal molecules acting at 
the cell surface receptors produce their ultimate intracellular effect.
2. They are the major mechanism through which events that occur discontinuously in 
the cell cycle are initiated and timed.
Regulatory protein phosphorylation normally occurs on serine or threonine residues 
(about two thirds) but it can also occur on tyrosine residues.
An important class o f protein kinases are activated by the binding o f second 
messengers. This class includes cAMP-dependent protein kinase (protein kinase A), 
cGMP-dependent protein kinase, and PKC. Another class o f protein kinases are those 
activated by extracellular signals (receptor protein kinases). In these cases the protein 
kinase catalytic domain is present as the cytoplasmic domain o f a transmembrane 
receptor in which the external domain binds an extracellular messenger. This binding 
activates the internal protein kinase, probably by causing aggregation o f receptors. 
The most well-studied examples are receptors for polypeptide hormones or growth 
factors in which the protein kinase is tyrosine specific, such as PDGF. However, a 
few recent examples have been found where the protein kinase domain is more
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closely related to serine/threonine kinases, for example the TGF-p receptor. As stated 
previously, some protein kinases are themselves regulated by phosphorylation of 
other protein kinases.
1.8 Extracellular receptors.
Cells are sensitive to a large number of chemical signals that control cell and tissue 
behaviour. The ‘target cells’ for each signal are the cells that bear receptors for that 
agent. Each extracellular stimulus acts at a unique receptor, but onward transmission 
of information into the cells is channelled through signalling pathways built into the 
plasma membrane. As a result, one signalling pathway may mediate the effects of 
many extracellular agents on many intracellular responses in many target cells. The 
way in which this information is processed fi'om the outside of the cell to the nucleus 
is summarised in Figure 1.2.
The genome o f every cell encodes many more receptors than the number o f different 
chemical signals that any individual cell ever has to recognise. A small subset o f these 
genes is expressed in a differentiated cell at a particular time. This allows each cell to 
respond only to the limited range o f stimuli for which it is a target, and each cell’s 
receptor repertoire is constantly undergoing environmental regulation rather than 
remaining static.
There are several ways in which a cell can process information from the extracellular 
to the intracellular and these will be discussed below.
1.9 G -  protein coupled receptors.
Some cell surface receptors signal through relay systems in which three components 
act in sequence:
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Receptor G protein -> effector protein 
G proteins are guanine-nucleotide dependent coupling proteins and are the largest 
most versatile class o f cell surface signal transducing proteins known. The effector 
protein is usually an enzyme or an ion channel (lismaa & Shine, 1992). The receptors 
that function in this way seem to be members o f a single structural family o f 
polypeptides termed 7-span receptors. These ‘7-span’ receptors are embedded within 
the plasma membrane and have cytoplasmic domains. G proteins are heterotrimeric 
and consist o f an a  subunit that binds GDP/GTP, and two intimately associated 
subunits p and y. The Py subunits are common between different G proteins, and it is 
mainly the a  subunits that confer specificity for downstream signalling although the 
Py subunits are the effectors in a few cases.
Receptor activation o f adenylate cyclase is mediated through the a  subunit o f one 
particular G protein, Gs- The GTPase activity o f as is such that several thousand 
molecules o f cAMP are produced through activation of a single receptor. Over 20 
different a  subunits o f G proteins have been identified by purification or by cDNA 
cloning.
G proteins are known to regulate hydrolysis o f plasma membrane phospholipids such 
as phosphatidylinositides (PI) and phosphatidylcholine (PC). Gq regulates PI 
hydrolysis through phospho lipase Cp (PLCp). Other G proteins are involved in the 
regulation o f ion channels such as those for K" and Ca^  ^.
Another large family o f 7-span receptors feeds its input to the cell through a signalling 
system based on the hydrolysis o f the membrane phospholipid phosphatidyl-inositol
4,5-bisphosphate (PIP2) by PLC (Berridge, 1993b). By recruiting different isozymes 
of PLC, it can be activated either tlirough receptor tyrosine kinases (RTK) (via PLCy) 
or by G protein coupled receptors (GPCRs).
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Figure 1.2
Extracellular stimuli:
Hormones, neurotransmitters, cytokines, etc.
Receptors
Signalling^echanisms
1
Intracellular second (and third) messengers
‘Primary’ protein kinases and phosphatases, and 
other directly responsive proteins.
i
‘Secondary’ protein kinases and phosphatases 
(on some regulatory pathways)
I
Regulated enzymes/genes.
Figure 1.2 Overview of extracellular signalling into the cell
A schematic summary of the manner in which cells use a limited number o f signal 
transduction pathways to transmit to the cell interior the diverse regulatory information that is 
brought by a very large number of stimuli which act at an even larger number of receptors. 
This summary also gives an approximate idea o f the magnitude o f the genetic resources that 
cells invest in machinery for the receipt and interpretation o f extracellular information.
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1.10 Agonist-stimulated phospholipid hydrolysis in fibroblast cells
The majority o f agonists which evoke proliferation of fibroblasts are believed to act 
via stimulation o f phospholipase C (PLC) (Lee and Rhee, 1995). Stimulation o f PLC 
results in the rapid breakdown o f the membrane phospholipid, phosphatidy 1 inosito 1
4.5-bisphosphate (PIP2), resulting in the generation of the second messenger inositol
1.4.5-tris phosphate (IP3) and diacylglycerol (DAG).
Following the hypothesis o f Berridge and Irvine (1984) that IP3 is the “missing link” 
between the plasma membrane receptors and internal Ca^^ stores, several papers 
demonstrated that IP3 acts by mobilising Ca^ "^  from intracellular pools (Berridge and 
Irvine, 1989; Carsten & Miller, 1990; Coburn & Baron, 1990; Somlyo & Somlyo,
1992). It has been shown that IP3 is rapidly generated in fibroblasts and smooth 
muscle cells after agonist stimulation (Berridge, 1987; Cook et al, 1990) and the 
finding that IP3 can lead to release o f intracellular calcium stores are compelling 
evidence that IP3 production is directly linked to the initiation o f fibroblast and 
smooth muscle cell proliferation.
As noted previously, hydrolysis o f PIP2 generates IP3 and another second messenger, 
DAG, which remains associated with the membrane. The principal function o f DAG 
is to activate a family of plasma-membrane protein kinases collectively termed 
protein kinase C (PKC). In the absence of hormone stimulation, PKC is present as a 
soluble cytosolic protein that is catalytically inactive. A rise in the cytosolic Ca^^ level 
causes PKC to bind to the cytoplasmic leaflet of the plasma membrane, where it can 
be activated by the membrane-associated DAG. Thus activation o f certain PKC 
iso forms depends on both Ca^ "^  ions and DAG, suggesting an interaction between the 
two branches o f the inositol-signalling pathway.
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The activation o f PKC in different cells results in a varied array of cellular responses, 
indicating that it plays a key role in many aspects o f cellular growth and metabolism. 
PKC represents a family o f related kinases, which are of central importance in 
intracellular signalling pathways. At least 11 distinct isozymes o f PKC have been 
identified, several of which exist in pulmonary artery fibroblasts (Pai et al, 1991).
1.11 Phospholipase D
Regulation o f phospholipase D (PLD) has received considerable attention as 
hydrolysis o f the membrane phospholipid, phosphatidylcholine (PC), by this enzyme 
produces phosphatidic acid, a potential second messenger in many cell types (Exton,
1994). The activity of PLD in a wide variety o f cells is influenced by many hormones, 
neurotransmitters, growth factors and other agonists linked to heterotrimeric G 
proteins or tyrosine kinases (Exton, 1994; Exton, 1997), The mechanisms by which G 
protein-coupled receptors and receptor tyrosine kinases (RTKs) are linked to PLD are 
not well understood but PKC activation appears to play a major role in many cell 
types. (Elder et al, 1993; Balboa et al, 1994). Since the majority o f agonists that 
promote PLD activation also stimulate PLC, a logical mechanism is that PLD 
activation is secondary to PKC stimulation due to production o f DAG from PIP2 
(Exton, 1997). At present, the mechanism(s) by which PKC activates PLD is 
undefined, indeed the role for PLD in early mitogenic signalling is controversial, with 
both supporting and conflicting evidence (Boarder, 1994).
1.12 Phospholipase Â2
The hydrolysis of PC by phospholipase A2 (PLA2) was one of the earliest 
phospholipase pathways to be described. The ‘classical’ role o f PLA2 activation is to
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generate arachidonic acid, which is the rate limiting precursor of prostaglandin and 
leukotriene biosynthesis (Lark et al, 1995). It is possible that in inflammatory states 
this is the major function of arachidonate, however in mitogenic signal transduction, 
other pathways may be important. These alternative pathways include the activation 
o f certain iso forms of PKC (Asaoka et al, 1992a) as well as PLD stimulation (Wang 
et al 1992). Although PLAz is activated by many agonists linked to heterotrimeric G 
proteins, there is no compelling evidence that G proteins interact directly with this 
enzyme (Clark et al, 1995). RTK growth factors such as PDGF and EGF can 
stimulate PLA] activity (Goldberg et al, 1990), indeed it has been demonstrated that 
PLA2 can be phosphorylated and activated by MAP kinase (Lin et al, 1993). Since 
growth factors stimulate MAP kinase, it is possible that both RTK-linked growth 
factors and G protein-coupled receptor agonists control the activity o f PLA2 through 
MAP kinase activation.
1.13 Other lipid/lipid-derived second messengers
The mechanisms discussed previously account for the major routes o f phospholipid 
signalling. However, other modes o f signalling for phospholipid second messengers 
are known to exist.
Arachidonic acid (apart from being a precursor for eicosanoids) and 
lysophosphatidyIcholine may function as lipid second messengers through the 
activation of effector enzymes such as PKC (Khan et al, 1993; Naor et al, 1988). 
Lysophosphatidylcholine has been shown to have several biological actions such as 
stimulation of chemotaxis and smooth muscle contraction (Asaoka et al, 1992b), 
whilst arachidonic acid stimulates expression o f early growth responsive genes such 
as c-fos and c-jun in VSMC (Rao et al, 1994; Rao et al, 1993).
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The structure, regulation and function o f PI3K has been extensively reviewed by 
Downes & Carter (1992) and Fry (1994). This kinase is a receptor-controlled enzyme 
capable of phosphorylating the 3-OH group o f the inositol ring of PIP2, leading to the 
formation of IP3. It is activated by many receptor tyrosine kinases in response to 
growth factors by recruiting p85/pllO heterodimer to the membrane where they 
associate via the SH2 domains in p85 with phosphorylated YXXM motifs within the 
cytoplasmic receptor domain o f the receptor itself (Carpenter et al, 1993). The ability 
o f GPCRs to regulate PI3K was first indicated by observations that stimulation of 
platelets with thrombin resulted in the rapid accumulation o f 3-phosphorylated 
phosphoinositide species (Traynor-Kaplan et al, 1988; Kazlauskas & Cooper, 1989; 
Escobedo et al, 1991). PI3K has been proposed to mediate a number o f intracellular 
events involved in mitogenesis such as activation o f PKC (Nakanishi et al, 1993; Liu, 
1996), stimulation o f a ribosomal kinase (Lane et al, 1993) and activation o f the MAP 
kinase pathway (Rodriguez-Viciana et al, 1994).
1.14 Protein kinase C
1.14.1 Protein kinase C structure
The effects o f phospholipid-derived DAG are mediated through the activation of 
PKC. However, PKC exists as a growing family of serine/threonine protein kinase 
iso forms that are differentially expressed in various cells and subcellular localities and 
can be subdivided into three groups based on their structural and bio-^hemical 
properties. Members of the PKC family so far examined are dependent on 
phosphatidyIserine, but show clearly different requirements o f Ca^^ and phospholipid 
metabolites for their activation. The classical or conventional PKC isoforms (cPKC)
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include, [31, [311 and y are regulated by Ca^^ and DAG. The novel or non-classical 
isoforms (nPKC) ô, 8 , q and 0 are insensitive to Ca^^ as they lack the Ca^^ -binding 
C2 domain although they respond to DAG. The atypical PKC subgroup (aPKC) X and 
Ç  isoforms are insensitive to Ca^^ and DAG or phorbol ester (Reviewed by Musashi 
et al, 2 0 0 0 ).
The specific regulatory requirements o f the different members of the PKC family 
produce distinct PKC activation patterns with respect to the subspecies o f PKC that 
becomes activated, the extent and duration o f the response and perhaps their 
intracellular localisation. In particular, a number of reports have demonstrated 
differential functions o f DAG derived from PIP2 and PC in the activation of PKC. In 
IIC9 fibroblasts, translocation o f the Ca^^ -dependent PKCa isoform from the cytosol 
to the plasma membrane by thrombin, regarded as a parameter o f enzyme activation, 
parallels the initial peak in DAG formed from phosphoinositide, but not from PC 
hydrolysis (Leach et al, 1991; Ha and Exton, 1993). Conversely, translocation o f  the 
Ca^”^ -independent isoform PKCe, also occured rapidly but was maintained during the 
persistant phase o f DAG production derived from PC (Ha and Exton, 1993). The 
presence of Ca^^ accompanying the initial DAG peak, rather than different molecular 
species o f DAG derived from PIP2 and PC, vaiying in their fatty acid composition, 
accounted for the differential activation o f the PKC iso forms (Ha and Exton, 1993).
1.14.2 Role o f PKC in mitogenic signal transduction.
PKC has been implicated as a major component of cellular signalling networks 
regulating a variety o f cell functions including cell growth and differentiation 
(reviewed by Nishizuka, 1992; Dempsey et al, 1997). The role of PKC in mitogenesis 
has received much attention ever since the discovery that the enzyme was the major
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receptor for tumour promoters o f the phorbol ester family, cell permeable analogues 
of DAG. Exogenous application o f phorbol esters has been reported to mimic the 
effect of growth factors, and down regulation o f PKC by prolonged PMA pre­
treatment has been shown to inhibit the mitogenic effects of a number o f agonists in 
different cell types. While the tissue-specific distribution and distinct modes of 
activation suggests functional diversity o f  the PKC family members, information on 
their specific biological roles including the control o f proliferation, however, is still 
limited as few o f the physiological substrates o f PKC have been identified, and of 
those that have, no clear difference in substrate specificity among the members has 
been demonstrated. Furthermore, phorbol esters are not selective in the PKC species 
that they activate or downregulate, potentially exerting pleiotropic effects. The lack of 
specific inhibitors has prevented the dissection o f  responses attributable to particular 
iso forms. Despite this, studies in which distinct PKC isoenzymes have been 
overexpressed have revealed that PKC (31 and s exhibit transforming characteristics 
(Housey et al, 1988). Other studies using similar approaches complimented by data 
with a selective pseudo substrate peptide inhibitor indicated that the atypical PKC 
iso form Ç is involved in mitogenic signalling (Berra et al, 1993). The precise role of 
PKC in regulating cellular proliferation has not been clarified. However, PKC can 
either directly or indirectly control the expression of certain genes by inducing 
transcriptional activation through TRE, serum-response element (SRE) (Hata et al,
1993) and NFkB (Hirano et al, 1995) -responsive promoters in an isoenzyme specific 
manner. These effects may be mediated by the integration o f PKC in growth factor- 
initiated phosphorylation cascades, by phosphorylating and activating kinases that are 
intrinsic components o f such pathways, including c-Raf-1 o f the MAP kinase cascade
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(Chapter 1.16.3; Sozeri et al, 1992; Kolch et al, 1993) and elements upstream of the 
p7 0 s6k (Susa et al, 1992).
1,15 Receptors with intrinsic tyrosine kinase activity
The role o f tyrosine kinase-linked signal transduction pathways has been examined 
largely in the context o f long-term responses such as cell proliferation. RTKs form a 
large and important class o f cell surface receptors. Several sub-classes o f RTK exist, 
but all share a similar molecular structure consisting o f a large extracellular ligand- 
binding region, a single hydrophobic transmembrane segment, a cytoplasmic portion 
containing the tyrosine kinase catalytic domain and lastly, a carboxy-terminal 
regulatory region (see Cardenn & Gill, 1992; Panettieri, 1996). Activation of the RTK 
is necessary for transduction o f the growth factor-mediated response. Once a receptor 
is phosphorylated, its kinase site opens to provide access for the phosphorylation by 
other proteins (Cardenn & Gill, 1992). The tyrosine phosphorylated receptors and 
other tyrosine-phosphorylated proteins then associate with a number o f target proteins 
that transfer to the cell interior the signals received by the receptors. These proteins 
that associate with some or all activated RTKs include:
1 RasGAP, a GTPase-activating protein which modulates the activity o f the Ras 
proteins (a trio o f small GTP-dependent switch proteins encoded by c-ras proto­
oncogenes).
2 R a f  1, a serine-threonine protein kinase encoded by the c-rq/ proto-oncogene.
3 The cytoplasmic protein tyrosine kinase Src which is encoded by the c-src proto­
oncogene.
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4 The phospholipase Cy (PLCy) and PI3K, which hydrolyse and phosphorylate 
inositol-containing phospholipids.
5 She protein, the product o f the she gene (Pazin & Williams, 1992).
O f these, RasGAP, c-src, PLCy, the Mr regulatory subunit o f PI3K, and She all 
contain one or more copies o f a shared polypeptide sequence motif, known as the Src 
homology domain type 2 (SH2 domain).
Substrates with SH2 domains are responsible for coupling activated growth factor 
receptors to intracellular pathways involved in the control o f  a variety of cellular 
functions such as proliferation and gene expression. Proteins with one or more SH2 
domains include PLC, PI3K (PI 3-kinase), Ras and other cytoplasmic kinases 
(Carpenter, 1992). Many o f  the proteins that have SH2 domains also contain a distinct 
sequence o f approximately 50 amino acid residues termed the SH3 domain. SH3 
domains modulate protein-protein interactions through the recognition o f short 
peptide sequences that do not require phosphorylation. Signalling complexes based on 
the formation of SH2/SH3 interactions are then followed by activation o f downstream 
effector proteins which involve, for example, non-receptor tyrosine kinases and MAP 
kinases (Satoh & Kaziro, 1992; L’Alleman et cil, 1991; Meloche et al, i992) (Figure 
1.3).
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Figure 1.3 
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I
Receptor tyrosine kinases 
(or receptor-activated tyrosine kinases of the src family)
i
She
(an SH2 protein)
I
GRB2 
(an (SH2)2/SH3 protein)
i
CDC25'**"'
(a guanine nucleotide exchange catalyst for Ras)
I
Ras
(a Guanine nucleotide-regulated switch protein)
1
Raf-1 (= MAP kinase kinase kinase) 
(a Ser-Thr protein kinase)
MAP kinase kinase
I
MAP kinase/ERKs 
(Ser-Thr- and Tyr protein kinases)
i
Elkl (= M A T al = TCF)
Serum response factor (SRF)
Serum response elements (SRE) 
(E lkl, SRF and SRE form a regulated 
and gene-regulatory ternary complex)
i
Gene expression 
(e.g. of myc)
Figure 1.3 Tyrosine kinase cell signalling overview
63
1.16 The Mitogen Activated Protein Kinase Pathway
Activation o f the MAP kinase pathway, also known as extraeellular regulated kinase 
(ERK), is believed to play an important role in cell growth and proliferation (Milanini 
et al, 1998). MAP kinase is initially located within the cytoplasm (Northwood et al,
1991), however following activation, MAP kinase translocates to the nucleus (Chen et 
al, 1992; Sanghera et al, 1992) and initiates the activation o f transcription factors such 
as Elk-1. Thus, MAP kinase provides a physical link in the signal transduction 
pathway from the cytoplasm to the nucleus.
Two forms of MAP kinase has been purified from fibroblasts with molecular weights 
of 42 and 44 kDa and referred to as ERKl and ERK2, respectively. Expression o f 
both the 42 and 44-kDa iso forms appears to be essential for agonist-induced 
mitogenesis in various cell types (Pages et al, 1993; Cowley et al, 1994; Mansour et 
al, 1994). The activation of MAP kinase requires phosphorylation o f both tyrosine 
and tlueonine residues (Anderson et al, 1990) by dual speeifieity tyrosine/threonine 
kinase MAP kinase kinases, MEKl and MEK2 (MaeDonald et al, 1993; Yan & 
Tempelton, 1994). Raf-1 is currently the only activator of MEK, although there is 
evidence for the existence o f other MEK kinases (Lange-Carter, 1993). Raf is in turn 
activated by the membrane-bound small guanine-nucleotide binding protein Ras 
(McCormick, 1993) which is linked to RTKs by intermediate guanine nucleotide 
exchange factors (GEFs) such as SOS and Grb (Bonfini et al, 1992; Bowtell et al, 
1992; Egan et al, 1993) (Figure 1.4). The SH3 domain o f Grb binds to SOS, which is 
a GEF for Ras and facilitates the replacement o f GDP to GTP (Rebello and Martinez, 
1999). When Ras becomes GTP-loaded, Raf binds to Ras and becomes activated.
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Figure 1.4
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Figure 1.4 Overview of p42/p44 MAP kinase cell signalling
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The MAP kinase pathway has been associated with growth factor receptors which 
display intrinsic tyrosine kinase activity (FantI et al, 1993; Egan et al, 1993) however, 
it is now clear that signals from GPCRs can also impact on the Ras/MAP kinase 
signal transduction cascade (DeVivo & Iyengar, 1994).
The intracellular pathways that link GPCRs to MAP kinase activation are poorly 
understood, but for many agonists, stimulation o f PKC appears to be a critical step 
(Granot et al, 1993; Bogoyevitch et al, 1994). Evidence suggests that the (3y subunit 
from individual G proteins may be able to stimulate Ras (Faure et al, 1994; Crespo et 
al, 1994), thus leading to MAP kinase activation.
In pulmonary artery fibroblasts, MAP kinase is activated by a number o f mitogenic 
factors including PDGF, ET-1, thrombin and 5-HT (Trejo et al, 1996; Lee et al, 1999; 
Kivinen and Laiho, 1999). Sustained activation o f MAP kinase is associated with 
mitogenesis, whereas agonists, which stimulate only a transient activity o f MAP 
kinase, fail to induce a proliferative response (Malarkey et al, 1995a; Kelleher et al,
1995). The identification of additional MAP kinase members (including JNK and p38 
MAP kinase homologues as described in Chapter 1.17) implies this family o f kinases 
is extensive and some cross-talk between the family does exist (Figure 1.5).
1.16.1 Regulation o f p42/44 MAP kinase by MFK
MAP kinase becomes activated by a single protein kinase which is unusual in 
exhibiting dual specificity and capable of phosphorylating both the regulatory 
threonine (Thrl83) and tyrosine (Tyrl 85) residues and is termed M.AP kinase kinase 
or MEK. In addition to M EKl, a second cDNA encoding closely related MAP kinase 
activator has been identified in humans and designated MAK2 (Zheng & Guan,
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1993). Overexpression o f MEK in cultured cells increases MAP kinase activity (Seger 
el al, 1992)
1.16.2 Regulation o f MEK by Raf-1
A 74 kDa serine/threonine protein kinase known to be involved in mitogenic 
signalling is c-Raf-1 (Morrison et al, 1988), A vast amount of evidence has shown 
that c-Raf-1 is at least one o f the intermediates directly upstream o f MEK in a linear 
cascade leading to activation o f MAP kinase (Dent et al, 1992; Howe et al, 1992; 
Kyriakis et al, 1993). Cells transformed with c-Raf, or overexpression o f oncogenic 
mutants o f c-Raf-1, display elevated MEK and MAP kinase activities (Dent et al,
1992). Furthermore, c-Raf-1 immunoprecipitated from mitogen-stimulated cells can 
directly phosphorylate the active MEK in vitro (Dent et al, 1992; Howe et al, 1992; 
Kyriakis et al, 1993). Other studies have demonstrated that Raf-1 forms a stable 
complex with MEKl in vivo and in vitro (Huang et al, 1993) and phosphorylates 
MEKl exclusively on serine residues (Yan and Tempelton, 1994, Zheng and Guan,
1994).
1.16.3 Regulation o f  MEK independent o f Raf-1
It has been demonstrated that other serine/threonine kinases can serve as direct 
regulators o f MEK, which include other members o f the R af family o f proto­
oncogene products. B-Raf has been identified as an activator o f MEK in NIH3T3 
fibroblasts (Catling et al, 1994) and A-Raf in Hela cells has been shown to activate 
MEKl but not MEK2 (Wu et al, 1996).
Other kinases that activate MEK include MEKl kinase (MEKKl). Initially it was 
thought that MEKK may be responsible for MEK activation by heterotrimeric GPCR
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agonists, however, recent evidence suggests that this kinase is more likely to act 
upstream of another MEK family member responsible for activating the MAP kinase 
homologue c-jun N-terminal kinase in the parallel stress-activated protein kinase 
pathway (Chapter 1.17) (Minden et al, 1994 and Yan et al, 1994).
1.16.4 Raf-1 activation by Ras
The proto-oncogene gene product Ras plays a central role in signal transduction 
pathways involved in cellular processes including cellular proliferation (Mulcahy et 
al, 1986). Ras becomes active then GTP binding takes the place o f the inactive state 
when GDP is bound. This can be stimulated by the addition o f growth factors. The 
mechanism by which Ras aids in the activation o f Raf-1 is by causing c-Raf-1 
translocation to the plasma membrane where additional protein-protein or protein- 
lipid interactions regulate Raf-1 activity (Chapter 1.16 and Reuter et al, 2000).
1.16.5 Ras-independent activation of MAP kinase
It has been well documented in the literature that phorbol esters stimulate MAP kinase 
activation. Furthermore, depletion of PKC by prolonged pre-treatment with phorbol 
esters has been shown to block the activation o f MAP kinases following stimulation 
with agonists (de Vries-Smits et al, 1992). This indicates the existence of at least two 
distinct pathways regulating MAP kinase that can operate in one cell type and also 
implicates PKC in this role. PKC is thought to activate the MAP kinase pathway at 
the level o f Raf-1 since chronic phorbol ester pre-treatment prevents agonist- 
stimulated c-R af 1 activation (Kolch et al, 1993).
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1,16.6 Cellular targets of p42 and p44 MAP kinase
Downstream o f MAP kinase, several proteins have been identified as substrates. 
These include lipases, transcription factors and other protein kinases (reviewed by 
Reuter et al, 2000). MAP kinase can activate the dephosphorylated 90 kDa ribosomal 
protein S6  kinase II (p90'^ '^^ ) (Sturgill et al, 1988). It can also directly regulate gene 
expression by phosphorylating the ternary complex transcription factor EIk-l/p62^‘'^ 
(Gille et al, 1992) which in turn facilitates the transcription o f c-fos', one of the 
immediate early genes induced by many stimuli. MAP kinase also phosphorylates and 
activates the cytosolic PLA2 (PLA2) in vitro and in intact cells (Lin et al, 1993). A 
role for PLA2 as a substrate of MAP kinase in vivo is supported by the finding that 
expression o f a recombinant CPLA2 in which the MAP kinase phosphorylation site 
Ser505 is mutated, does not become activated on agonist-stimulation (Lin et al, 1993).
1.17 Stress-Activated Protein Kinases
The last few years have marked the arrival o f novel members o f what now appears to 
be a MAP kinase superfamily. Two protein kinases that are highly related to the 
classical p42/p44 MAP kinases have been identified, and characterised as integral 
components o f parallel protein kinase cascades activated by pro inflammatory 
cytokines and cellular stresses. It has now become apparent that these MAP kinase 
homologues may play a role in the cellular effects of an increasingly large number o f 
extracellular stimuli including GPCR agonists (Coso et al, 1995)
As their name suggests, stress-activated protein kinases (SAPK) are activated by 
agents which induce cellular stress, such as hypoxia, UV light and the cytokines, 
tumour necrosis factor a  and interleukin-1 (Scott et al, 1997; Kolesnick & Goldie,
1994). An investigation of kinases responsible for phosphorylating the transcription
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factor c-Jun on Ser^^ and Ser^  ^ within its amino terminal activation domain in cells 
exposed to UV irradiation identified that this activity was attributable to two protein 
kinases o f 46 and 55 kDa named c-Jun N-terminal kinases 1 and 2 (JNKl and JNK2), 
respectively (Hibi et al, 1993). Subsequent cloning o f JNKl revealed that this protein 
kinase shared sequence homology to the p42/p44 MAP kinases (Figure 1.6; Derijard 
et al, 1994).
In addition to JNKs, a stress-activated MAP kinase homologue has also been 
identified, termed p38, that led to the activation o f M /PK A P kinase-2, a serine kinase 
responsible for phosphorylating one o f a family o f small heat shock proteins (Hsp 25) 
in response to chemical stress or heat shock (Figure 1.7; Rouse et al, 1994). These are 
thought to exist in signal transduction cascades distinct from MAP kinase. There is 
evidence, however, for the existence o f cross-talk between the two pathways since 
RTK-linked growth factors (Minden et al, 1994) and GPCR agonists (Dalton & 
Treisman, 1992) can also activate the SAPK. In recent studies SAPKs were shown to 
be upregulated in cells from the pulmonary vasculature exposed to hypoxia (Welsh et 
al 1998; Stenmark et al 1999).
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Figure 1.7 Overview o f p38 MAP kinase cell signalling
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1.17.1 MKK homologues involved in JNK and p38 activation.
The pathways leading to the activation o f the SAPKs are not as well understood as 
those of the classical p42/p44 MAP kinases. However, like the p42/p44 pathway, the 
SAPK pathways consists o f several protein kinases acting in sequence; a MAP kinase 
homologue (or SAPK/JNK/p38), MAP kinase kinase homologue (or 
MKK/MEK/SEK/JNKK) and a MAP kinase kinase kinase (or MEKK). Again, like 
MAP kinase, the activation o f the SAPKs relies on their phosphorylation at specific 
dual phosphorylation motifs, although in this case the sequences are defined by TPY 
for JNK (Derijard et al, 1994) and TGY for p38 MAP kinase (Rouse et al, 1994). 
These residues are specifically phosphoryiated by MKK/MEK homologues (also 
termed SAPK kinases (SAPKK)) distinct from MKK/MEKs 1 and 2 that are 
responsible for the activation o f the classical p42/p44 MAP kinase iso forms. Another 
MAP kinase kinase identified in humans and designated MKK3, has been shown to 
selectively activate p38 MAP kinase (Derijard et al, 1995).
1.17.2 Activation o f MKK homologues by MEKKs
Activation o f the relevant MKK/MEK/SAPKK activity requires its phosphorylation 
by an upstream kinase analogous to the Raf kinase isoforms that function upstream in 
the classical p42/p44 M.AP kinase pathway. The novel serine/threonine kinase 
M EKKl, which was originally identified as a kinase able to phosphorylate MEK-1 in 
vitro (Lange-Carter et al, 1993), has been subsequently shown to be a more efficient 
activator o f .MEKK/>4EK4/SEK-1/JNKK in in vitro and co-infection studies (Yan et 
al, 1994). In this role, MEKKl, but not Raf-1 was also found to participate in both 
growth factor and TNF-stimulated activation o f JNK.
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The identity of the equivalent MEKK-like protein upstream of MKK3/6 in the p38 
pathway is less well understood. However, TAK-1 which has been isolated from 
TGF-p-activated kinase and which has been related to MEKK (Yamaguchi et al,
1995) has been shown to directly activate both MKK6  and MKK3 in vitro. Thus, 
activation o f p38 MAP kinase may occur via a kinase pathway involving TAK-Î, 
MEKK 3/6 and p38 MAP kinase.
1.17.3 Possible role o f p38 and JNK activation in cell growth
There have been a number o f papers which link p38 MAP kinase and JNK :o 
apoptosis and cell cycle arrest (Verheij et al, 1996; Xia et al, 1995). However 
evidence suggests that SAPKs may have a positive role to play in cell growth (Auer et 
al, 1998). Clerk and colleagues (1998) found that ET-1 and phenyieplii'ine, both 
mitogens, stimulated p38 MAP kinase phosphorylation 12-fold. It has also been 
shown that tlu'ombin stimulation o f JNK in airway smooth muscle cells correlates 
with DNA synthesis (Shapiro et al, 1996). It is also true that these SAPK have the 
ability to activate transcription factors, which regulate genes that are induced on 
mitogenic stimulation.
1.18 Hypothesis
Characterisation o f the cellular signalling events that occur during cell proliferation 
by hypoxia is an important issue from both biological and clinical perspectives. From 
a biological view, this will further our understanding o f the processes by which 
hypoxia mediates cellular effects during proliferation. From a clinical view, this will 
provide a model for the pathways that operate in response to acute and chronic 
hypoxia, such as during the pathogenesis o f pulmonary hypertension characterised by
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blood vessel cell wall remodelling. In addition, intracellular targets may be identified 
for the development o f novel pharmaceuticals to alleviate such disease.
The review of the literature indicates that while hypoxia causes proliferation of a 
number o f cell types, the mechanisms by which this is achieved is unknown. It is 
possible that clues to finding more about these mechanisms may lie in the differences 
seen between pulmonary arteries, which constrict to hypoxia, and systemic arteries 
which dilate in response to hypoxia in vivo. It is not known whether isolated 
pulmonary artery fibroblast cells would proliferate in vitro to cellular stresses such as 
hypoxia and if so whether these cells may differ with regards to the potency of 
agonists, activity o f intracellular pathways as well as growth characteristics to 
hypoxia. It is also unknown whether hypoxia would have a differential effect on 
fibroblast cells isolated from the systemic circulations. Furthermore, there is very 
little information on the involvement o f the MAP kinase signalling pathway or the 
SAPKs in hypoxia-stimulated mitogenesis o f pulmonary and systemic artery 
fibroblasts.
Cunently defined signalling phenomena associated with stimulation o f  cell growth 
have been exposed by studies, which have routinely used immortalised cell lines and 
therefore their growth regulatory mechanisms have been fundamentally altered. This 
may be problematic particularly when examining pathways involved in proliferation. 
Caution must therefore be taken in predicting how cells will behave physiologically 
by extrapolating from signalling events characterised in these cells. The investigations 
in this thesis have been carried out in fibroblasts obtained from primary cultures. We 
believe that these represent a better model of mammalian cells under physiological or 
pathophysiological conditions.
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We have hypothesised that hypoxia may cause increased proliferation o f pulmonary
artery fibroblast cells by an intracellular mechanism(s) present in the pulmonary
vasculature which is not present in systemic fibroblasts.
1.19 Aims
The aims of this thesis were as follows:
1 To establish a cell model for studying proliferation o f fibroblasts from the 
pulmonary and systemic arteries in response to acute hypoxia.
2 To study acute hypoxia in mitogenic proliferation of bovine pulmonary artery 
and bovine mesenteric artery fibroblasts.
3 To look at early signalling events involved in acute hypoxic proliferation o f 
pulmonary and mesenteric artery fibroblasts.
4 To study the effects o f acute hypoxia on classical and stress-activated protein 
kinases in bovine pulmonary artery fibroblasts.
We also aimed to compare the effects o f acute hypoxia on fibroblasts with fibroblasts
obtained from rats exposed to chronic hypoxia by:
5 Studying the proliferation and generation o f MAP kinases in pulmonary and 
aortic fibroblasts harvested from chronically hypoxic rats.
6  Examining the effects o f 5-HT on proliferation and generation o f MAP 
kinases in pulmonary aitery fibroblasts harvested from chronically hypoxic 
rats.
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Chapter 2
Materials & Methods
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2. MATERIALS & METHODS
2.1 Materials
Ail general chemicals were o f Analar grade and were supplied by Merck 
(Thornliebank, Glasgow) or Sigma (Poole, Dorset) unless otherwise stated. All tissue 
culture plastics were from Greiner Labortechnick Ltd (Gloucestershire.UK). All 
components o f tissue culture medium were purchased from Gibco Life Technologies 
(Paisley, Scotland). [y-^^P]ATP and [^H]thymidine were from Amersham (Little 
Chalfont, Bucks). Antibodies used for Western Blot analysis were from New England 
Biolabs (Hertfordshire, UK). Gel electrophoresis equipment was purchased from Bio- 
Rad Laboratories (Herts, UK). Incubators were supplied by LEEC (Nottingham, UK).
1 would like to thank Dr R. Plevin (University o f Strathclyde) for the gift o f GST-c- 
jun and GST-MAPKAP kinase 2 used as substrates for measuring activity o f JNK and 
p38 MAP kinase.
2.2 Animal Models
2.2.1 Bovine
Cells derived from bovine pulmcmary and mesenteric arteries were used. Tissue was 
obtained fresh on the day o f experimentation from a local abattoir (Sandyford, 
Paisley). Lungs were removed from fieshly slaughtered cattle and transported to the 
laboratory in a container filled with chilled Krebs-Henseleit Solution (NaCi 118mM, 
NaHCOs 25mM, KCl 4.7mM, KH2PO4 1.2mM, MgS0 4  1.2mM, C aC f 2.5mM, and 
Glucose 1 ImM).
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2.2.2 Rat
Cells derived from the pulmonary artery and aorta of adult Wistar rats from the “In 
House” breeding stock o f the University o f Glasgow’s Central Animal Facility were 
also used. Thirty to thirty-three day old rats were maintained in either normoxic 
conditions or hypoxic conditions in a hypobaric chamber (P02= 70mmHg) for 2 
weeks (Chapter 2.5). Animals were maintained on a 12 hour (h) light/dark cycle and 
allowed free access to standard diet and water.
2.3 Primary Cell Culture
Fibroblasts used throughout these studies were obtained from primary culture by 
explant using tissues derived either from bovine or rat.
Since the conditions (warm, humid and nutrient rich) necessary for culturing the cells 
are an ideal environment for promoting fungal and bacterial growth, extreme caution 
must be taken to avoid contamination. All steps such as making up solutions, 
changing media, etc were conducted under sterile conditions, that is, within a clean. 
Micro flow laminar flow hood (model number M25121/1) (Figure 2.1). The flow hood 
was dismantled and cleaned regularly and before use each day was sprayed liberally 
with 70% (v/v) ethanol. Anything taken inside the flow hood ^.e. pipettes and reagent 
bottles) was also sprayed with ethanol and sterile gloves were worn throughout. 
Pipette tips and distilled water were sterilised using a prestige Medical “Omega” 
autoclave (model number 220140).
2,3.1 Routine Cell Maintenance
Cells were grown routinely in 75cm^ culture flasks in Dulbeccos modification of 
Eagles medium (DMEM), supplemented with penicillin (200 units/ml) and 
streptomycin (200 ug/ml), L-glutamine (27 mg/ml) and 10% foetal calf serum (FCS).
The cultures were kept in a humidified atmosphere of 5% CO2 in air at 37”C. Cell 
lines were checked for mycoplasma contamination on a monthly basis using a 
commercially available mycoplasma detection kit (Gen-Probe, San Diego, USA). 
Culture medium was changed every 2 days and cells were passaged just prior to 
confluency.
Cell passage was performed by removing the culture medium and washing the cells 
with 5ml of filter-steriled (2pm membrane) pre-warmed phosphate buffered saline 
(PBS; NaCl 137mM, KCl 2.7mM, KH2PO4 1.5mM, Na2H2P0 4  8Jm M , CaCl 0.9mM, 
MgCl 0.5mM, pH 7.4). Trypsin solution (0.05% trypsin / EDTA 0,02%) was added to 
the layer o f cells (2ml) and then aspir ated. A further 2ml o f trypsin solution was then 
added and left on the surface o f the cells for approximately 10s before aspiration. The 
cells were then incubated at 37^3 until they had began to detach from the surface o f 
the flask. This was observed under a light microscope (Olympus CK2). Gentle 
tapping o f the dish was used to dislodge the cells and 10ml o f DMEM containing 10% 
FCS was added to the flask to re-suspend the cells. A portion o f this cell suspension 
(3 ml) was then aliquoted into new flasks containing another 7mls o f fresh medium. At 
this stage cells could be plated out onto dishes as required for experimentation. Cells 
were used for experimentation between passage 3-10.
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Figure 2.1
Figure 2.1 Microflow Biological Laminar Safety Cabinet.
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2.3.2 Primary fibroblast culture
Lobar pulmonary artery was dissected free from the lung o f either a freshly dissected 
cow or rat (Figure 2.2). A section o f artery (diameter o f 5mm and 15cm in length) 
located towards the apex (Figure 2.3) of the lobe was cut longitudinally and opened 
into a flat sheet (Figure 2.4 and 2.5). Pulmonary artery fibroblasts were prepared 
using the technique o f Freshney (1983), with some modifications. Muscular tissue and 
endothelial cell layers were removed by gentle abrasion o f the vessel using a sterile 
razor blade (Figure 2.6). The remaining tissue (adventitia) was then dissected into 
5mm^ portions (Figure 2.7). Approximately 25 portions o f tissue were evenly
distributed over the base o f a 25cm^ culture flask containing 2ml of DMEM with 20% 
FCS, supplemented with penicillin/streptomycin (400iu/ml and 400pg/ml) and 
amphotericin B (5pg/ml) (Figure 2.8). The explants were incubated in a humidified 
atmosphere o f 5% CO^ in air at 37^C. Within a few days cells were observed growing 
out from the tissue fragments (Figure 2.9). Once a monolayer o f cells had partially 
covered the flask, cells were lifted from the flask by trypsinisation as described in 
Chapter 2.3.1. Tissue fragments were removed by aspiration.
In the bovine and rat model the main branch o f the pulmonary artery was used to 
acquire pulmonary aitery fibroblasts. To study fibroblasts from the systemic 
circulation, the mesenteric artery was dissected from the cow and the aorta dissected 
from the rat. The method used to culture primary cells was the same as described 
above.
Figure 2.2
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Pulmonary Artery
Figure 2.2 Location of Pulmonary Artery from Freshly Excised Bovine Lung
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Figure 2.3
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Figure 2.3 Pulmonary Artery from Freshly Excised Lung
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Figure 2.4
PnlaioBary 
aitery
Figure 2.4 Pulmonary Artery Prior to Cleaning
Figure 2.5
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Figure 2.5 Pulmonary Artery after cleaning
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Figure 2.6
Endothelium scraping
Figure 2.6 Removal o f Endothelial layer
Figure 2.7
Figure 2.7 Pulmonary artery explants

88
Figure 2.8
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Figure 2.8 Explants in 25cm Culture Flasks
Figure 2.9
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Figure 2.9 Pulmonary artery fibroblasts growing from explants
89
2.3.3 Immunohistochemicai Characterisation of Primary Fibroblast Cultures 
All primary cell cultures were established as having a fibroblast-like origin by 
determining whether they expressed smooth muscle a-actin. Primary fibroblast 
cultures were allowed to grow to confluence on sterile acid-etched coverslips grown 
in 35mm^ culture flasks. These were then fixed using 70% methanol / 10ml 30% 
hydrogen peroxide (Sigma, UK) for 30 mins at room temperature. The coverslips 
were then washed in sterile PBS. 50pl PBS containing 3% (w/v) bovine serum 
albumin (BSA, Sigma, UK) was placed onto each coverslip, for 30 minutes, in a 
humidified incubator at 37“C. Without rinsing, 10% goat serum (Sigma, UK) in PBS 
was added and the coverslips were then incubated for a further 30 mins. The 
coverslips were then rinsed once in PBS and the primary monoclonal antibody against 
smooth muscle a-actin (Tsukada et al, 1987) (Sigma, UK) was added to each 
coverslip (diluted in PBS at 1:1000). The coverslips were then left for Ih at 37°C 
without agitation.
Each coverslip was then rinsed 3x in PBS and a biotinylated anti-mouse IgG (1:500 in 
PBS) was added. The coverslips were then incubated for a further hour at 37“C, after 
which they were rinsed 3x in PBS. Strepavidin-peroxidase (Sigma, UK) diluted 
1:1000 in PBS was then added to each coverslip. The coverslips were then incubated 
for an hour at 37°C, and then rinsed 3x in Tris Buffer (0.05M, pH 7.4). Coverslips 
were then placed in Tris Buffer containing diaminobenzidine tetrahydrochloride 
(0.5mg/ml) (Sigma, UK) and 10.5 % (v/v) hydrogen peroxide (30% solution). They 
were incubated for 10 minutes and then washed 3x in PBS. Coverslips were then 
mounted onto microscope slides using DPEX mountant (Sigma, UK) and observed 
under a light microscope (Olympus) (Figure 2.10). A distinct brown coloration 
determined the localisation o f smooth muscle a-actin. Primary fibroblasts derived
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from bovine or rat pulmonary and systemic arteries were compared to smooth muscle 
cells cultured from bovine trachea and Rat 2 fibroblast cell lines that acted as positive 
and negative controls, respectively.
2.3.4 Cell Freezing/Thawing
A cell suspension was collected from a 75cm^ flask by trypsinisation (Chapter 2.3.1) 
in 10ml o f culture medium. Cells were centrifuged at lOOOg for 10 minutes. The cell 
pellet was then resuspended in 1ml Cryopreservation Medium growth medium 
(DMEM containing 10% FCS and 10% DMSO). The resuspended cells in the 
freezing medium were placed in a 2ml cryotube and left in a fridge for 20 minutes 
followed by a -80°C freezer overnight. The tube was then transferred to the vapour 
phase o f the liquid nitrogen for Ih, then placed directly into the liquid nitrogen.
Frozen cells were removed from liquid nitrogen and thawed rapidly in a water bath at 
37°C. The cryotubes were then swabbed with tissue paper soaked in 70% ethanol and 
the caps loosened. Holding the vial in one hand, the cap was removed and the 
contents taken up into a pipette, then placed in a 10ml centrifuge tube. The cell 
suspension was diluted slowly with 5mis o f fresh growth medium and the tubes 
centrifuged at lOOOg for lOmins. The cells were resuspended in lOmls fresh growth 
medium and seeded onto a 25cm^ flask. After approximately 4h the cells attached to 
the flask. The medium was replaced with fresh medium.
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Figure 2.10
»
Figure 2.10 Olympus CK2 Light Microscope
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2,4 Hypoxia: Methods for studying acute hypoxic fibroblast cells in vitro
2.4.1 Generation o f Hypoxic Environment
A humidified temperature controlled incubator (Model GA156; LEEC, Colwick, 
Nottingham, UK) (Figure 2.11) was used to produce a hypoxic environment. This 
incubator allows control of internal oxygen levels between 0 and 21% using medical 
grade nitrogen, while the CO2 level is simultaneously controlled at 5%. Due to the 
large volume o f  nitrogen required to sustain a suitable degree o f hypoxia, nitrogen 
cylinders were linked using a Pneuchange automatic gas cylinder change over unit 
(NTC, Woulton, Liverpool, UK) which activated a fresh supply o f nitrogen as 
required.
2.4.2 Measurement o f Hypoxia
The levels o f  hypoxia achieved within the environment o f the incubator could be 
monitored with the oxygen probe that was an integral part o f the unit. Measurements 
from within the bathing medium o f  the cells were also analysed with a portable 
oxygen probe (Jenway: 9015. Dunmon, Essex, UK) to determine the rate o f gaseous 
diffusion, and the pH o f the medium analysed throughout the course o f hypoxic 
exposure with the use o f a portable pH probe (Mettler Delta 340, Hanstead, UK). 
Cells were routinely maintained for acute hypoxia in an atmosphere o f 2% O2 and 5% 
CO2 at 3 7T .
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Figure 2.11
Figure 2.11 Hypoxic Chamber: LEEC O 2/C O 2 humidified temperature 
controlled incubator
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2.5 Hypoxia: Methods for studying cells from chronically hypoxic animals
2.5.1 Chamber design
The chamber is designed to hold two standard rat cages, with up to four rats in each 
cage. The structure of the chamber is made from transparent high resistance Plexiglas. 
Air is continually removed from the chamber by the pump. Air constantly flows 
through the chamber at 45L/minute, ensuring that moisture and CO2 do not build up. 
Temperatures are similar both inside and outside o f the chamber.
2.5.2 Maintenance o f animals
The chamber was housed in a specially designed environmental room which 
maintains temperature at approximately 21 “C, humidity at 55%, gives 20 changes o f 
filtered air per hour and maintains a 12h on 12h off light cycle. Animals used in the 
experiments were obtained from credited commercial suppliers (Harlan UK Ltd, 
Nottingham). The rats supplied were male specific pathogen-free and ordered in at 
age 28-30 days (approximately 60g weight). Animals were allowed to acclimatise 
within the environmental chamber for five days before being split into two groups of 
four. One group o f animals were placed in the chamber and the other group remained 
in normal atmospheric conditions to act as age-matched controls.
2.5.3 Maintenance o f Chronic Hypoxic Rats
The chamber door was removed and the rat cage placed in the ehamber with the food 
and water dispensers at the rear, thus allowing observation o f the rats. The chamber 
door was replaced and the pump switched on. The chamber was taken down to the 
desired pressure (55mbar -  418mmHg) in small steps by slowly closing the inlet
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valve and observing the pressure reading on the gauge. Once the stable experimental 
pressure was reached, rats were checked every 15min for the following hour to ensure 
that the pressure remained stable and the animals were not in distress. The chamber 
could then be left to run for the experimental time required. Checks were made 5 
times a day to ensure that pressure readings were not fluctuating beyond desired 
levels, temperature inside and outside the chamber remained between 20 and 23^C, 
animals were not showing signs of distress and that the pump was in good operating 
condition. At weekends a member o f the Central Animal Facility staff (University o f 
Glasgow) checked the chamber. When the animals required fresh food and water, 
usually every three days, the chamber was taken down to atmospheric pressure over 
2h by opening the inlet valve. Once atmospheric pressure was reached, the pump was 
switched off and allowed to cool for half an hour' while the rat cages were cleaned and 
animals given fresh food and water. Following this, the animals were placed back in 
the chamber, the pump switched on and the chamber taken back to 55mbar over a 
period o f two hours. After 14 days in the chamber, two o f the rats were removed and 
the remaining two rats taken back to the experimental chamber for a further two days. 
O f the two rats removed, one was immediately sacrificed and studied on that day 
along with an aged matched control. The second rat was left in room air to be studied 
no longer than 24h after removal from the chamber. The same procedure occurred on 
day 16 for the remaining two rats.
2.6 Assessment of Cell Proliferation
Cell proliferation was measured by determining the uptake o f [^H]thymidine into 
DNA. Cells were seeded at a density o f  5x10^ cells / well into 24-well plates in 500pl 
o f culture medium. Cells were grown to 60% confluency in 24-well plates and then
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growth-arrested for 48h by replacing the medium with 500p,l serum-free DMEM. 
Cells were then stimulated with appropriate agonists and incubated for 24h, either in a 
normal CO2 incubator (5% CO2) or in the hypoxic incubator to obtain an acute 
hypoxic exposure (Chapter 2.4). In the latter case, the O2 content o f the atmosphere 
was reduced from 21% to 2% by flooding with N2.
For the final 4h o f agonist stimulation, cells were labelled with thymidine 
(O.lpCi/well). The reaction was stopped by washing the cells twice in ice-cold PBS 
(500|ul/well). Proteins were precipitated by washing three times with 500p,l/well 5% 
trichloroacetic acid (TCA) and lipid fractions were solubilised by washing twice with 
90% ethanol (500pl/well) for 30mins. The remaining cell contents were incubated in
0.3M NaOH (SOOpl/well) for 30mins. The contents o f each well was transferred to 
scintillation vials, to each o f which was added 3mis o f Ecoscint A (Ecoscint, Atlanta, 
Georgia, USA) scintillation fluid. Vials were vortexed for Imin before radioactivity 
was measured by scintillation counting using a Wallac scintillation counter. Results 
are expressed as disintegrations per minute (DPM).
2.7 Inositol 1,4,5-Trisphosphate Mass Assay
2.7.1 Production o f Binding Protein
Approximately 20 bovine adrenal glands were obtained from the local abattoir, 
immediately placed in ice, and brought back to the laboratory. Fat was removed from 
the glands and they were dissected longitudinally. The Central straw-coloured 
medulla was scraped off and disposed of leaving the red/brown cortex, which was 
homogenised and blended. The homogenate was then centrifuged at 5000g for 15min 
at 4‘^’C and the resulting supernatant centrifuged at 20,000g for 23mins at 4‘^ C. The
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final pellet was then resuspended in Homogenisation Buffer (20mM NaHCO] and 
1 mM DTT, pH 7.5, 4"C) and centrifuged again at 20,000g for 23mins. The binding 
protein was stored in 10ml portions at -80"C and was stable for at least 6 months. The 
binding protein could tolerate approximately four freeze-thaw cycles without loss of 
binding activity. 20 adrenal glands produced approximately 100ml o f binding protein 
normally giving 40mg protein/ml which was sufficient for ~ 4000 individual assay 
samples.
2.7.2 Cell Preparation
Cells were seeded at a density o f 5x10^ cells/well into 24-well dishes and grown for a 
further 3 days until confluent. Cells were then growth-arrested for 24h by culturing in 
serum-free DMEM. The reaction was started by the addition o f agonists and then 
stopped by the addition of 25pl ice-cold 10% perchloric acid (PCA, v/v). 30-40pi of 
Neutralisation Buffer (60mM Hepes pH 8.9, 1.5M KOH) and 3pi aliquots of 
Universal Indicator was then added until the bathing media had turned green. Cells 
were mechanically disrupted by scraping using a cell scraper and the contents placed 
in micro fuge tubes on ice. The samples were centrifuged in a bench top micro frige at 
5000g at 4°C for 5mins. The resulting supernatant was stored at -2 0 ‘^ C until time of 
assay.
2.7.3 The binding assay (for Standard Curve)
A stock o f unlabelled Ins (1,4,5)P] (4pM) was diluted into Eppendorf tubes in dH20 
as shown in Table 2.1 in a final volume o f 25pl. The following solutions were then 
added to these standards (25pi):
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(1) Neutralisation Buffer (lOOpI)
(2) Incubation Buffer (Tris-Base 0.04M, pH9.0, EDTA 4mM, EOTA 4mM, 0.4% 
BSA).
(3) pH]Ins(l,4,5)P3 (5|^Ci) diluted in dHzO (150)11).
(4) Binding protein (40mg/ml stock) diluted in Homogenisation Buffer (125pl) to a 
final concentration of 8mg/ml.
The binding protein was always added last.
Samples were then mixed by vortexing and left on ice for 30mins. After this time the 
samples were centrifuged at 3660g for ISmins at 4“C. The supernatant was removed 
and 1ml o f scintillation fluid was then added to each pellet and mixed by vortexing to 
dissolve. Radioactivity was measured in a scintillation counter.
2.7.4 The binding assay (for Samples)
This procedure was the same as the assay for the standard curve except 25 pi o f 
sample (prepared as in Chapter 2.6.2) replaced the standards.
Table 2,1
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[Stock Solution] Dilution pmoles Ins (1 ,4 ,5 ) ? 3
4pM 1 100
IpM 1/4 25
0.5pM 1/8 12.5
0.15pM 1/16 6.25
0.125pM 1/32 3.125
62.5nM 1/64 1.56
31.25nM 1/128 0.78
15.6nM 1/256 0.39
7.8nM 1/512 -0.2
3.9nM 1/1024 -0.1
H2O Only 0 0
Table 2,1 Dilution of stock IP3 for use with standard curve
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2.7.5 Calculation o f lns( 1,4,5)P] mass.
% B/ Bo was calculated where:
B ^  Specific binding (of unknown or of standard)
= DPM in pellet -  DPM in non-specific binding sample 
Bo = maximum specific
= DPM in pellet o f 0 pmol IP3 tubes -  DPM in non-specific binding sample.
%B/Bo vs. pmol Ins(l,4,5)P3 was then plotted as a standard curve on semi-log paper. 
(See Figure 5.1)
The %B/Bo values o f unknowns from the standard curve = pmoles / sample (i.e. not a 
concentration).
Concentration o f IP3 in assay was dependent upon the assay volume used,
i.e. 5pmol in 500pl assay = lOnM.
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2,8 Detection and Analysis of Proteins
2.8.1 Preparation o f samples for SDS-PAGE and immunoblotting
Cells were seeded at a density o f 5x10^ cells/well onto 6-well dishes. After the cells 
had reached 60% confluency, they were growth-arrested in serum-free DMEM for a 
period o f 24h. After the cells had been agonist-stimulated, the medium was removed, 
the cells placed on ice and the cell monolayer washed 2x with 500pl ice-cold PBS. 
The cells are then lysed with 50pl RIPA buffer (Tris-HCl 50mM pH 7.4, NP-40 1%, 
C24H3904Na 0.25%, NaCl 150mM, EGTA ImM, PMSF ImM, Na3V0 4  ImM, NaF 
ImM, CLAP 1/1000, pH 7.4)
The cells were scraped on ice into the RIPA buffer and the contents placed in 
microcentrifuge tubes. After a further 15mins on ice, the lysates were centrifuged at 
14,000g at 4°C for 15mins. The supernatant was then transferred to fresh tubes, 
aliquoted and stored at ~70°C.
2.8.2 Assay o f protein concentration
Quantification o f protein concentration was determined using a Bio-Rad™ DC Protein 
Assay Kit based on a colorimetric assay devised by Lowry et al (1951). Protein 
samples were prepared in appropriate lysis buffer. For each assay performed, a 
standard curve was prepared using five dilutions of BSA as a protein standard diluted 
in RIPA buffer over the concentration range o f lmg-16pg/ml protein. Appropriate 
dilutions of both samples and standards were made in H2O to a volume o f 200pl. 
Reagent A (an alkaline copper tartrate solution supplemented with 5% SDS) (lOOpl) 
was added to each of the standards and samples. These were vortexed and SOOpls
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Reagent B (a dilute Folin Reagent) added and immediately vortexed. Samples were 
left for 15min for colour development from pink to green as a result o f reduction of 
Folin reagent by copper-protein complex. Colour development was quantified by 
absorbance spectroscopy at 750nm within Ih. Estimates o f protein content in samples 
were made from the standard curve.
2.8.3 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Protein samples were analysed using a SDS-PAGE system
2.8.3.1 Preparation o f acrylamide gels
The casting apparatus was Bio-Rad™ mini gel electrophoresis units assembled 
according to manufacturer instructions. The separating and stacking gels were made 
as follows:
Resolving polyacrylamide gels: Normally 10% resolving gels were used which were 
prepared using the following composition; 37% acrylamide / 0.8% bisacrylamide (to a 
final 10%) (w/v); 0.375M Tris-HCl pH 8.5, 0.1% SDS (w/v), 0.05% ammonium 
persulphate (w/v), 0.05% TEMED (v/v). Polymerisation was initiated by addition of 
the ammonium persulphate and TEMED. The solution was mixed and poured into the 
assembled glass plates, leaving sufficient space at the top for the stacking gel. Gels 
were overlaid with 200-400pl of 0.1% SDS and allowed to polymerise for 30-45 
mins.
Stacking polyacrylamide gels: Following polymerisation o f the resolvmg gels, the 
overlay was removed and the surface o f the gel rinsed with water to remove any 
unpolymerised acrylamide. The stacking polyacrylamide gels used were o f the 
following composition: 5% acrylamide/bisacrylamide (w/v), 0.125M Tris-HCl pH
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8.5, 0.1% SDS (w/v), 0.05% ammonium persulphate (w/v) and 0.1% TEMED (v/v). 
Stacking polyacrylamide gel components were overlaid on the polymerised resolving 
gel and combs added immediately. After polymerisation of the stacking gel, combs 
were removed and the wells rinsed with Electrophoresis Buffer (Tris-base 25mM, 
glycine 192mM and SDS 0.1%).
2.8.3.2 Electrophoresis conditions
All protein samples to be examined by SDS-PAGE were first diluted to 50pg in SDS 
Sample Buffer, (93mM Tris-HCl pH 6.8 and 20niM dithiothreitol (DTT), ImM 
sodium-EDTA, 10% glycerol (v/v), 2% SDS (w/v) and 0.002% bromophenol blue 
(w/v)). DTT was added fi’esh, immediately before use. Samples were boiled for 5 min 
to denature proteins and disrupt disulphide bonds. The requiied volume was loaded 
into the individual wells o f  the stacking gel using loading tips. Pre-stained SDS 
protein molecular weight markers (Biorad) o f known size were also placed in one lane 
o f the gel. After loading samples, polyacrylamide gels were assembled into a Bio-Rad 
electrophoresis unit. The two chambers of the unit were filled with Electrophoresis 
Buffer and the polyacrylamine gel subjected to electrophoresis for approximately 1.5- 
2h at a constant current of 240mA.
The molecular weight o f proteins was estimated by comparing their mobility to that o f 
pre-stained SDS-PAGE standards. The standards used were myosin (205kDa), P- 
galactosidase (120kDa), bovine serum albumin (87kDa) and ovalbumin (48kDa).
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2.8.3.3 Fixing and drying gels
Gels containing radioactive proteins were fixed in 20% methanol (v/v)/10% acetic 
acid (v/v) for 30 min and rinsed in distilled water. The gel was sandwiched between 
cellophane sheets in a drying frame and dried under vacuum for 60 min at 80°C by a 
Floeffer Eazy-Breeze™ gel dryer. The radio labelled protein was detected by 
autoradiography. The dried gel was exposed to Kodak X-OMAT LS X-ray film for 4- 
24h at ~20'^C in a spring loaded metal cassette and developed by a KODAK M35-M 
X-OMAT processor.
2.8.4 Western blot analysis.
2.8.4.1 Transblotting to nitrocellulose.
Following completion o f electrophoresis, polyacrylamide gels were removed from the 
apparatus and washed once in Blotting Buffer (20% methanol (v/v), 25mM Tris-base, 
192mM glycine). Proteins were transferred from the polyacrylamide gel to the 
nitrocellulose by assembling a transfer cassette with the nitrocellulose juxtapositioned 
between the polyacrylamide gel and the cathode. By this method negatively charged 
proteins were transferred to nitrocellulose for 1.5-2h at a constant 1 amp current.
2.8.4.2 Immunoblotting
Samples (30-50pg of protein) were subjected to SDS-PAGE (Chapter 2.8.3) and the 
proteins transferred to nitrocellulose by Western blotting (Chapter 2.8.4.1). The 
nitrocellulose blots were washed in PBS/T (PBS containing 0.02% Tween-20 (v/v)) 
and blocked for non-specific binding for 3h on a rocking platform at room 
temperature in PBS/T supplemented with 10% non-fat milk (Marvel) (w/v). Blots
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were incubated for Ih in PBS/T supplemented with 5% Marvel (w/v) containing the 
appropriate dilution of primary antibody. The primary antibody dilutions used for 
detection o f specific antigens is detailed in Table 2.2. The nitrocellulose blots were 
rinsed in PBS/T, and washed 4x over an hour with PBS/T. The blots were then 
incubated for a further 60mins in PBS/T containing 5% Marvel (w/v) containing 
donkey anti-rabbit IgG antibody conjugated to HRP (NEB; 1:15000). The blots were 
then washed as before. Following completion of washing procedure proteins were 
detected using a method o f Encanced Chemilumenescence (ECL). Blots were 
incubated in ECL solution (Amersham) for 30s and sandwiched between acetate film. 
Care was taken to ensure all aii' bubbles were removed. Blots were then placed in an 
X-ray cassette and light emission from the HRP enzymatic action on its substrate 
contained within the ECL solution was detected following exposure (1-1 Omins) o f 
nitrocellulose blots to a piece o f X-ray film using a KODAK M35-M X-OMAT 
processor.
Analysed Protein
Table 2.2 
Antibody Type Dilution
phospho p38 rabbit monoclonal anti-phospho p38 IgG antibody 1:1000
whole p38 rabbit monoclonal anti- whole p38 IgG antibody 1:1000
phospho p42/44 rabbit monoclonal anti- phospho p42/44 IgG antibody 1:1000
whole p42/44 rabbit monoclonal anti- whole p42/44 IgG antibody 1:1000
phospho Ink rabbit monoclonal anti- phospho Jnk IgG antibody 1:1000
whole ink rabbit monoclonal anti- whole Jnk IgG antibody 1:1000
Table 2.2 Primary antibody dilutions utilised for Western blotting
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2.8.4.3 Re-probing nitrocellulose membranes
In instances where the same membrane was used to probe for different proteins, 
primary and secondary antibodies were stripped from the nitrocellulose by incubating 
in Stripping Buffer (lOOmM B-mercaptoethanol, 2% SDS and 62.5mM Tris-HCl, pH 
6.7) for 30 minutes at 50°C with agitation. Blots were then rinsed with PBS/T 4x over 
40 mins before the immunodetection protocol was repeated (Chapter 2.8.4.2)
2.8.5 Solid phase JNK activity assay
JNK activity was measured using recombinant truncated N-terminus o f c-jun (c-Jung. 
89) immobilised on glutathione (GSH)-sepharose beads (GST-c-jun) (Dai et al, 1995). 
Cells were grown to subconfluence on 6-well plates and treated as required. To stop 
the reaction, cells were washed 2x with ice-cold PBS, then stimulated eells were 
scraped on ice in 500pl Solubilisation Buffer (20mM HEPES pH7.7, 50mM NaCl, 
O.lmM EDTA, 0.2mM PMSF, 0.5mg/ml leupeptin, 0.5mg/ml aprotinin and 1% (v/v) 
Triton X-100). Lysates were centrifuged at 14,000g for 15min at 4°C. Protein 
concentration was measured in the supernatant as in chapter 2.8.2. Aliquots (150 pg) 
of solubilised cell extracts were added to 20pl o f GST-c-jun and mixed for 3h on a 
rotary wheel at 4°C to allow binding o f active JNK in the cell extracts. The sepharose 
beads were centrifuged at 10,000g for Imin at 4“C and the supernatant removed. The 
beads were washed 3x in 500pl Solubilisation Buffer and Ix in 500pl Kinase Buffer 
(25mM HEPES pH 7.6. 20mM MgCb, 5mM p-glycerophosphate, O.lmM Na]V0 4  
and 2mM DTT). The beads were resuspended in 30pl o f Kinase Buffer [y-^^P]ATP 
(20pM, 2pCi) and the tubes were incubated for 30min at 30°C. The reaction was 
terminated by adding lOpl 4x Laemmli SDS sample buffer. Samples were boiled for 5
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minutes and proteins resolved by SDS-PAGE (Chapter 2.8.3) on 10% polyacrylamide 
gels. Gels were fixed and dried as in Chapter 2.8.3.3 and incorporation o f [y-^^P] into 
GST-c-Jun detected by autoradiography.
2.8.6 Solid phase p38 MAP kinase assay
The activity o f p38 MAP kinase was assayed in vitro by a procedure based on 
Bogoyevich, et al (1996). Cell extracts were prepared in a p38 MAP kinase 
Solubilisation Buffer (20mM Tris-HCl pH7.4, 150mM NaCl, 1% Triton X-100, 10% 
glycerol, 2mM EDTA, 20mM NaF, 2.5mM p-glycerophosphate, 0.2mM PMSF, 
0.5mg/ml leupeptin and 0.5 mg/ml aprotinin) and p38 affinity-purified by incubating 
lysates with MAPKAP kinase-2 immobilised on GSH-sepharose beads (GST- 
MAPKAP kinase-2). The kinase reaction was carried out in the same buffer as that 
used for the c-jun activity assay (Chapter 2.8.5). The incorporation o f [y-^^P]ATP into 
MAPKAP kinase-2 was carried out using a similar method to that for GST-c-jun.
2.8.7 p42/44MAP kinase activity assay
In vitro MAP kinase activity was assessed using a BIOTRAK MAP kinase assay kit 
to measure the incorporation o f radio label led phosphate into a specific MAP kinase 
substrate peptide (KRELVEPLT^^^PAGEAPNALLAR) derived from a portion of the 
EGF receptor (EGFR^^'"^^^). This method was carried out according to the 
manufacturers instructions.
After treatment, cells in 6-well plates were rinsed 2x in ice-cold PBS and scraped on 
ice in 500pl Lysis Buffer (lOmM Tris pH7.5, 150mM NaCl, ImM EDTA, ImM 
EGTA, 0.2mM Na3V0 4 , 1% Triton X-100, 0.5% NP-40, 0.2mM PMSF, 0.5 pg/ml 
leupeptin and 0.5pg/ml). Lysates were transferred to eppendorf tubes then left on ice
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for 30mins followed by were centrifugation at 13000g for 5mins at 4"C. Protein 
concentration was measured in the supernatant as in Chapter 2.8.2. Equal quantities 
(approximately 50pg protein) o f supernatant were transferred to fresh tubes in a 
volume o f 15pl to which was added lOpM (600pM). The reactions were
initiated by addition of 5pi [y-^^P]ATP (50pM, IpCi) in 75mM HEPES buffer (pH 
7.4) containing 1.2mM MgCb. The reactions were incubated at 37”C for 15 min. 
Reactions were stopped by the addition o f 25pl o f 300mM H3PO4 and aliquots (25pl) 
were spotted onto 3x3cm P-81 phosphocellulose paper. Filters were washed 2x for 
5min with 75mM H3PO4 and 2x for 5min with dHiO, then transferred to 6ml plastic 
scintillation vials to which 3mis Ecoscint A, was added. Radioactive phosphopeptide 
bound to the filter was quantified by liquid scintillation counting in a Wallac 
scintillation counter. In every assay, background activity was measured from a sample 
of kinase buffer reaction mixture in the absence of lysate.
2.9 Densitometric analysis of blots
Densitometric analysis o f blots was carried out using a computer programme that 
allowed for comparison o f blot density in graphical form (Quantiscan).
2.10 Data analysis
Data are expressed as mean + S.D. for replicate plates from the same experiment. 
Experiments were repeated in cells ranging from 4-8 different animals. The statistical 
significance o f differences between mean values from control and treated groups were 
determined by Student’s t-tests, unpaired and paiied where applicable, using OXTAT 
software. Two-tailed probability values o f less than 0.05 (P<0.05) were considered to 
be significant.
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Chapter 3
Establishment of a Cell Model for Studying Bovine Pulmonary 
Artery Fibroblast Cell Proliferation in Acute Hypoxia
no
3.1 INTRODUCTION
Pulmonary hypertension causes remodelling o f the fibroblast, smooth muscle and 
endothelial cell layers of the pulmonary artery (Meryrick and Reid, 1979). The 
hypoxic environment results in increased proliferation of all three cell layers 
(Meryrick and Reid, 1979). The cause o f this increased cell replication is not 
understood. Hypoxia causes different effects in various cell types in cell culture. For 
example, acute hypoxia causes an increase in proliferation o f smooth muscle and 
endothelial cells (Lou et 1996; Lou et al, 1997). However, in other cell types such 
as PC I2 cells, hypoxia causes a decrease in cell proliferation (Yamakawa et al, 2000). 
Work has been carried out to study proliferation of endothelial and VSMC derived 
from the pulmonary artery (Stenmark et al, 1997; Feng and Cai, 1996), however, the 
effect o f hypoxia on primary fibroblast cells derived from this tissue is unknown. A 
model to study pulmonary artery-derived fibroblasts in culture has been established in 
this chapter which provided the basis for experiments in the future chapters.
Some o f the earliest and most dramatic structural changes following hypoxic exposure 
occur in the adventitial compartment o f the vessel wall (Stenmark and Mecham, 1997; 
Stenmark et al, 1988). In animal models o f hypertension, the resident adventitial 
fibroblasts have been shown to exliibit early (within 24h) and sustained increases in 
proliferation and exhibit dramatic increases in extracellular matrix protein synthesis 
(Meryrick and Reid, 1979; Rabinovitch et al, 1987; Reeves and Herret, 1984). These 
proliferative changes in the fibroblasts are associated with luminal narrowing and a 
progressive decrease in the ability of the vessel wall to respond to vasodilating stimuli 
(Morin and Stenmark, 1995). The mechanisms contributing to the excessive fibroblast
I l l
growth in the pulmonary adventitia under conditions of acute and chronic hypoxia 
remain poorly understood.
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3.2 METHODS
3.2.1 Assessment of fibroblast determination.
All primary cell lines used in this thesis were obtained by the explant procedure 
outlined in Chapter 2.3.2, and tested for smooth muscle a-actin. The morphology of 
the cells was visually assessed to discount the presence o f endothelial cells.
3.2.2 Determination o f ["Hjthymidine Uptake
For measurement o f DMA synthesis, [^HJthymidine was added at a time when it 
would be incorporated into DNA. To determine the optimum time for incorporation of 
[^HJthymidine, this was added for various times prior to stopping the reaction and 
measuring incorporated [^H]thymidine (Chapter 2.6).
3.2.3 Assessment o f PO2 and pH
Cells were grown to approximately 60% confluency in 24-well plates, serum-starved 
for 48h, and then transferred to an environment o f 2% O2 . At 0, 1, 3, 6, 12 and 24h a 
portable oxygen probe was used to determine the PO2 and a portable pH meter used to 
determine the pH in the cell growth medium. ['H]Thymidine uptake was used to 
assess the effect of the pH change on the growth o f bovine pulmonary arter)/ 
fibroblast (BPAF) cells. To alter the pH o f the growth medium, IM HCL (prepared in 
IM Hepes Buffer) was added until the desired pH was reached. The medium was re- 
sterilised by filtration through a 0.2pm filter.
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3.2.4 Assessment o f Proliferation of BPAF cells Grown in Hypoxic Conditions 
Cells were grown to approximately 60% confluency in 24-well plates, serum-starved 
for 48h, then either maintained in normoxia (21%) or transferred to an environment of 
2% O2. After preincubation, as described in Chapter 3.2.3, the cells were maintained 
in the absence of serum, for various lengths o f time under normoxic or hypoxic (2% 
O2) conditions. [^HjThymidine was added 4h prior to the end o f the assay period at 
which time [^HJthymidine uptake was measured (Chapter 2.6). Experiments, which 
used various preincubation times to assess maximum proliferation, were also studied.
3.2.5 Statistics
Results are expressed as the mean ± S.D. Statistical analysis was carried out as in 
Chapter 2.10.
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3.3 RESULTS
3.3.1 Assessment of the fibroblast cell type
a-Actin staining was used routinely to assess the presence o f  smooth muscle cell 
contamination in cells derived from the pulmonary artery. A dark brown colouration 
is a positive stain for smooth muscle a-actin. Figure 3.1 A shows fibroblasts derived 
from the pulmonary artery, which were found to be contaminated with smooth muscle 
cells and would not have been used for further experimentation. Figure 3 .IB show 
fibroblasts derived from the pulmonary artery after hypoxic exposure. The shape o f 
the cell also provided an identification o f the cell type. The fibroblast were sub- 
confluent by which they assume multipolar or bipolar shapes and are well spaced on 
the culture surface, but at confluence they are bipolar and less well spread (Freshney, 
1994).
Figure 3.1
115
positive a- 
actin staining
B TT
V *
Figure 3.1 a-A ctin Staining of Normoxic and Hypoxic Pulmonary Artery 
Fibroblasts.
Fibroblasts from the pulmonary artery were stained for a-Actin as described in 
Chapter 2.3.3.
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3.3.2 Determination of maximal [^Hlthymidine incorporation
To assess the growth of primary fibroblast cell cultures it was first necessary to 
optimise the method for determining [^HJthymidine uptake in these cells. Figure 3.2 
demonstrates the time o f maximal [^HJthymidine incorporation in pulmonary artery 
fibroblast cells. As thymidine is incorporated whilst the cells are synthesising DNA 
this gives a good estimation o f whether cells are proliferating or not. The addition of 
[^HJthymidine for time points > 4h prior to the end of a 24h-proliferation assay 
resulted in maximum incorporation. It was decided to add the thymidine as late as 
possible as to reduce background incorporation.
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Figure 3.2 Determination of Maximum [^H]Thymidine Uptake in Pulmonary 
Artery Fibroblast Cells
BPAF cells were grown to 60% confluency in normoxic conditions in the presence o f 
10% serum in 24-well plates. The cells were serum-starved for 24h before stimulation 
with 5% serum. The cells were then allowed to grow in normoxic conditions for a 
period o f 24h. [^H]Thymidine was added to different wells for every horn o f the 24h 
growth assay. Values shovm are the mean ± S.D. for four replicate wells from one 
experiment. The experiment was repeated four times using cells derived from 
different animals.
118
3.3.3 Determination of time taken to reach an adequate hypoxic environment.
In order to determine the time required to achieve a hypoxic environment in the 
growth medium o f cells cultured in 24-well plates, cells were placed in a hypoxic 
incubator at 2% O2 and O2 levels in the growth medium measured over time. A 6h- 
incubation period was required for the growth medium to reach the desired 35mmHg 
which represents the physiological level that is found in the pulmonary artery of 
patients with pulmonary hypertension (Souhami & Moxham, 1998) (Table 3.1). The 
hypoxic environment in the medium was maintained for the times > 6h (Table 3.1). A 
similar length of time was necessary to reach 35mmHg in different sizes o f  tissue 
culture dishes used in other experiments (data not shown).
To determine the effect o f hypoxia on the pH of the growth medium, a portable pH 
meter was used to measure pH during the time the cells were grown in the hypoxic 
incubator. The pH of the medium decreased from pH 7.5 as the PO2 o f the medium 
decreased and stabilised at pH 7.1 ± 0.2 (average of several experiments) (Table 3.2). 
To determine the effect o f this pH change on the proliferation o f fibroblasts, [^H] 
thymidine uptake was used to measure the effect of slight changes in pH o f  the 
growth medium. The pH of the cell culture medium was altered to that exhibited in 
hypoxic conditions by growing the cells in media at a pH range o f 7.0-7.5. The pH 
remained constant throughout the assay period (results not shown). Normoxic BPAF 
cells subjected to this pH change did not exhibit changes in their ability to proliferate 
(Figure 3.3) and hence, a change in pH of the growth medium does not alter cell 
proliferation.
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Table 3.1
Hours of 
preincubation
in 2% O2
PO2 in 
Bathing 
Medium 
(mmHg)
0 147
1 126
3 63
6 35
12 35
24 35
Table 3.1. Generation of a Hypoxic Environment for BPAF Cells
BPAF cells were grown to 60% confluency in 24-well plates before being placed in 
the hypoxic incubator set at an oxygen level o f 2%. At the times indicated a portable 
oxygen probe was used to determine the pOz in the cell growth medium. Values 
shown are representative o f one individual well per time point. The experiment was 
repeated four times and results shown are typical o f those obtained.
Table 3.2
1 2 0
Hours of 
preincubation 
in 2% O2
pH
0 7.5
1 7.2
3 7.2
6 7.1
12 7.0
24 7.1
Table 3.2 Effect of Hypoxia on pH of Growth Medium
BPAF cells were grown to 60% confluency in 24-well plates before being placed in a 
hypoxic incubator set at an oxygen level o f  2%. At the various times indicated a 
portable pH probe was used to determine the pH in the cell growth media. Values 
shown are representative o f one individual well per time point. The experiment was 
repeated four times and results shovm are typical o f those obtained.
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Figure 3.3 Effect of pH on [^H]Thymidine Uptake in Normoxic Pulmonary 
Artery Fibroblasts
BPAF cells were grown to 60% confluency in 24-well plates and then serum-starved 
for 48h. At this point the medium was replaced in different wells with media at a 
range o f pHs. The pH had been altered to 7.5, 7.2, 7.1 and 7.0 (Chapter 3.2.3). The 
cells were then left for a hirther 24h with [^HJthymidine added for the final 4h. Values 
shown are the mean ± S.D. for four replicate wells from one experiment. The 
experiment was repeated in cells derived from four different animals.
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3.3.4 Effects of hypoxia on proliferation of Bovine Pulmonary Artery 
Fibroblasts
To determine the effect of hypoxia on the growth o f BPAF’s, serum-starved ceils 
were pre-incubated for various lengths o f time prior to a 24h proliferation assay as 
described in Chapter 3.2.3. In the absence o f a 6h pre-incubation period in hypoxia, 
which was shown in Table 3.1 to be required for the cell growth medium to become 
hypoxic, no hypoxic growth o f the fibroblast cells was noted over a 24h period (288 ±
43.5 DPM for hypoxic cells which was not significantly different from control cell 
levels at 255 ± 33.7 DPM). Figure 3.4 demonstrates that following a 6h preincubation 
in hypoxic conditions BPAF cells proliferated at an increased level (1753.3 ± 69.6 
DPM) which was significantly (P<0.001 for data sets) greater than those of control 
cells (286.9 ± 19.4 DPM). Further pre-incubation in hypoxic conditions did not 
enhance the growth o f these cells. The graph suggests that further preincubation may 
cause the cells to either die or stop proliferating, however, the apparent reduction in 
growth was due to the cells becoming over confluent and lifting from the base o f the 
cell culture plate.
To determine whether a longer growth assay period following the 6h pre-incubation 
would result in greater ['HJthymidine uptake, the effects o f varied lengths of growth 
time was examined. Figure 3.5 demonstrates that there would appear to be no 
advantage to allowing the cells a longer period of growth over 24h to enhance the 
hypoxic response.
Visual confirmation of the hypoxic proliferation of these cells over a 24h period when 
compared with those maintained in normoxia can be seen in Figure 3.6. Figure 3.6A 
and B shows serum-starved normoxic fibroblast cells at To. Figure 3.6C and D shows 
fibroblast cells 24h later after 5% serum stimulation. Figure 3.6C shows fibroblasts
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maintained in normoxia and figure 3.60 fibroblasts kept in hypoxic conditions. Even 
visually, increased proliferation o f the hypoxic cells it is quite apparent.
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FIGURE 3.4a
Pre­
incubation 
Time (h)
Normoxic
BPAF
S.D. Hypoxic
BPAF
S.D. p value
255 33 288 44 >0.05
0 290 54 318 76 >0.05
301 72 327 97 >0.05
287 19 1753 70 < 0.001
6 319 43 1810 102 < 0.001
331 54 1796 72 <0.001
325 58 1018 92 < 0.001
12 352 71 1412 96 <0.001
362 107 1019 141 < 0.001
413 98 438 44 >0.05
24 441 107 429 76 >0.05
481 135 477 87 >0.05
Figure 3.4a Effects of Hypoxic Pre-Incubation on BPAF Cell Proliferation
Figure 3.4a summarises data from 3 different animals. Data in bold is represented in 
Figure 3.4. Each data point represents the mean o f  4 individual wells from the same 
experiment.
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Figure 3.4 Effect of Hypoxic Pre-Incubation on BPAF Cell Proliferation
Uptake o f [^HJthymidine in BPAF cells in normoxia (white) and hypoxia (black). 
Cells to be made hypoxic were pre-incubated in 2% O2 for 0 ,6 , 12 and 24h prior to a 
24h proliferation assay. Each data point represents the mean ± S.D. o f 4 individual 
wells from three separate experiments.
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Figure 3.5 Effect of a 6h Hypoxic Pre-Incubation with Varied Lengths of 
Growth Time on the Proliferation of BPAF Cells
Uptake of [^HJthymidme in BPAF cells in normoxia (white) and hypoxia (black). 
Cells to be made hypoxic were pre-incubated in 2% 0% for 6h prior to addition o f  10% 
serum for 24, 30, 35, 40 and 45h. Each data point represents the mean ± S.D. o f 4 
individual wells from three separate experiments. Each data point represents the mean 
± S.D. of 4 individual wells from three separate experiments.
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Figure 3.6
Figure 3.6 Visual Assessment of BPAF Cell Proliferation.
BPAF cells (A and B) were grown to 50% confluency in 75cm^ flasks and serum- 
starved for 48h. 5% serum was then added and the cells allowed to proliferate in 
normoxic (C) and hypoxic (D) conditions for a further 24h.
127
3.4 Discussion
In this chapter a cell mode! has been established for looking at changes in the 
proliferative response o f primary cultures o f fibroblast cells derived from the 
pulmonary artery in response to acute hypoxia. It was established that the cell culture 
medium required a hypoxic pre-incubât ion o f 6h to achieve a suitable level o f hypoxia 
in the growth medium. During this time there was a slight drop in pH, but we have 
shown that this change in pH did not effect the proliferative response o f the fibroblast 
cells. It was consistently found (that is, in fibroblast cells from at least four animals) 
that the cells derived from the pulmonary artery exhibited an enhanced growth 
response when cells were cultured in hypoxic conditions.
Changes in oxygen concentration within the physiologic range have a profound effect 
on the proliferation o f mammalian cells. Reducing the oxygen concentration from 
normal levels o f 21% to 2.5% enhances the growth o f fibroblasts and lymphocytes in 
tissue culture in conjunction with growth factors and/or serum (Packer and Fuehr, 
1977; Taylor et al, 1978; Storch and Talley, 1988). Feng et al, (1996) showed that 
acute hypoxia (2%) significantly increased [^Hjthymidine uptake in pulmonary artery 
smooth muscle cells which were grown in the presence o f 2% serum. Similarly, Lou 
et al, (1997) showed the same was true for retinal microvessel endothelial cells (133% 
increase in 24h). However, the proliferative response o f hypoxia alone without the 
addition of growth factors has not been reported in fibroblast cells. The results 
presented in this chapter show hypoxia alone can stimulate the proliferation o f BPAF 
and this is the first report to show this effect in this particular cell type. The results 
presented here are also comparable to work carried out on fibroblast cells derived 
from neonatal calves exposed to clironic hypoxia after birth (Das et al, 1999). In that
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study, cells from chronically hypoxic animals showed increased growth 
characteristics to purified mitogens when compared to those from control animals.
In general, techniques used to assess proliferation measure the assimilation of 
radio label led nucleotides such as [^HJthymidine into newly synthesised DNA. 
Thymidine is commonly used for this purpose. Most tissue cultures comprise cells at 
various stages o f the cell cycle, so cells are typically growth-arrested in serum-free 
media. This synchronises cells to the Go/Gi phase o f the cell cycle in which cells 
minimally incorporate [^HJthymidine (Panettieri et al, 1989).
There are a number o f potential drawbacks in relating [^HJthymidine uptake to DNA 
synthesis. Firstly, although most DNA synthesis occurs during cell replication, some 
o f the DNA synthesis may be for ongoing reparative processes rather than for 
proliferation. Secondly, [^HJthymidine may be incorporated into cellular 
macro molecules other than DNA, such as RNA and lipids. Despite these potential 
artefacts, measuring uptake o f [^H]thymidine remains one o f the best and most widely 
used methods for assessing cell proliferation.
These studies have established that pulmonary artery fibroblasts exposed to acute 
hypoxia are associated with a significant change in the proliferative phenotype. It is 
now important to understand the mechanisms contributing to the excessive fibroblast 
proliferation under these conditions. The results presented in this chapter are the 
foundations for the remaining chapters, which study further the responses of 
pulmonary artery fibroblasts with respect to acute and chronic hypoxia and compare 
these responses to those o f cells from the systemic circulation.
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Chapter 4
Effect of Acute Hypoxia on Mitogenic Stimulation of Bovine 
Pulmonary Artery and Bovine Mesenteric Artery Fibroblast cells.
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4.1 INTRODUCTION
In the previous chapter a cell model was established and characterised for measuring 
acute hypoxic effects on the growth of primary cultures o f fibroblast cells. Results 
from that chapter showed that hypoxia increased [^Hjthymidine uptake in the 
fibroblast cells derived from bovine pulmonary artery.
It has been known for some time that hypoxia causes vasoconstriction in the 
pulmonary circulation and vasodilation in the systemic circulation (von Euler and 
Liljestrand, 1946). We hypothesised that there are fundamental differences in oxygen 
sensing and cell signalling between systemic and pulmonary artery cells in response 
to hypoxia, that is there is a link between the observed physiological vasoconstriction 
and vascular remodelling. Growth factors are implicated in a wide variety o f 
physiological and pathological processes. These include growth and development and 
cell survival and tissue repair (Evered et al, 1985). An important link between growth 
factors or their receptors and oncogene products has also been established (He Id in and 
Westermark, 1984; Bishop, 1985; Weinberg, 1985). Thus, the elucidation o f the 
mechanism o f action o f growth factors has emerged as one o f the fundamental 
problems in biological sciences and may prove a crucial prerequisite for 
understanding the cause or causes underlying the unrestrained proliferation of 
pulmonary cells to hypoxia in disease states like pulmonary hypertension or o f other 
hypoxic lung diseases (Lafont, 1995). In fact, it has been shown that there may be 
some synergistic effects between hypoxia and mitogens on the proliferation o f cells. 
For example, Feng and Cai (1996) demonstrated a synergistic effect o f hypoxia on 
smooth muscle cell proliferation with ET-1, whilst others (Das et al, 1999) recently
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showed synergism o f hypoxia on proliferation o f neonatal bovine pulmonary artery 
fibroblasts to PDGF, basic fibroblast growth factor and insulin-like growth factor-1. 
Previous work has shown that in pulmonary hypertension there is an increase in the 
levels o f several mitogens such as ET-1, PDGF, thrombin, angiotensin II and 5-HT 
(Rose et al, 1986; Ono and Voelkel, 1991 ; Giaid et al, 1993). In this chapter, we have 
determined the effect o f hypoxia in combination with these mitogens to determine the 
proliferative response o f BPAF and BMAF. We chose to compare the response with 
that o f systemic vascular cells from the mesentery since previous work has suggested 
that hypoxia affects ion exchange (potassium currents) differently in mesenteric and 
pulmonary artery cells (Weir and Archer, 1995).
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4.2 METHODS
BPAF and BMAF were grown in 24-welI plates as described in Chapter 2.3.1. 
Following growth arrest, cells were either transferred to a hypoxic environment o f 2% 
O2 or left in normoxic 21% O2 conditions. After a 6h preincubation to allow the cell 
culture medium to become hypoxic, cells were stimulated with various agonists for 
24h, [^HJthymidine being added for the final 4h. The uptake o f [^Hjthymidine was 
measured as in Chapter 2.6.
4.3 RESULTS
4,3.1 Effect of hypoxia on serum-stimulated proliferation of BPAF and BMAF 
cells.
In the previous chapter it was shown that growth arrested BPAF cells proliferated in 
response to acute hypoxia in the absence o f mitogens (Chapter 3.4). To test the effects 
o f hypoxia on proliferating bovine fibroblasts, growth-arrested BPAF were exposed to 
2% O2 for 6h to make the cells hypoxic and then stimulated with 5% serum for 24h.
Thymidine uptake was used as a measure o f proliferation. These cells were 
compared with those grown under normoxic conditions. In addition, growth of 
fibroblasts derived ftom the pulmonaiy artery were compared to those from the 
mesenteric artery. Serum concentrations as low as 0.1% were enough to stimulate 
proliferation o f both BPAF and BMAF (Figure 4.1) by 6.6-fold and 5.5-fold 
respectively. Hypoxia significantly enhanced the effect o f serum in BPAF cells by
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about 6-fold (p<0.001). In contrast, there was no elfect o f hypoxia in growth arrested 
or serum-stimulated BMAF cells (Figure 4 .IB).
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Figure 4.1 Effect of Hypoxia on Serum -Induced Proliferation of BPAF and 
BMAF cells.
BPAF (A) and BMAF (B) cells were grown to 60% confluency in 24-well plates and 
then quiesced in serum-free medium. Cells were either maintained in a normoxic 
environment for a further 6 h or were placed in a hypoxic incubator (2 % O2) for 6 h. 
The cells were then stimulated for 24h with a range o f serum concentrations as 
indicated in the graph. The cells were then allowed to grow in either normoxic or 
hypoxic conditions for a period o f 24h. Cell growth was assessed by thymidine 
uptake. Values shown are the mean ± S.D. for four replicate wells from the same 
experiment. The experiment was repeated in cells derived from four different animals.
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4.3.2 Effect of hypoxia on PDGF-stimulated proliferation of BPAF and BMAF 
cells
To study the effect o f a specific growth factor on the proliferation o f BPAF and 
BMAF cells in culture, similar experiments were carried out as described in the 
previous section. PDGF concentrations as low as 3ng/ml was enough to stimulate 
proliferation o f both BPAF and BMAF cells (Figure 4.2) by 5.5-fold and 6 -fold, 
respectively. Hypoxia significantly enhanced the effect o f PDGF in BPAF cells by 2- 
fold (p<0..001). In contrast, there was no effect o f hypoxia in growth-arrested or 
PDGF-stimulated BMAF cells (Figure 4.2B). There appeared to be no effect o f 
hypoxia at 30ng/ml PDGF. This was due to the cells being 100% confluent in the 
plates and by the end o f the experiments the cells had become contact inhibited.

1 3 7
Figure 4.2 Effect of Hypoxia on PDGF-Stimulated Proliferation of BPAF and 
BMAF Cells.
BPAF (A) and BMAF (B) cells were grown to 60% confluency in 24-well plates and 
then quiesced in serum-free medium. Cells were either maintained in a normoxic 
environment for a further 6 h or were placed in a hypoxic incubator (2 % O2) for 6 h. 
The cells were then stimulated for 24h with a range o f PDGF concentrations as 
indicated in the graph. The cells were then allowed to grow in either normoxic or 
hypoxic conditions for a period o f  24h. Cell growth was assessed by [^HJthymidine 
uptake. Values shown are the mean ± S.D. for four replicate wells from the same 
experiment. The experiment was repeated in cells derived from four different animals.
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Figure 4.2a Effects of Hypoxia on PDGF-Stimulated Proliferation of BPAF and 
BMAF Cells
Figure 4.2a summarises data from 4 different animals. Data in bold is represented in 
Figure 4.2. Each data point represents the mean o f 4 individual wells from the same 
experiment.
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4,3,3 Effect of hypoxia on G-protein coupled receptor (GPCR) agonist- 
stimulation of BPAF and BMAF cells.
There are several GPCR’s that may be involved in re-modelling o f the pulmonary 
artery exposed to hypoxic conditions (Sudhir et al, 1993; Malek and Izumo, 1992). 
The effect o f these mitogens on growth o f cells maintained in a hypoxic environment 
was investigated as described in Chapter 2.4. To test the effects o f hypoxia on 
proliferating bovine fibroblasts using selected GPCR agonists, growth-arrested 
hypoxic and normoxic cells were stimulated with varied concentrations o f  ET-1, All, 
5-HT and Thrombin. [^H]Thymidine uptake was used to measure DNA synthesis.
ET-1 did not significantly stimulate either cell type above basal levels in normoxic 
conditions (p>0.05). The stimulation o f BPAF cells in hypoxic conditions was no 
greater than that seen with hypoxia alone (Figure 4.3). Similarly, All did not 
significantly stimulate either cell type above basal levels in normoxic conditions 
(p>0.05). The stimulation o f BPAF cells in hypoxic conditions was no greater than 
that seen with hypoxia alone (Figure 4.4). In contrast, 5-HT caused a significant 
increase in [^Hjthymidine uptake under both normoxic and hypoxic conditions 
reaching <\ maximum effect at lOpM where the increase was by 13.5-fold and 20-fold, 
respectively (Figure 4.5) (p<0.001). The effect was greater in conditions of hypoxia 
for the BPAF cells than for the BMAF cells. 5-HT caused a dose-dependent increase 
in cell replication for both types o f cell, but whereas hypoxia shifted the dose 
response curve (but not maximal response) to the left on the BPAF cells, this effect 
was not seen in the BMAF cells. Thrombin caused a marked increase in replication 
under both normoxic and hypoxic conditions by 4-fold and 7-fold, respectively 
(Figure 4.6) (p<0.001). The effect was greater in hypoxic conditions for the BPAF
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cells than for the BMAF cells by about 1.7-fold. Thrombin caused a dose-dependent 
increase in cell replication for both types o f cell, but whereas hypoxia shifted the dose 
response curve (but not maximal response) to the left on the BPAF cells, this effect 
was not seen in the BMAF cells.
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Figure 4.3 Effect of Hypoxia on ET-l-Stimulated Proliferation of BPAF and 
BMAF Cells.
BPAF (A) and BMAF (B) cells were grown to 60% confluency in 24-well plates and 
then quiesced in serum-free medium. Cells were either maintained in a normoxic 
environment for a further 6 h or were placed in a hypoxic incubator (2 % 0 %) for 6 h. 
The cells were then stimulated for 24h with a range o f ET-1 concentrations as 
indicated in the graph. The cells were then allowed to grow in either normoxic or 
hypoxic conditions for a period o f 24h. Cell growth was assessed by [^H]thymidine 
uptake. Values shown are the mean ± S.D. for four replicate wells from the same 
experiment The experiment was repeated in cells derived from four different animals.
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Figure 4.4 Effect of Hypoxia on AH-Stimulated Proliferation of BPAF and 
BMAF cells.
BPAF (A) and BMAF (B) ceUs were grown to 60% confluency in 24-well plates and 
then quiesced in serum-free medium. Cells were either maintained in a normoxic 
environment for a further 6 h or were placed in a hypoxic incubator (2 % O2) for 6 h. 
The cells were then stimulated for 24h with a range o f A ll concentrations as indicated 
in the graph. The cells were then allowed to grow in either normoxic or hypoxic 
conditions for a period o f 24h. Cell growth was assessed by [^HJthymidine uptake. 
Values shown are the mean ± S.D. for four replicate wells from the same experiment. 
The experiment was repeated in cells derived from four different animals.
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Figure 4.5 Effect of Hypoxia on 5-HT-Stimulated Proliferation of BPAF and 
BMAF Cells.
BPAF (A) and BMAF (B) cells were grown to 60% confluency in 24-well plates and 
then quiesced in serum-free medium. Cells were either maintained in a normoxic 
environment for a further 6 h or were placed in a hypoxic incubator (2 % O2) for 6 h. 
The cells were then stimulated for 24h with a range of 5-HT concentrations as 
indicated in the graph. The cells were then allowed to grow in either normoxic or 
hypoxic conditions for a period o f 24h. Cell growth was assessed by [^H]thymidine 
uptake. Values shown are the mean ± S.D. for four replicate wells from the same 
experiment. The experiment was repeated in cells derived from four different animals.
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Figure 4.6 Effect of Hypoxia on Thrombin-Stimulated Proliferation of BPAF 
and BMAF Cells.
BPAF (A) and BMAF (B) cells were grown to 60% confluency in 24-well plates and 
then quiesced in serum-free medium. CeUs were either maintained in a normoxic 
environment for a fiirther 6 h or were placed in a hypoxic incubator (2 % O2) for 6 h. 
The cells were then stimulated for 24h with a range o f thrombin concentrations as 
indicated in the graph. The cells were then allowed to grow in either normoxic or 
hypoxic conditions for a period o f 24h. Cell growth was assessed by [^HJthymidine 
uptake. Values shown are the mean ± S.D. for four replicate wells from the same 
experiment. The experiment was repeated in cells derived from four different animals.
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4.4 Discussion
This chapter demonstrates that oxygen concentrations at the physiological 
concentration of 5%, which is similar to that observed in pulmonary hypertensive 
patients (Souhami & Moxham, 1998), increases the proliferation o f BPAFs over and 
above the response o f  these cells to serum and specific growth factors and GPCR’s. 
DNA synthesis was increased in BPAF’s in response to serum, as well as to PDGF, 5- 
H l' and thrombin and this was enhanced further under hypoxic conditions. This effect 
was specific to cells derived from the pulmonary artery since cells derived from the 
systemic circulation were non-responsive to an acute hypoxic challenge. We have 
previously shown ET-1 to be a potent agonist on pulmonary artery fibroblasts in the 
rat (Peacock et al, 1992), but this did not affect bovine pulmonary artery cells in 
either hypoxic or normoxic conditions. This is consistent with our previous studies 
where we showed that ET-1 does not promote replication in bovine cells (Peacock 
and Aidulis, 1994). We have been unable to find any other study where BMAF cell 
replication has been studied.
As well as changes observed here in hypoxia-stimulated proliferation between BPAF 
and BMAF cells, other workers have observed physiological differences between the 
two types o f cell. For example, there is also a differential effect o f hypoxia on 
channel activation in isolated pulmonary and mesenteric artery cells (Weir and 
Archer 1995).
Increased pulmonary artery fibroblast proliferation in cells derived from the cow in 
response to hypoxia was accompanied by changes in specific protein kinase C (PKC) 
isozymes, suggesting a signal transduction pathway linking hypoxia with
150
proliferation in the adventitial fibroblast (Stenmark and Mecham, 1997). These 
results agree with the findings by others that oxygen concentrations within the 
physiological range may control proliferation indirectly by altering the activity o f a 
signalling pathway that regulates the response to growth factors.
It is possible that the additive effect o f hypoxia over and above normal growth 
responses leading to increased proliferation triggers a novel signalling pathway, or 
enhances the activation o f an existing pathway leading to the increased proliferation. 
Hypoxia may also cause the increase in transcription o f proteins involved in cell 
growth, for example, VEGF or LNOS. The gene for this has already been show to be 
turned on in hypoxic conditions (Feldkamp et al, 1999) There is evidence in other cell 
types o f specific genes switched on by hypoxia such as EPO (Firth et al, 1994). It is 
possible that pulmonary artery cells contain genes not present in BMAF cells allowing 
both contraction and replication to hypoxia and that these phenomena are coupled 
(Scott and Peacock, 1995).
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Chapter 5
Effects of Acute Hypoxia on IPi Generation in 
BPAF and BMAF cells.
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5.1 INTRODUCTION
In the previous chapter, it was shown that exposing quiescent cells to an oxygen 
concentration at a physiological level o f hypoxia could increase proliferation. In 
addition, it also enhances the effect o f some growth factors and GPCR agonists. This 
effect appeared to be specific for pulmonary derived fibroblast cells since this did not 
occur in the same cell type derived from the mesenteric artery. If low oxygen 
concentrations can control cell proliferation then it might be expected that the activity 
o f signalling enzymes, and pathways, might be altered in the cellular response to 
hypoxia. The aim o f the studies described in this chapter was to investigate the 
possible importance o f the second messenger IP3 to the hypoxic response o f cells.
The actions of many GPCR agonists and growth factors are mediated by the 
hydrolysis of PIP2 catalysed by PLC (Berridge and Irvine, 1989). This hydrolysis 
releases IP3, which mobilises Ca^ "^  from the endoplasmic reticulum, and DAG, which 
activates some PKC iso forms (Hug and Sarre, 1993).
Previous work has shown that hypoxia increases cytosolic [Ca^^]i in pulmonary artery 
smooth muscle cells. It was not known whether or not the source o f this increased 
Ca^ "^  was intracellular or extracellular, since previous reports have not specifically 
looked at the effect o f hypoxia in IP3 mediated generation of Ca^^ (Cornfield et al, 
1993). The Ca^^ may be derived from intracellular stores or by Ca^^ influx mediated 
by voltage-dependent or receptor-operated Ca^^ channels (Berridge, 1993b). In 
general, transient increases in [Ca^ ]^,- are mediated by IP3 release o f Ca^^ from 
intracellular stores whilst sustained increases in [Ca^ "^ ]j are mediated by Ca^^ influx 
through activation of the Ca^ "^  channels (Chadwick et al, 1990). M inami et al (1991) 
examined AH induced changes in IP] levels in VSMC from hypertensive rats and
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found a rapid increase in IP3 levels peaking at 5 seconds. Similar results were 
demonstrated by Yokokawa et al (1995), who studied the response of endothelial cells 
from hypertensive rats to ET-1. Transient increases in IP3 levels were also reported 
when frogs were subjected to hypoxic/anoxic conditions (Holden and Storey, 1997).
In the present study, IP3 levels were measured in quiescent BPAF and BMAF cells 
exposed acutely to hypoxic conditions in the presence and absence of various 
agonists, which have been shown to be increased in patients with pulmonary 
hypertension.
154
5.2 METHODS
BPAF and BMAF cells were plated out into 24-well plates and quiesced as described 
in chapter 2.3.1. Cells were then either maintained in normoxic conditions or exposed 
to 2% O2 for 6 h prior to addition o f agonists. IP3 mass was measured as described in 
2 .6 .
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5.3 RESULTS
5,3.1 Typical standard curve for IP3 generation.
Figure 5.1 shows a typical standard curve generated using a competitive binding assay 
with bovine adrenal glands which was used to find the unknown levels o f IP3 in 
stimulated cell extracts.
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Figure 5.1 Typical Standard Curve used to Measure IP3 Generation
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5.3.2 Effect of agonists and hypoxia on IP3  generation
The effect o f hypoxia on agonist-stimulated IP3 generation was investigated. Figure
5.2 demonstrates the effect o f PDGF and hypoxia on IP3 generation. Under normoxic 
conditions PDGF (30ng/ml) did not significantly alter IP3 mass in BPAF (A) or in 
BMAF (B) cells. Hypoxia alone had no significant effect on IP3 mass in either BPAF 
o f BMAF cells. However, when BPAF cells were incubated under hypoxic 
conditions, there was a sharp increase in IP3 mass in the presence o f PDGF (maximal 
at 10s) by 2-fold (p<0.001) which fell to basal levels at 30s (Figure 5.2A). In contrast, 
there was no change in IP3 mass when the BMAF cells were grown in hypoxia 
(Figui'e 5.2B). Figure 5.3 demonstrates the effect o f ET-1 and hypoxia on IP3 
generation. Unlike that o f PDGF, ET-1 (lOpM) caused a rise in IP3 mass in the BPAF 
cells (Figure 5.3A) in normoxic conditions (also maximal at 10s). However, hypoxia 
did not significantly increase this stimulation o f IP3 above normoxic values (p>0.05). 
In the BMAF cells (Figure 5.3B), ET-1 did not give rise to IP3 generation in either 
normoxic or hypoxic conditions. Figure 5.4 demonstrates the effect o f thrombin and 
hypoxia on IP3 generation. Under normoxic conditions thrombin (300nM) did not 
significantly alter IP3 mass in BPAF (Figure 5.4A) or in BMAF (Figure 5.4B) cells. 
When BPAF cells were incubated under hypoxic conditions, there was a sharp 
increase in IP3 mass in the presence o f thrombin (maximal at 10s) by 2.6-fold 
(p<0.001). In contrast, there was no change in IP3 mass when the BMAF cells were 
grown in a hypoxic environment.
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Figure 5.2 Effect of PDGF and Hypoxia on ÏP3  Generation in BPAF and BMAF Cells.
BPAF (A) and BMAF (B) cells were grown to 90% confluency in 24-well plates and then 
serum-starved for a further 48h. Cells to be made hypoxic were placed in the hypoxic incubator 
for 6 h and normoxic controls kept in a normal CO2 incubator. The reaction was started by the 
addition o f  PDGF (30ng/ml). The reaction was then stopped by the addition o f  25pi ice-cold 
10% PGA (w/v) at 0, 5, 10, 20, 30, 60, 120 and 300s time points. After lysis, the resulting 
supernatants were assayed for IP3 content as described in Chapter 2.7.4. Values shown aie 
mean+S.D. for four replicate wells from the same experiment. The experiment was repeated in 
cells from four different animals.
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Figure 5.3 Effect of ET-1 and Hypoxia in IP3 Generation in BPAF and BMAF Cells.
BPAF (A) and BMAF (B) cells were grown to 90% confluency in 24-well plates and then 
serum-starved for a further 48h. Cells to be made hypoxic were placed in the hypoxic incubator 
for 6 h and normoxic controls kept in a normal CO2 incubator. The reaction was started by the 
addition o f  ET-1 (lOpM). The reaction was then stopped by the addition o f  25pi ice-cold 10% 
PCA (w/v) at 0, 5, 10, 20, 30, 60, 120 and 300s time points. After lysis, the resulting 
supernatants were assayed for IP3 content as described in Chapter 2.7.4. Values shown are 
mean±S.D. for foui' replicate wells fi'om the same experiment. The experiment was repeated in 
cells fi'om four different animals.
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Figure 5.4 Effect of Thrombin and Hypoxia in IF3 Generation in BPAF and BMAF Cells.
BPAF (A) and BMAF (B) cells were grown to 90% confluency in 24-well plates and then 
serum-starved for a further 48h. Cells to be made hypoxic were plaeed in the hypoxic incubator 
for 6h and normoxic controls kept in a normal CO2 incubator. The reaction was started by the 
addition o f thrombin (300nM). The reaction was then stopped by the addition o f  25p,l ice-cold 
10% PCA (w/v) at 0, 5, 10, 20, 30, 60, 120 and 300s time points. After lysis, the resulting 
supernatants were assayed for IP3 content as described in Chapter 2.7.4. Values shown are 
mean±S.D. for four replicate wells ftom the same experiment. The experiment was repeated in 
cells from four different animals.
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5.4 DISCUSSION
In this chapter, IP3 mass was analysed in both BPAF and BMAF cells in response to 
various agonists in cells grown under normoxic or hypoxic conditions. Hypoxia alone 
did not increase basal IP3 mass but stimulated an early rise in IP3 mass when cells 
were stimulated with PDGF or thrombin. ÏP3 mass was found to be increased in 
response to ET-1 in the BPAF cells hrespective o f the oxygen environment. BMAF 
cells did not display this IP3 peak in response to hypoxia with any o f  the agonists 
used, and basal levels o f IP3 in the cells made hypoxic were not altered.
In the previous chapter, hypoxia was found to increase cell proliferation over and 
above that o f agonists alone, for example, in response to PDGF and thrombin. We 
have shown for the first time that there is a rapid rise in IP3 mass when hypoxic cells 
ai’e stimulated with agonists, which also stimulate proliferation, such as thrombin. In 
the case o f E T - 1 , which does not stimulate B P A F  proliferation, there is no additional 
increase in IP3 mass with hypoxia. In contrast to the pulmonary cells, fibroblast cells 
from the mesenteric artery did not have an increase in IP3 mass generation under 
hypoxic conditions.
The difference in response to hypoxia between pulmonary cells and mesenteric cells 
may be due to an hypoxia-activated pathway which is either present only in 
pulmonary artery cells, or is repressed in mesenteric artery cells. Activation o f  cell- 
surface receptors and their associated tyrosine kinase and phospholipases (C-y, A2 or 
D) leads to the generation o f  the lipid seeond messengers IP3 and DAG (Kohno et al, 
1992; Nishizuka, 1992). IP3 promotes mobilisation o f intracellular Ca^^ stores (Short 
et al, 1993) whereas DAG is an endogenous activator o f PKC (Nishizuka 1992). 
Hence, an increase in IP3, caused in BPAF by hypoxia, may accompany an increase in
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DAG or PKC activity. Although DAG was not examined in this chapter, it has been 
reported that hypoxia can increase PKC activity in PASMC (Xu et al, 1994). Thus, 
PKC activity could be enhanced in two ways; firstly, by increasing DAG and, 
secondly, by IP3 induced release o f Ca^^ from intracellular Ca^^ stores. Increases in 
intracellular Ca^^ can directly activate some isoforms o f  PKC (Ho et al, 1988). 
Interestingly, activators o f PKC have been shown to promote many o f the same 
cellular responses (contraction, hypertrophy and proliferation) attributed to hypoxia 
(Orton et al, 1990; Starksen et al, 1986; Dempsey et al, 1991). In addition, induction 
and phosphorylation o f PKCa has been observed in response to hypoxia in lung 
fibroblast cells (Hasen et al, 1996). This iso form is involved in the PKC-dependent 
regulation o f the erythropoetin (EPO) gene, which is induced by hypoxia (Fandrey et 
al, 1994). If  this explanation o f the activation o f  hypoxia is true it is not clear why the 
same pathway is not acth'ated in mesenteric cells. The differences within the two cell 
types studied here do, however, show the same trends as seen in the circulation o f 
humans in vivo when given hypoxic challenges (Von Euler and Liljestrand, 1946). 
That is, the pulmonary arteries contract and cellular proliferation ensues, whereas in 
the systemic circulations this does not happen.
It is likely that pulmonary artery cells contain genes allowing both contraction and 
replication to hypoxia and that these phenomena are coupled (Scott and Peacock, 
1995). It is tempting to speculate that the phosphoinositide pathway might be 
involved downstream from any hypoxic sensor and responsible for vasomotor - cell 
growth coupling, that is, IP3 causes increased intracellular Ca^^ resulting in cellular 
contractions but also augmentations o f DAG-induced cell replication.
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Chapter 6
n f  Acute H v n o x i a  on the Stimi.iation of the Stress-Activated 
prnfAln kinases in Pulmonary Artery Fibroblasts
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6.1 INTRODUCTION
As described in previous chapters, serum-deprived BPAF cells proliferate under 
hypoxic conditions, and the second messenger, IP3, is increased in these hypoxic cells. 
However, the intracellular signalling mechanisms by which hypoxia stimulates cell 
proliferation in pulmonary artery fibroblasts need to be further characterised.
O f particular importance in growth factor signalling is the activation o f  a series o f 
kinase cascades involving multiple serine/threonine and tyrosine phosphorylation 
events (Malarkey et al, 1995). One such pathway is the MAP kinase cascade (Davis, 
1993) which stimulates the phosphorylation o f several intracellular substrates, such as 
p9 0 rsk and Elk-1, believed to play a role in initiating mitogenesis (Ballou et al, 1991 ; 
Gille et al, 1995). MAP kinases are pro line-directed protein kinases that mediate the 
effects o f numerous extracellular stimuli on a wide array o f biological processes, such 
as cellular proliferation, differentiation and death (Datta et al, 1999). MAP kinase is 
also regulated in a cell cycle-dependent fashion and is required for cells to enter S- 
phase (Tamemoto et al, 1992). For example, in Chinese hamster lung fibroblasts, 
Pages and co-workers (1993) found that activation o f both p42 and p44 iso forms o f 
the ‘classical’ p42/p44 Map kinases were essential for proliferation. Similarly, using 
human airway smooth muscle cells (HASM), Orsini and co-workers (1999) found that 
proliferation in this cell type required prolonged activation o f p42/p44 MAP kinase. 
Not only have these forms o f MAP kinase been shown to be activated in response to 
mitogens, but also have been shown to be activated in response to hypoxia. For 
example, in rat cardiac myocytes, components o f the MAP kinase cascade, including 
Raf-1, MEK and MAP kinase, have been shown to be activated in response to low 
oxygen conditions (Seko et al, 1996). However, these responses are very small when
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compared to mitogen stimulation o f these pathways. Other workers (Richard et al, 
1999), again using Chinese hamster lung fibroblasts, found that p42/p44 MAP kinase 
phosphorylated hypoxia-inducible Factor l a  (H IF-la) and enhanced the 
transcriptional activity ofF tlF-l.
In recent years, protein serine/threonine kinases related to the ‘classical’ forms of 
MAP kinase have been identified, and are referred to as the stress-activated protein 
kinases (SAPK) (Kyriakis, ei al, 1994). These kinases, consisting o f at least two 
homologues, c-Jun N-tenninal kinase (JNK) and p38 MAP kinase (Han et al, 1994; 
Rouse et al, 1994; Raingeaud et al, 1995), are strongly activated by environmental 
stress including heat shock and UV irradiation, cytokines such as tumour necrosis 
factor (TNF), interleukin-1 (IL-1), toxins such as lipopolysaccharide (LPS) and 
hypoxia (Han et al, 1994; Rouse et al, 1994; Raingeaud et al, 1995; Verheij et al, 
1996; Lee et al, 1994b). Others have shown that the JNK cascade is a key pathway by 
which agonists stimulate DNA synthesis in primary cultures o f rat hepatocytes (Auer 
et al, 1998) whilst a role for p38 has been shown to increase myocardial cell growth 
and gene expression (Zechner et al, 1997), and also is involved in the proliferation of 
adventitial fibroblasts from chronically hypoxic calves (Das et al, 1999). Since these 
kinase pathways play a critical role in responding to cellular stress and promoting cell 
growth and survival (Widmann et al, 1999), we have investigated the effect of 
hypoxia upon the p38 KAP kinase, JNK and p42/p44 MAP kinase signalling 
enzymes.
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6.2 METHODS
6.2.1 Cell Culture
Bovine lungs from adult cows were obtained from the local abattoir and pulmonary 
artery fibroblasts from the freshly excised lung tissue were harvested as described in 
Chapter 2.3.2. The identity o f fibroblast cells was confirmed by immunohistochemical 
stains as described in Chapter 2.3.3.
6.2.2 Growth of cells in a hypoxic environment
A humidified temperature controlled incubator (LEEC model GA156 Colwick, 
Nottingham, UK) was used as a hypoxic chamber as described in Chapter 2,4,1.
6.2.3 Solid-Phase JNK Assay
JNK activity was measured by a solid-state kinase assay with GST-c-Jun as the 
substrate (Chapter 2.8.5). Phosphorylated proteins were separated by SDS-PAGE and 
detected by autoradiography.
6.2.4 Solid-Phase p38 MAP kinase Assay
p38 MAP kinase activity was measured by a solid-state kinase assay utilising GST- 
MAPKAP kinase-2 as the substrate (Chapter 2.8.6).
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6.2.5 p42/44 MAP kinase phosphorylation and activation
MAP kinase phosphorylation status was assessed by Western blotting using 
retardation on SDS-PAGE gels as a marker o f phosphorylation (Chapter 2.8.4). 
Activity was assayed in solubilised cell lysates using the EGF receptor peptide
EGF^^O-681 as substrate (Chapter 2.8.7). The phosphorylated peptide was separated 
from other products by ion-exchange chromatography on Whatman p81 paper and 
quantified by liquid scintillation counting.
6.2.6 Statistics
Results are expressed as the mean ± S.D. Statistical analysis was undertaken as 
reported in Chapter 2.10.
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6.3 RESULTS
6.3.1 Effect of hypoxia on JNK and p38 MAP kinases
Hypoxia is an extremely common physiological stressor. To investigate the effects of 
hypoxia on the stress-activated signalling pathways, BPAF cells were exposed to 2% 
oxygen for various times. Cell lysates were used to study the phosphorylation of GST- 
c-jun (JNK activity) or GST-MAPKAPK-2 (p38 activity).
Figure 6 .1 shows the effect o f hypoxia on JNK activity over a 24 h period. After a lag 
period o f up to 3h a large increase in JNK activity was observed in response to 
hypoxia which peaked at approximately 6h before decreasing slowly towards basal 
values for the remainder o f the time course. Stimulation o f JNK activity under 
hypoxic conditions at the 6h time point was 10.5-fold increased over basal activity, 
and was at least as great as that induced by 0.5M sorbitol, a known activator o f JNK.
Figure 6.2 shows the effect o f hypoxia on p38 MAP kinase activity over a 3Oh time 
period. It was found that hypoxia could also stimulate p38 MAP kinase activity. Like 
JNK, maximum activity was reached by 6h before returning to basal between by 12h 
(Figure 6.2A). However, in contrast to JNK activity, a second peak o f p38 MAP 
kinase activity was observed which was maximal between 18-24 h before returning to 
basal levels again by 30h (Figure 6.2B).
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GST-c-Jun
C S 0.5 1 3 6 12 18 24
Hypoxia (hrs)
Figure 6.1 Acute Hypoxic Stimulation of JNK activity in BPAF Cells.
JNK activity as assessed by a solid state kinase assay as described in Chapter 2.8.5. Cells were 
incubated in hypoxic conditions for 0 (control, C), 0.5, 1, 3, 6, 12, 18 or 24h or with sorbitol 
(S) (0.5M for 30mins). Numbers represent time in h. The blot is a representative example from 
at least 4 independent experiments.
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A
'iauwtfr _GST-MAPKAP
kinase-2
C S 0.5 1 3 6 12 18 24
Hypoxia (hrs)
B
m m tm MgggggL - __ GST-MAPKAPkinase-2
C S  6 16 20 24 28 30 C30
Hypoxia (hrs)
Figure 6.2 Acute Hypoxic Stimulation of p38 MAP Kinase Activity in BPAF 
Cells
p38 activity as assessed by a solid state kinase assay as described in Chapter 2.8.6. 
Cells Avere incubated in hypoxic conditions in the first instance (A) for 0, (Control, C), 
0.5, 1, 3, 6, 12, 18 and 24h, or in the second instance 0, (Control, C), 6, 16, 20, 24, 28 
and 3Oh or with sorbitol (0.5M for 30 mins). Numbers represent the time in hours. The 
blot is a representative example firom at least 4 independent experiments.
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6.3.2 Effect of hypoxia on p42/44 MAP kinase phosphorylation and activity
To determine whether the observed increases in p38 MAP kinase and JNK activities 
were components o f a general response to hypoxic conditions by all MAP kinase 
family members, we analysed the effect o f lowered O2  on p42/44 MAP kinase 
activity. Figuie 6.3 shows the effect o f acute hypoxia upon the phosphorylation and 
activity o f  p42/44 MAP kinase. A decrease in the electrophoretic mobility o f a protein 
was indicative o f its phosphorylation. Cells incubated over a time cour se o f up to 28h 
in 2% O2  showed no change in electrophoretic mobility o f  p42 or p44 MAP kinase 
iso forms representative o f their phosphorylation (Figure 6.3A). In contrast, 
stimulation o f cells with 10% serum for 30min resulted in a decrease in the 
electrophoretic mobility o f both p42 and p44 MAP kinase iso forms, representative o f 
their phosphorylation (Figure 6.3 A). In addition, there was a weak activation o f MAP 
kinase activity (Figure 6.3B) in response to lowered 0 2  with a maximum 1.8-fold 
increase in activity after 3h o f hypoxic challenge. In contrast, 10% serum stimulated 
a substantial 6-8 fold increase in activity o f MAP kinase.
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Figure 6.3 Acute Hypoxic Stimulation of p42/p44 MAP Kinase Activity in BPAF Ceils
MAP kinase activity as assessed by western blot analysis (A) and an in vitro kinase assay (B) as 
outlined in Chapters 2.8.4 and 2.8.7, respectively. In A, cells were incubated in hypoxia (H) for 0 
(Control, C), 2, 4, 6, 20, 24 and 48h or with Serum (S) (10%) for SOmins. Cell extracts were 
prepared and equal protein amounts subjected to SDS-PAGE and western blot analysis o f 
p42/p44 MAP kinase isoforms. In B, cells were incubated in hypoxia for 0, 0.5, 1, 3, 6, 12, 18 
and 24h or with serum (S) (10%) for BOmins. Cell extracts were prepared and used in an assay to 
measure MAP kinase activity. Numbers represent time in hours. Each experiment is 
representative o f at least 3 independent experiments.
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6.3.3 Inhibition of Hypoxic Stimulation of p38 MAP Kinase Activity by 
SB203580
Since whole cell lysates were utilised as a source o f p38 MAP kinase in these activity 
assays, we utilised a specific inhibitor if this enzyme to ascertain whether p38 MAP 
kinase was the enzyme that phosphorylated MAPKAPK-2 in these assays. Following 
6h o f hypoxic challenge, a 9.9 ± 3.8 fold (n=3) phosphorylation o f MAPKAPK-2 was 
observed (Figure 6.4). This response was approximately 50% o f the phosphorylation 
o f this substrate in response to sorbitol (18.2-fold ± 4.5; n=3). At the 24h time point, a 
5-fold increase in phosphorylation o f MAPKAPK-2 was observed in response to 
hypoxia (4.9 fold ± 2.8; n=3). SB 203580 (0.1 pM), a specific inhibitor o f p38 MAP 
kinase (Cuenda et al, 1995), prevented the rise in p38 MAP kinase activity caused by 
hypoxia and sorbitol (Figure 6.4).
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Figure 6.4 Inhibition of Hypoxic Stimulation of p38 MAP kinase by SB203580
p38 MAP kinase activity as assessed by an in vitro kinase assay as outlined in Chapter 2.8.6.
Cells were incubated in hypoxic conditions (H) for 6 and 24h or with sorbitol (S; 0.5M) for 
30mins. Whole cell lysates were prepared which were then used to measure MAPKAP-kinase 2 
phosphorylation. The experiments were repeated following pre-incubation with 0.1 pM 
SB203580 (SB), a specific p38 MAP kinase inhibitor, for 60min. Each value is the mean+S.D. o f 
3 independent experiments.
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6.3.4 Reversal of the late phase of hypoxie-mediated p38 MAP kinase activity 
by re-oxygenation.
In order to determine if continuous hypoxia was requked for the late phase (24h) of 
p38 MAP kinase activity observed in Figure 6.2, cells were re-oxygenated at different 
times after the initial stimulation period. Re-oxygenation prevented the hypoxic 
stimulated p38 MAP kinase activity after 6 and 12h (H6, H I2) but not after 18 and 
24h (HI 8, H24) (Figuie 6.5), suggesting the requirement o f a continued hypoxic 
environment for the initiation o f  the second phase o f the response.
Figure 6.5
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Figure 6.5 Reversal of the Late Phase of Hypoxic-Mediated p38 MAP Kinase Activity 
by Re-Oxygenation.
Effect o f re-oxygenation on reversal o f  hypoxic mediated p38 MAP kinase activity by re­
oxygenation. Cells were either exposed to hypoxic conditions for various times (H6 and 
H24) without subsequent re-oxygenation (R) or were exposed to hypoxia for 6, 12 and 18h 
followed by 18, 12 and 6h o f re-oxygenation, respectively. Following this time, cell 
extracts were prepared and used to measure p38 MAP kinase activity as in Chapter 2.8.6. 
Each value is representative o f  at least three experiments (R = re-oxygenation).
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6.4 DISCUSSION
In Chapter 4 we showed that acute hypoxia stimulated a significant increase in 
incorporation o f pHJthymidine into DNA in fibroblast cells derived from the 
pulmonary artery. This suggests that hypoxia could increase the proliferation o f these 
cells. The present chapter has focussed on the effect o f acute hypoxia on the MAP 
kinase family o f enzymes that have been implicated as playing an important role in 
cell growth and proliferation (Milanini et al, 1998). A study by Seko et al (1996), 
showed that the classical p42/p44 MAP kinase isoforms were involved in the 
initiation o f hypoxia-mediated increases in cell growth and division in rat cardiac 
myocytes. In that study only a small stimulation o f p42/44 MAP kinase activity was 
observed which agrees with the findings o f this chapter. Whilst some studies have 
implicated stress-activated MAP kinases in the stress responses o f cardiac myocytes 
to ischaemic damage and reperfusion (Morooka et al, 1995; Bogoyevitch et al, 1996; 
Bogoyevitch et al, 1995), this is the first study which implicates a role for stress- 
activated protein kinase activation in the response o f cells derived from the pulmonary 
vasculature to hypoxia.
An initial peak o f JNK and p38 MAP kinase activity was observed between 3 and 6 
hours o f hypoxic challenge which was comparable in magnitude to sorbitol 
stimulation, a well-recognised activator o f the SAP kinases. This result was similar to 
that described by Conrad et al (1999) who observed maximal p38 MAP kinase 
phosphorylation after 6h exposure by hypoxia in PC12 cells. This is unlike the p38 
MAP kinase and JNK response to other environmental stress agents and cytokines, 
where peak activation occurs between 30 and 60 min (Han et al, 1994; Rouse et al, 
1994; Raingeaud et al, 1995; Verheij et al, 1996; Lee et al, 1994b). One possible
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reason for this may be the time required to equilibrate the media to low oxygen 
conditions in this study. However, this time course o f activation is similar to that 
observed in PC 12 cells following serum-deprivation (Xia et al, 1995) and so it is 
possible that this is a physiologically relevant pattern o f cellular activation o f stress- 
activated protein kinases following certain stimuli, including hypoxia. We also found 
that the classical p42/p44 MAP kinases were stimulated in response to hypoxia, 
however, this was a weak stimulation in comparison to that seen with the stress- 
activated forms.
A second peak o f p38 MAP kinase activity was observed under hypoxic conditions in 
pulmonary artery fibroblasts, occurring between 18 and 24h at a time when JNK 
activity was low in these cells. Significantly, this second phase o f  p38 MAP kinase 
activity coincided with the time required for the initiation o f  DNA synthesis in this 
cell type (Belham et al, 1996). This second phase also required the continued 
presence o f a hypoxic environment suggesting a clear specificity in the signals 
required to initiate this response. The effect was blocked by the specific p38 MAP 
kinase inhibitor, SB 203580. To date only one other study has indicated activation o f 
p38 MAP kinase in the absence o f JNK and this is following ischemic challenge o f 
cardiac myocytes (Bogoyevitch et al, 1996). Thus, under certain conditions related to 
the oxygen environment, p38 MAP kinase may be activated specifically.
Following the early peak in JNK and p38 MAP kinase activity in response to hypoxia, 
the activation o f these enzymes decreases. It is possible that these are being 
inactivated by phosphatases. Interestingly, recent publications have shown specific 
mitogen-activated protein kinase phosphatases (MKP) which are induced by low 
oxygen conditions and are specific for SAPKs (Laderoute et al, 1999; Keyse/, 1999;
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Thoedosiou et al, 1999). Such phosphatases may be responsible for the observed 
decreases in JNK and p38 MAP kinase activities.
Following the initial peak in p38 MAP kinase, there was a second peak in activity and 
it may be that the activity o f this enzyme is regulated during the cell cycle in response 
to hypoxia. Since pulmonary artery cells are stimulated to contract and proliferate in 
response to hypoxia, it is possible that p38 MAP kinase plays a positive role in cell 
division by regulating cell cycle progression (Lavoie et al, 1996).
These studies have established that both JNK and p38 MAP kinase are activated in 
response to acute hypoxic stimulation o f pulmonary artery-derived fibroblasts. Since 
the effects o f pulmonary hypertension are a result o f continuous, chronic exposure of 
cells to hypoxia, it is o f interest to establish if  these enzymes are also activated by 
long-term hypoxic exposure.
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Chapter 7
Effects of Serum on Proliferation and Generation of MAP Kinases in 
Fibroblasts Harvested from Pulmonary Arteries from Chronically
Hypoxic Rats
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7.1 INTRODUCTION
In the previous chapters it was shown that acute hypoxia was capable of causing 
BPAFs to proliferate, either on its own or in conjunction with mitogens. In addition, it 
was also shown that hypoxia gave rise to increases in SAPK activity, p38 MAP kinase 
and JNK. Although hypoxia induces structural remodelling and vasoconstriction of 
the pulmonary arteries in vivo, the effects o f hypoxia on systemic vascular cells are 
quite different (Welsh et al, 1998). As hypoxia does not result in vasoconstriction but 
rather induces vasodilation o f systemic vessels (von Euler and Liljestrand, 1946), we 
have proposed that there are fundamental differences in oxygen sensing and cell 
signalling between systemic and pulmonary artery cells. Indeed, our own work has 
shown that hypoxia stimulates proliferation and second messenger production in 
pulmonary artery fibroblasts but does not affect fibroblasts derived from the 
mesenteric artery.
For the first time our studies have shown a link between vasoconstriction and 
remodelling since acute hypoxia was found to increase the rate o f replication of 
pulmonary artery derived fibroblasts but not fibroblasts from the systemic circulation 
(Welsh et al, 1998). The biochemical and molecular mechanisms by which hypoxia 
stimulates proliferation of pulmonary artery fibroblasts are unknown. There is 
however, considerable evidence in the literature that p42/p44 MAP kinases, and the 
related stress-activated kinases, JNK and p38 MAP kinase, which have been 
implicated as key regulators o f cell proliferation (Scott et al, 1998), can be activated 
in response to hypoxic stress (Robinson and Cobb, 1997; Takahashi and Berk, 1998). 
These modulate the phosphorylation, and hence activation status o f transcription 
factors, and link transmembrane signalling with gene induction events in the nucleus 
(Robinson and Cobb, 1997).
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In this current study we have investigated whether fibroblasts derived from the 
pulmonary and systemic circulations o f  chronically hypoxic rats, in which irreversible 
pulmonary vascular re-modelling has taken place (Hunter et al, 1974), exhibit 
differential replicative properties. In addition, we compared some of the cell 
signalling enzymes that were activated in pulmonary artery fibroblasts derived from 
chronically hypoxic rats with those derived from control rats kept under normoxic 
conditions. In particular, we investigated the roles of p42/p44 MAP kinase and stress- 
activated MAP kinases in hypoxia-induced pulmonary artery fibroblast proliferation 
and pulmonary vascular remodelling following chronic exposure to hypoxia.
7.1.1 Normobaric versus Hypobaric hypoxia
Hypoxic animal models (mainly rats and mice) have been used since the 1920’s to 
study various environmental conditions and disease states. The animals were exposed 
to hypoxic environments by the use o f environmental chambers (normobaric hypoxia; 
a decreased inspired O2 at normal atmospheric pressure, or hypobaric hypoxia; a 
decreased inspired O2 due to decreased atmospheric pressure) or by actual relocation 
o f the animals to altitude where the inspired O2 levels are lower than at sea level 
(Campbell, 1927a,b,c; Timiras et al,, 1957). These early investigations studied the 
acclimatisation of animals to altitude, or the O2 tensions that would be experienced at 
altitude. Animals exposed to these hypoxic environments exhibited initial weight loss 
and alterations in certain organ weights (Camprell, 1935; Timiras et al., 1957). The 
basic principles o f no rmo baric and hypobaric hypoxia are described below.
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7.1.2 Normobaric hypoxia
The normobaric method o f chronic hypoxia used by most investigators has been 
adapted from a chamber described by Cryer and Bartley (1974). The O2 concentration 
within the chamber is reduced from the normal 21% to -10%  (IbOmmHg to 
~80mmHg O2) by intermittent gaseous infusion o f N 2 . To prevent the build up of 
CO2, humidity and other gases, the air is circulated through specific chemical 
absorbers.
7.1.3 Hypobaric hypoxia
Hypobaric hypoxia reduces the inspired O2 content o f the environment by reducing 
the atmospheric pressure within the chamber. This is the equivalent o f taking the 
animals to high altitude. As the atmospheric pressure decreases, the partial pressure of 
the gaseous components of air decreases. Therefore, while the percentage o f the 
gaseous components o f the air remains the same (O2 ~ 21% and N2 -  78%), the 
effective partial pressure o f inspired O2 declines. Hypobaric hypoxia is achieved by 
withdrawing air from the chamber by use o f a pump until the pressure within the 
chamber is equivalent to -0.5 atmospheres, which reduces the inspired O2 pressure 
from IbOmmHg to 80 mmHg. The chamber is continuously flushed with room air to 
maintain conditions o f low humidity and CO2 .
Wliile normobaric and hypobaric chambers are both commonly used (mainly for the 
study o f pulmonary hypertension), the hypoxic hypobaric chamber has proved to be 
more econimical and it is the type which was used in these studies. The Royal 
Hallamshire Hospital (Sheffield) designed and manufactured the hypoxic hypobaric 
chamber for Dr Margaret MacLean and her pulmonary research group based in the 
Institute of Biomedical and Life Sciences at the University o f Glasgow. The chamber 
conforms to the high safety standards required by the Home Office.
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Cells were derived from animals maintained in the hypobaric chamber and compared 
to those from animals from a normoxic environment. Differences in proliferation and 
signalling mechanisms between these cells have been studied.
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7.2 METHODS
7.2.1 Chronic hypoxic rat model of pulmonary hypertension.
Pulmonary hypertensive rats were made hypoxic using the technique of MacLean et 
al (1995) (Chapter 2.5).
7.2.2 Pulmonary artery fibroblast cell culture
Rat pulmonary artery fibroblast (RPAF) and rat aortic fibroblast (RAF) cells were 
hai vested from fr-eshly excised lung tissue o f control and chronically hypoxic animals 
as described in Chapter 2.3. All tissue was obtained from the laboratory o f Dr. M. 
McLean (Dept, o f Physiology and Pharmacology, University o f Glasgow) and age- 
matched animals were always used as controls. The identity o f the fibroblast cells was 
confirmed by immunocytochemical staining as described in Chapter 2.3.3.
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7,2.3 Measurement of Serum-Stimulated [^HjThymidine Uptake in RPAF and 
RAF cells.
For these experiments, primary cultures o f RPAF or RAF cells derived from normoxic 
or chronically hypoxic rats were transferred to 24-well plates. For acute hypoxic 
conditions we used an atmosphere o f 2% O2 (Chapter 3.2.3). Our previous studies 
(Chapter 3.2.3) have established that a 6h preincubation under these conditions o f 
hypoxia is required to achieve the desired PO2 levels (35mmHg) in the culture 
medium. Once established, we found the PO2 levels to remain constant at 35mmHg 
(Welsh gr a/, 1998).
Proliferation o f rat pulmonary artery fibroblasts was assessed by measuring the uptake 
o f [^H]thymidine (Chapter 2.6). Cells were grown to approximately 60% confluency
in 24-well plates at 37®C and then serum-starved for 24h. After this time 5% serum 
was added for a further 24h in the presence and absence of the p38 MAP kinase 
inhibitor, SB203580 (0.1 pM) or o f the MAP kinase inhibitor, U0126 (IpM ). 
[^H]Thymidine was added for the final 4h o f the incubation. The reaction as stopped 
and assessed as in Chapter 2.6.
7.2.4 Assessment of Phosphorylation of p42/p44 MAP kinase and members of 
the Stress-Activated MAP kinase family
Cells were grown to approximately 90% confluency in 6-well plates at 37^C and then 
serum starved for 24h. After this time the following additions were made as described 
below.
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To determine the effect o f serum on p38 MAP kinase, p42/p44 MAP kinase and JNK 
activity on RPAF and RAF cells from normoxic and chronically hypoxic cells, 5% 
serum was added to the cells for 0, 1,2, 4, 8, 16, 24, 32 and 48h.
To determine the effect o f SB203580 on p38 MAP kinase activity, RPAF and RAF 
cells from normoxic and chronically hypoxic animals, 0.1 pM SB203580 was added to 
the cells for Ih prior to serum-stimulation for 2h.
To determine the effect o f U0126 on p42/p44 activity on RPAF and RAF cells from 
normoxic and chronically hypoxic animals, IpM  U0126 was added to the cells for Ih 
prior to serum stimulation for 2h.
Assessment o f the phosphorylation status o f  these enzymes was by SDS-PAGE gel 
electrophoresis and western blot analysis using phospho-specific antibodies (Chapter 
2.8). In each case, the primary rabbit anti-dual phosphorylated, activated MAP kinase 
antibody for the protein o f interest (p42/44, p38 and JNK) were utilised.
7.2.5 Statistics
Results are expressed as the mean ± S.D. Statistical analysis was undertaken as 
reported in Chapter 2.10.
7 3  RESULTS
73.1 Effect of Acute Hypoxia on RPAF and RAF cells Derived from Normoxic 
and Chronically Hypoxic Rats,
In Chapter 3 it was shown that BPAFs proliferate in response to hypoxia in the 
absence o f any mitogens. To test the effect o f acute hypoxia on rat cells, growth- 
arrested and serum-stimulated pulmonary artery-derived rat fibroblasts (RPAF) were 
exposed to 2% O2 or left under normoxic conditions. The effect o f acute hypoxia on 
the same cells derived from rats exposed to chronic hypoxia (2 weeks 18% O2) was 
also investigated. Figure 7.1 shows the effects o f acute hypoxia on proliferation o f 
RPAF and RAF cells from rats either kept in normoxic conditions or kept in hypoxia 
for 2 weeks.
There was a 9.3-fold increase in [^H]thymidine uptake when RPAF cells were 
cultured in the presence o f 5% serum following serum-starvation for 24 h (p<0.01) 
(Figure 7.1 A). When RPAF cells were simultaneously exposed to 5% serum and acute 
hypoxia, there was a 19.2-fold increase in the resultant level o f DNA synthesis 
observed (p<0.01) in comparison to control, unstimulated cells (Figure 7.1 A). 
Similarly, RAF cells showed a 9-fold increase in [^Hjthymidine uptake in response to 
serum (Figure 7.IB). In contrast to RPAF cells, however, RAF cells do not exhibit an 
enhanced level o f DNA synthesis in response to acute hypoxia (p>0.05) (Figure 
7 .IB). Unlike pulmonary artery fibroblasts derived fiom cows, the same cells derived 
from rats do not respond to acute hypoxia alone (Figure 7.1 A).
RPAF cells from chronically hypoxic rats exhibited an 18-fold increase in the level of 
DNA synthesis relative to cells from control rats (p<0.01) (Figure 7.1 A and 7.2A). 
Further increase above the enhanced level o f  DNA synthesis observed in RPAF cells
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from chronically hypoxic rats could not be achieved by exposing these cells to acutely 
hypoxic conditions (p>0.05) (Figure 7.2A). RAF cells showed similar levels o f 
replication regardless of whether the explants were derived from normoxic or 
chronically hypoxic rats (639±47) (Figures 7.1B & 7.2B) (also Table 1: stimulation 
indices for pooled data for 8 different animals).
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Table 7.1
Control 5% Serum
RPAF
Control 
Chronic Hypoxic 
RAF
Control 
Chronic Hypoxic
Normoxia Acute Hypoxia Normoxic Acute Hypoxia
0.996 ± 0.09 
1 .1+0.97
0.97 ± 0.05 
0.96 ± 0.7
7.39 ± 0.39 
14,76 ± 0.91
7.57 + 0.56 
7.49 ± 0.95
14.39 ± 0.76 
14.95 ± 0.87
7.62 ± 0.48 
7.51+0.21
Definition o f  abbreviations: RPAF = Rat pulmonary artery fibroblasts, RAF = 
Rat aortic fibroblasts.
Table 1 Stimulation Indices of DNA Synthesis for Control and Chronic 
Hypoxic Rat Fibroblast cells from the Pulmonary and Aortic Circulation 
Following Acute Hypoxic Challenge.
RPAF and RAF cells from control and chronically hypoxic animals were grown in 
normoxia to 60% confluency in 24-well plates then quiesced in serum-free medium 
for 24h before stimulation with 5% serum. The cells were then allowed to grow in 
either normoxia or transferred to an environment o f 2% oxygen (PO2 o f 35mmHg) for 
a period o f  24h. Cell growth was assessed by [^H]thymidine uptake. Values shown are 
the stimulation indices (mean ± S.D.) for pooled data for 8 different animals for the 
‘typicaT results shovm in Figures 7.1 & 7.2.
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Figure 7.1
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Figure 7.1 The Effect of Serum on [^H]thymidine Uptake from Normoxic (□ ) and Acutely 
Hypoxic (■ ) RPAF and RAF cells.
RPAF (A) and RAF (B) cells were grown to 60% confluency in 24-well plates and then quiesced 
in serum-free medium. Cells were either maintained in a normoxic environment for a further 6h 
or were placed in a hypoxic incubator (2% O2,35mmHg) for 6h. The cells were then stimulated 
with 5% serum as indicated in the graph and allowed to grow in either normoxic or hypoxic 
conditions for a period o f 24h. The experiment was repeated with cells from 8 different animals 
and the results shown ate typical o f those obtained. See table 7.1 for pooled results from all 
animal data. (DPM = Disintegrations per minute, * = values for hypoxia significantly greater 
than normoxia).
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Figure 7.2 Effect of Serum on [^H]thymidine Uptake in RPAF cells from Chronically 
Hypoxic Rats (□ ) and Fibroblasts from Chronically Hypoxic Rats exposed to Acute 
Hypoxia (■ ) and in RAF cells
RPAF (A) and RAF (B) cells were grown to 60% confluency in 24-well plates and then quiesced 
in serum-free medium. Cells were either maintained in a normoxic environment for a further 6h 
or were placed in a hypoxic incubator (2% O2,35mmHg) for 6h. The cells were then stimulated 
with 5% serum as indicated in the graph and allowed to grow in either normoxic or hypoxic 
conditions for a period o f 24h. The experiment was repeated with cells from 8 different animals 
and the results shown are typical o f  those obtained. See Table 7.1 for pooled results from all 
animal data. (DPM = Disintegrations per minute, * = values for hypoxia significantly greater 
than normoxia.
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7.3.2 Differential p38 and p42/p44 MAP kinase phosphorylation in RPAF and 
RAF cells from normoxic and chronically hypoxic rats.
We have previously shown that exposure o f BPAFs to acute hypoxia induces the 
activation o f the SAPKs, JNK and p38 MAP kinase. We therefore investigated 
whether these signalling enzymes played a role in the enhanced proliferation and 
remodelling o f fibroblasts observed after prolonged (14 days) exposure to chronic 
hypoxia. To do tliis, we have examined the activation of members o f the MAP kinase 
family by detecting their dually phosphorylated (tyr/thr) forms by Western blotting 
using specific anti-active phosphokinase antibodies (Feng et al, 1999). Serum- 
stimulation o f RPAF from control rats incubated under normoxic conditions showed a 
weak activation o f p38 MAP kinase as indicated by its dual phosphorylation of its 
regulatory thr/tyr motif which peaked at between 1 and 4 h stimulation with serum 
(Figure 7.3A, upper panel). In contrast, p38 MAP kinase was found to be strongly 
constitutively active in RPAF cells derived from rats subjected to chronically hypoxic 
conditions, and this activity was further enhanced in the presence o f serum, 
particularly in the period I6-48h post-stimulation (Figure 7.3A, upper panel). This 
increase in p38 MAP kinase phosphorylation was not due to an upregulation o f the 
p38 protein expression, as Western Blot analysis using an antibody which detects total 
amounts o f p38, revealed compaiable levels o f p38 MAP kinase expression in RPAF 
cells from chronically hypoxic and normoxic rats (Figure 7.3A, lower panel). RAF 
cells, however, despite expressing substantial levels of p38, did not show significant 
change in the phosphorylation o f p38 MAP kinase in response to serum, nor was this 
activity modulated following chronic exposure o f the rats to hypoxia (Figure 7.3B).
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A similar pattern was observed for p42/p44 MAP kinase. Serum-induced p42/p44 
MAP kinase (particularly the p42 MAP kinase isoform) activity in normoxic RPAF 
cells in a multiphasic manner (peaks at Ih and 24h), and RPAF from chronically 
hypoxic rats showed strong constitutive activity o f p42/p44 MAP kinase (Figure 
7.4A). Although, there appeared to be a slight upregulation in p42/p44 MAP kinase 
expression in these cells, this upregulation was not sufficient to explain the very high 
levels o f kinase activity observed (Figure 7.4A). As with p38 MAP kinase, chronic 
exposure to hypoxia did not modulate p42/p44 MAP kinase activation in RAF cells, 
which already appeared to exhibit a considerable level o f constitutive p42/p44 MAP 
kinase activity which was not significantly modulated by addition o f serum (Figure 
7.4B). There was a small increase in phosphorylation of JNK on the addition o f serum 
to normoxic and hypoxic RPAF cells, however, there was no significant difference in 
the amount o f phosphorylated JNK or amount o f total JNK protein following serum- 
stimulation o f hypoxic RPAF relative to that observed in RPAF from control 
normoxic rats (Figure 7.5A). There was no significant change in the phosphorylation 
o f JNK in response to serum in RAF cells derived from either normoxic or hypoxic 
rats (Figure 7.5B).
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Figure 7.3 p38 M AP kinase Phosphorylation in Pulm onary A rtery and Aortic F ibroblast
cells from Normoxic and Chronically Hypoxic Rats.
RPAF (A) and RAF (B) cells were grown to 90% confluency in 6-well plates and then quiesced 
for 24h in serum-free medium. The cells were then stimulated with 5% serum for a range o f 
times as indicated in the graph. Assessment o f phosphorylation was by SDS-PAGE gel 
electrophoresis and western blot analysis using phospho-speciflc antibodies (Chapter 2.S.4.2). (N 
= cells from normoxic rats: H = Cells from chronically hypoxic rats). The experiment shown is 
one o f 4 replicate experiments and is typical o f those obtained.
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Figure 7.4 p42/p44 MAP kinase phosphorylation in Pulmonary Artery and Aortic 
Fibroblast Cells from Normoxic and Chronically Hypoxic Rats.
RPAF (A) and RAF (B) cells were grown to 90% confluency in 6-well plates and then quiesced 
for 24h in serum-free medium. The cells were then stimulated with 5% serum for a range o f 
times as indicated in the graph. Assessment o f phosphorylation was by SDS-PAGE gel 
electrophoresis and western blot analysis using phospho-speciflc antibodies (chapter 2.S.4.2). (N 
= cells from normoxic rats: H = Cells from chronically hypoxic animals). The experiment shown 
is one o f 4 replicate experiments and is typical o f those obtained.
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Figure 7.5
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FIGURE 7.5 JNK Phosphorylation in Pulmonary Artery and Aortic Fibroblast Cells from 
Normoxic and Chronically Hypoxic Rats.
RPAF (A) and RAF (B) cells were grown to 90% confluency in 6-well plates and then quiesced 
for 24h in serum-free medium. The cells were then stimulated with 5% serum for a range o f 
times as indicated in the graph. Assessment o f phosphorylation was by SDS-PAGE gel 
electrophoresis and western blot analysis using phospho-speciflc antibodies (Chapter 2.8.4.2). (N 
= cells from normoxic rats; H = Cells from chronically hypoxic animals). The experiment shown 
is one o f 4 replicate experiments and is typical o f those obtained.
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7.3.3 Differential Roles for p38 and p42/p44 MAP kinase in RPAF and RAF 
DNA synthesis from Normal and Chronically Hypoxic Rat Cells.
As p38 and p42/p44MAP kinase were highly phosphorylated in RPAF cells derived 
from hypoxic but not normoxic rats, we decided to investigate, using specific 
pharmacological inhibitors, the role of these kinases in the hypoxia-enhanced 
proliferation o f RPAF cells. A selective and potent inhibitor o f the p42/p44 MAP 
kinase cascade, U0126, mediates its effects by binding to and inactivating MEK, 
whereas it has no effect on any o f the components o f the JNK or p38 MAP kinase 
cascades (Feng et al, 1999). Similarly, the compound SB203580 is a selective and 
potent inhibitor o f p38 MAP kinase that does not affect either p42/p44 MAP kinase or 
JNK (Cuenda et al, 1995). These reagents are usefiil pharmacological tools in 
identifying the functional activities mediated by p38 and p42/p44 MAP kinases. Pre­
incubation for Ih with SB203580 (0.1 pM) inhibited p38 phosphorylation (Figure 
7.6A) in RPAF and RAF cells. In addition, pre-incubation for Ih with U0126 (IpM ) 
profoundly inhibited both the hypoxia- and serum-stimulated p42/p44 MAP kinase 
activation in these cells (Figure 7.6B).
Having demonstrated the activity o f these kinase inhibitors, we used them to test the 
importance o f p42/44 and p38 MAP kinase activity observed in RPAF, but not RAF 
cells derived from chronically hypoxic rats on [^HJthymidine uptake (Figure 7.7). 
These results showed that SB203580 and U0126 had no effect on the DNA synthesis 
resulting from basal (results not shown) or serum-stimulation o f RPAF or PAF cells 
derived from normoxic rats (Figures 7.7A & 7.7B). In contrast, the p38 inhibitor 
SB203580 completely abrogated the enhanced serum-stimulated DNA synthesis 
observed in RPAF (701+72 with the inhibitor compared for 1217+118 without 
p<0.01), but not RAF cells from chronically hypoxic rats (981+117 with the inhibitor
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compared for 952+96 without p>0.05) (Figures 1.1 A  & 7.7B), such that the response 
was now equivalent to that observed in cells derived from control normoxic rats 
(652+51). The p42/p44 MAP kinase cascade inhibitor, U0126 had no effect on this 
hypoxia-induced enhancement o f DNA synthesis (1171+120 with U0126 compared 
with 1217+118 without p>0.05).
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FIGURE 7.6 Effect of Specific Kinase Inhibitors on Phosphorylation of p38 and 
p42/p44 MAP kinases in Pulmonary Artery and Aortic Fibroblast Cells from Normoxic 
and Chronically Hypoxic Rats.
RPAF cells were grown to 90% confluency in 6-well plates and then quiesced for 24h in serum- 
free medium. The cells were then pre-incubated with 0.1 pM SB203580 (A; lanes 1-8) or IpM  
U0126 (B; lanes 1-8) for either Ih  (T-1) or 2h (T-2) prior to stimulation with 5% serum for 2h. 
Assessment o f phosphorylation was by SDS-PAGE gel electrophoresis and western blot analysis 
using phospho-speciflc antibodies (Chapter 2.S.4.2). The experiment shown is one o f 4 replicate 
experiments and is typical o f those obtained.
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FIGURE 7.7 Effect of SB203580 and U0126 on the Enhancement of [^HJThymidine 
Uptake Observed Following Serum-Stimulated RPAF and RAF Cells from Chronically 
Hypoxic Rats.
Uptake o f [^H]thymidme from normoxic (□ ) and chronically hypoxic rats (■ ) in RPAF and 
RAF cells. RPAF (A) and RAF (B) cells were grown to 60% confluency in 24-well plates and 
then quiesced in serum-free medium. The cells were pre-incubated for 2h with either IpM  
SB203580 or with 0.1 fxM U0126 and then stimulated with 5% serum. Cells were then allowed to 
grow in either normoxic or hypoxic conditions for a period o f 24h. The experiment was repeated 
with cells from 8 different animals and the results shown are typical o f those obtained.
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7.4 DISCUSSION
In this chapter we have shown that pulmonary artery fibroblasts from chi’onically 
hypoxic rats exhibit enhanced proliferative responses to serum relative to those 
observed with RPAF derived from normoxie animals. This hypoxia-enhanced 
proliferation was maintained following multiple passages o f these primary cultures of 
cells, which were maintained under normoxic conditions following their eulture from 
the artery. This mirrors the changes observed in vivo in patients with hypoxic 
pulmonary hypertension, where remodelling o f the pulmonary arteries due to 
increased cellular proliferation remains even after oxygen therapy (Traver et al, 
1979). Sustained enhanced proliferative capacities have recently also been reported 
for fibroblasts isolated from the pulmonary artery o f neonatal calves with the severe 
fibroproliferative changes characteristic o f hypoxic neonatal pulmonary hypertension 
(Das et al, 1999). This latter study showed that the proliferative responses o f such 
fibroblasts could be further enhanced following subsequent exposure to acute 
hypoxia. However, in our system, the augmented responses to serum observed in 
RPAF could not be further enhanced by re-exposure to acute hypoxia. This suggests 
that the mechanisms regulating pulmonary vascular remodelling in neonates and 
adults may be different and may provide a rationale for the widely established finding 
that the effects o f hypoxia are more marked in neonates relative to adults (Das et al, 
1999). Interestingly, no remodelling o f the systemic circulation is observed in the 
patients with hypoxic pulmonary hypertension (von Euler and Liljestrand, 1946) and 
this is reflected in our rat model as fibroblasts from rat aorta did not show enhanced 
proliferative capacities following chronic exposure to hypoxia.
The molecular mechanisms by which hypoxia stimulates proliferation o f pulmonary 
artery fibroblasts, but not fibroblasts from the systemic circulation, are unknown. 
There is considerable evidence in the literature, however, that p42/p44 MAP kinases,
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As well as JNK and p38 MAP kinase can be activated in response to hypoxic stress 
(Robinson and Cobb, 1997; Takahashi and Berk, 1998). Indeed, we have shown in 
our model o f acute bovine pulmonary artery hypoxia, that the SAPKs JNK and p38 
MAP kinase, but not the classical p42/p44 MAP kinase isoforms, are activated in 
response to acute hypoxia (Scott et al, 1998). We therefore addressed the role o f all 
three classes of these MAP kinases by investigating whether there was differential 
activation o f these kinases in response to serum in fibroblasts derived from the 
pulmonary and systemic circulation of normoxic versus chronically hypoxic rats. 
Although JNK was strongly activated by hypoxia in the acute model (Chapter 6; Scott 
et al, 1998), we could find no evidence o f JNK phosphorylation in RPAF derived 
from rats subjected to chronic hypoxia (Figure 7.5). Moreover, we could not detect 
any differential phosphorylation o f JNK in response to serum in RPAF derived from 
chronically hypoxic versus normoxic rats (Figure 7.5). However, as the JNK 
activation observed in response to hypoxia in the acute model was transient, peaking 
between 3-6 h following hypoxic challenge, these results may indicate that whereas a 
JNK kinase signal may be required for the initiation o f  hypoxia-mediated events, it is 
not involved in the remodelling process. In contrast, we found strong and constitutive 
activation o f p42/p44 and p38 MAP kinases in RPAF from chronically hypoxic rats 
but not normoxic rats (Figures 3 and 4). In addition, this induction o f constitutive 
p42/p44 and p38 MAP kinase activity was not observed in RAF from either 
chronically hypoxic rats or normoxic rats. Taken together, these results suggested that 
p42/p44 and/or p38 MAP kinase played a role in the enhanced proliferative responses 
observed in remodelled fibroblasts from chronically hypoxic rats.
To address the relative roles o f p42/p44 and p38 MAP kinases in serum and/or 
hypoxia-induced proliferation of RPAF and RAF cells, we performed our
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proliferation assays in the presence o f spécifié inhibitors o f the p42/p44 (U0126) and 
p38 (SB203580) MAP kinase cascades. Given the widely established roles for 
p42/p44 MAP kinases in promoting cell proliferation (Lew et al, 1999; Belham et al, 
1996; Pages et al, 1993), and the strong constitutive activation o f this MAP kinase in 
RPAF cells by chronic hypoxia (Figure 4), it could be considered surprising that the 
p42/p44 cascade inhibitor U0126 had no effect on the enhancement o f serum- 
stimulated proliferation observed in RPAF from chronically hypoxic rats. However, 
examination o f the levels of p42/p44 MAP kinase activity in RAF cells showed that 
these cells also exhibited considerable levels o f  constitutive p42/p44 MAP kinase 
activity despite an inability to display enhanced proliferative capacities following 
exposure to chronic hypoxia. Indeed, p42/p44 MAP kinase activity was found to be 
strongly and constitutively activated in RAF cells regardless o f the oxygen status o f 
the rats they were derived from. Taken together with the finding that p42/p44 activity 
could be stimulated in RPAF cells from normoxic rats following stimulation with 
serum, these results could suggest that p42/p44 MAP kinase activity serves to render 
eells permissive for growth factor mediated-stimulation o f  proliferation. Thus, the 
enhanced p42/p44 MAP kinase signals observed in hypoxic RPAF cells could 
contribute to the augmented growth factor-stimulated responses observed in response 
to chronic hypoxia reported in the bovine neonatal study (Das et al, 1999).
In contrast, and consistent with the differential patterns o f p38 MAP kinase activity 
observed in RPAF and RAF from chronically hypoxic versus normoxic rats (Figure 
3), we found that although p38 MAP kinase activity appeared to be essential for the 
enhanced proliferative response observed in RPAF from chronically hypoxic rats, it 
did not appear to play an important role in transducing serum-induced proliferation in 
either RPAF or RAF cells. This important role for p38 MAP kinase in transducing 
proliferative signals in response to hypoxia reflects our earlier studies on the bovine
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acute hypoxia model which showed that p38 MAP kinase activation was dependent 
on the presence o f a maintained hypoxic environment as sustained p38 MAP kinase 
activity was blocked by re-oxygenation. Moreover, although p38 MAP kinase has 
generally been considered to play a role in the transduction o f apoptotic (Takahashi 
and Berk, 1998) rather than proliferative signals as evidenced by negative regulation 
o f cyclin D expression (Lavoie et al, 1996) and its activation under conditions of 
cellular stress (Xia et al, 1995; Chen et al, 1996) including ischemic damage and 
reperfiision o f cardiac myocytes (Morooka et al, 1995; Bogoyevitch et al, 1995), there 
is some evidence not only that crosstalk between JNK and p38 MAP kinase may be 
required for apoptosis (Wilson et al, 1996; Ichijo et al, 1997) but also that activation 
o f p38 MAP kinase can promote cellular activation, proliferation and differentiation 
(Zhang et al, 1999). Whereas most o f the physiologieal and chemieal stresses which 
can induce apoptosis generally activate both JNK and p38 MAP kinase (Wilson et al, 
1996; Ichijo et al, 1997), we find that under these stress conditions of chronic 
hypoxia, JNK does not appear to be activated and p38 MAP kinase acts to promote 
cellular proliferation.
Finally, there is an urgent need for drugs that eould reverse or prevent the pulmonary 
vascular remodelling whieh occurs in nearly all forms o f  cardiac and respiratory 
disease. At present, however, most vasodilating drugs used to counteract pulmonary 
hypertension result in systemic hypotension. However, since systemic fibroblasts do 
not replicate in the presence o f hypoxia and p38 MAP kinase does not appear to be 
neeessary for the normal replication o f pulmonary systemic vascular fibroblasts, it is 
possible that therapies targeting RPAF p38 MAP kinase could lead to the control of 
pulmonary vascular remodelling without affecting the systemic circulation.
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Chapter 8
Effect of 5-HT on Proliferation and Generation of MAP kinases in 
Fibroblasts Harvested from Pulmonary Arteries from Chronically
Hypoxic Rats
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8.1 INTRODUCTION
As described in Chapter 1, numerous groups have studied changes that take place in the 
pulmonary arteries as a result o f pulmonary hypertension. As a result o f these studies, 
numerous pro-inflammatory factors have been identified which can influence these changes 
(Bitterman and Henke, 1991). The aim of this chapter was to examine the possible role o f 
one such factor, serotonin, on fibroblast cell proliferation and intracellular signalling from 
the pulmonary arteries o f eontrol and chronically hypoxic animals.
Serotonin, also known as 5-hydroxytryptamine (5-HT), is secreted from neuroendocrine 
cells in the gut, and tumours o f these cells, called carcinoid tumours, are a source o f 
increased production o f 5-HT (Hart and Block, 1989; Perry and Vinik, 1996). Pulmonary 
neuroendocrine cells secrete vasoactive substances in response to airway hypoxia and 
hypercapnia (Johnson and Georgieff, 1989; Lauweryns et al, 1983). These eells commonly 
proliferate in patients with pulmonary hypertension, producing a variety o f peptides in 
addition to large amounts o f 5-HT (Gosney et al, 1989). In lung transplant recipients with 
end stage primary pulmonary hypertension the degree of hyperplasia o f these eells was 
found to correlate with the extent o f proliferation o f myofibroblasts in the pulmonary 
arteries (Madden et al, 1994). On a molar basis, 5-HT is the most potent pulmonary 
vasoconstrictor identified to date in humans (Heffner et al, 1987) but in the systemic 
vasculature it causes profound vasodilation (Comroe et al, 1953).
Because o f the prevalence of chronic lung disease, hypoxia is probably the commonest of 
all causes o f pulmonary hypertension. As stated previously, the mechanisms o f hypoxic 
vasoconstriction have been reviewed, but much remains unknown (Voelkel, 1986). In 
healthy subjects hypoxia per se does not appear to increase circulating 5-HT levels (Rahda
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el al 1976), but levels are increased in patients with several types of chronic lung disease 
and associated pulmonary hypertension (Bobrov et al, 1985; Pribilova, 1976).
5-HT is a mitogen causing hyperplastic and hypertrophic changes in smooth muscles 
(Pakala et al, 1994). At least ten classes of 5-HT receptors have been identified, these 
include 5 - H T i a - f ,  5 - H T 2 a -c ,  5 -HT3 and 5 -HT4 (Hoyer et al, 1994), and different receptors 
have been implicated in the pathogenesis of a number o f vascular disorders. For example, 
5-HT 1 and 5-HT] are the principal receptors relevant to the pulmonary arteries (Frishman el 
al, 1996). Under most experimental conditions, stimulation o f the 5-HT, receptor eauses 
vasodilation and the 5-H U  receptor often mediates vasospasm (Frishman et ai, 1996).
Use o f several drugs has indicated a strong link between pulmonary hypertension and levels 
o f 5-HT. Pulmonary hypertension can be induced in most mammals by numerous 
serotonergic drugs, some o f whieh are sympathomimetic anorexients. One such drug is 
dexfenfluramine (Brenot et al, 1993). In dogs, intravenous dexfenfluramine augments 
hypoxic pulmonary vasoconstriction and, with long term oral use, pulmonary vascular 
resistance is increased (Naeije, 1996). How this drug can induce pulmonary hypertension is 
unknown. In contrast to this, drugs that block 5-HT receptors reduce pulmonary 
hypertension. For example, the specific 5-HT]A receptor antagonist ketanserin is the best 
studied agent o f this type for reducing pulmonary hypertension or vascular resistance 
(Brogden and Sorkin, 1990). Like most vasodilators this drug has varying efficacy, 
reflecting the complex pathophysiology o f the disease. In the treatment o f primary 
pulmonary hypertension, McGoon and Vliestra (1984) detected an average reduction of 
pulmonary vascular resistance o f 18% with intravenous use in 10 patients. The effects of 
ketanserin on pulmonary hypertension suggest that serotonergic mechanisms may be 
contributing to the problem.
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The aim of this chapter is to study the effects of 5-HT on the proliferation and generation o f 
MAP kinases in rat pulmonary fibroblasts from control and chronically hypoxic animals. At 
the same time, the effects of specific 5-HT receptor antagonists, such as the 5-HT]a 
receptor antagonist, ketanserin, will be used to help identify if a specific 5-HT receptor is 
involved in the remodelling o f pulmonary arteries during pulmonary hypertension.
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8,2 METHODS
8.2.1 Chronic hypoxic rat model of pulmonary hypertension.
Pulmonary hypertensive rats were prepared using the technique of MacLean et al (1995) 
(Chapter 2.5)
8.2.2 Pulmonary artery fibroblast cell culture
Rat pulmonary artery fibroblast (RPAF) cells were harvested from freshly excised lung 
tissue o f control and chronically hypoxic animals as described in Chapter 2.3.2.
All tissue was obtained from the laboratory o f Dr. M. McLean and age-matched animals 
were always used as controls.
The identity o f the fibroblast cells was confirmed by immunocytochemical staining as 
described in Chapter 2.3.3
8.2.3 Assessment of Proliferation
Proliferation o f rat pulmonary artery fibroblasts was assessed by measuring the uptake of 
[■"Fljthymidine (Chapter 2.6). Cells were grown to approximately 60% confluency in 24-
well plates at 37®C and then serum-starved for 24h. After this time the following additions 
were made as described below.
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To determine the effect of serum and 5-HT on proliferation in the normoxic and chronically 
hypoxic cells, 0.2% serum and lOpM 5-HT were added to the cells for 24h. lOpM of 
specific 5-HT agonists, a-methyl-5-HT, BW723C86 and MK212 were also studied. In 
addition, the incubations were also carried out in the presence and absence of 5-HT 
receptor antagonists, 0.1 pM Ketanserin and IpM  SDZ SER 082 and R S I02221. All drugs 
were added 2h prior to addition o f growth factors for 24h.
In all experiments, for the last 4h of agonist stimulation, cells were labelled with 
[^H]thymidine (O.lpCi/ml) before the reaction was stopped by washing in PBS (Chapter 
2.6). Radioactivity was determined by liquid scintdation counting and results expressed as 
disintegrations per minute (DPM).
8.2.4 Assessment of MAP kinase activity.
Cells were grown to approximately 90% confluency in 6-well plates at 37®C and then 
serum-starved for 24h. After this time, the following additions were made as described 
below. To determine the effect o f serum and 5-HT on p42/44, p38 and JNK activity in the 
normoxic and chionically hypoxic cells, 0.2% serum and lOpM 5-HT were added to the 
cells for 24h. To determine the effects of the specific 5-HT antagonists on p42/44 MAP 
kinase, p38 MAP kinase and JNK activity in the normoxic and chronically hypoxic cells, 
0.1 pM Ketanserin and IpM  GR55562 were added 2h prior to addition o f growth factors for 
24h.
Assessment o f phosphorylation o f these MAP kinase family o f proteins was by SDS-PAGE 
gel electrophoresis and western blot analysis (Chapter 2.8.3). In each case, the primary
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rabbit anti-dual phosphorylated, activated MAP kinase antibody for the protein o f interest 
(p42/44, p38 and JNK) was incubated with the blot for at least Ih at room temperature. The 
blots were then washed in PBS/Tween before incubating with sheep anti-rabbit Ig HRP in 
5% non-fat dried milk for one hour with constant agitation.
8.2.5 Statistics
Results are expressed as the mean ± S.D. Statistical analysis was undertaken as reported in 
Chapter 2.10.
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8.3 RESULTS
8.3.1 Effects of 5-HT Agonists and Antagonists on proliferation of Fibroblast cells 
from normoxic and chronically hypoxic rats.
The effect o f 5-HT on the proliferation o f pulmonary artery fibroblasts was determined by 
measuring its effect on the uptake o f [^H]thymidine into cells. Figure 8.1 shows the effect 
o f 5-HT on the replication of pulmonary artery fibroblast cells from control and chronically 
hypoxic animals. The addition o f 0,2% serum, both 3pM and lOjuM 5-HT alone did not 
significantly enhance the proliferation o f fibroblast cells from either normoxic or those 
from chronically hypoxic animals in comparison with control untreated cells (p>0.05). 
However, in the presence o f 0.2% serum, both 3pM and lOpM 5-HT caused an 1.4-fold 
and 3.5-fold increase, respectively, in the [^Hjthymidine uptake in cells from normoxic 
animals. The effect was even greater in the cells from hypoxic animals where there was a 
3.3-fold increase over control cells with the addition o f 0.2% serum and 3pM 5-HT, and a 
7.2-fold increase with the addition of lOjuM 5-HT (Figure 8.1).
Figure 8.2 shows the effects o f lOjuM 5-HT on the proliferation o f  RPAF cells from control 
and chronically hypoxic animals in the presence o f increasing concentrations o f serum. 
There was an enhanced proliferative response in the presence o f 5-HT and serum in the 
cells fi'om chronically hypoxic animals (p<0.001) in comparison to serum alone. This was 
particularly true at lower concentrations o f serum less than 1 %. For example, the presence 
o f 0.5% serum had no effect on the proliferation of RPAF cells from chronic hypoxic 
animals (p>0.05). However, in the presence o f 10p.M 5-HT there was an 11.7-fold increase 
over control levels.
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Figure 8.3 shows the effects of specific 5-HT agonists and antagonists on the replication of 
pulmonary artery fibroblasts from control and chronically hypoxic animals. Unstimulated 
RPAF cells from control and hypoxic animals showed no difference in [^H]thymidine 
uptake (p>0.05). In addition 0.2% serum alone and 5-HT (lOpM) had no significant effect. 
However, as described for Figure 8.2, the addition of 5-HT (lOpM) in the presence of 0.2% 
serum resulted in a 2.7-fold increase in proliferation in normoxic cells (p<0.005). This 
response was further enhanced in cells from chronically hypoxic animals where there was 
an 6-fold increase in comparison to control, untreated cells.
To examine this effect more closely, we studied a range o f more specific 5-HT agonists. 
The addition o f a 5 -HT2 agonist, a-methyl-5-HT (10p,M) enhanced the proliferation o f cells 
from hypoxic rats to the same degree as that o f lOp-M 5-HT alone (1750+251 DPM and 
854+196 DPM respectively). In contrast, the 5-HTzB agonist BW723C86 (lOfiM) did not 
increase proliferation in either cell type (332+52 DPM for the hypoxic cells and 325+1 10 
DPM for the normoxic cells which was not significantly different from control cells). This 
was also true for the 5 -HT2C agonist, MK212 (lOpM) which did not increase proliferation 
in either cell type (324+225 DPM for the hypoxic cells and 339+211 DPM for the 
normoxic cells which was not significantly different from control cells).
To study this further, we also looked at the effect o f a range o f 5-HT antagonists on the 5- 
HT-induced [^H]thymidine uptake. The addition of the 5-HTiA antagonist, ketanserin 
(0.1 pM), abrogated the enhanced growth response observed in the cells from chronically 
hypoxic animals induced with 5-HT and 0.2% serum (926+115 DPM for the hypoxic cells 
which was not significantly different from normoxic cells 849+310 DPM). In contrast, 
neither the 5 -HT213+C inhibitor SDZ SER 082 (IpM ) nor the 5-HT2b inhibitor R SI02221 
(IpM ) had any effect on reducing proliferation o f cells in the presence o f 5-HT and 0.2%
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serum (1796+121 and 1847+314 DPM for the hypoxic cells which was significantly 
different (p<0.05) from normoxic cells 882+265 and 886+172 DPM, respectively).
Figure 8.4 shows the effect o f 5-HT with 0.2% serum and specific inhibitors for 5-HT 
(Ketanserin and GR55562) and MAP kinases (SB203580 and U0126) on the replication of 
pulmonary artery fibroblast cells from control and chronically hypoxic animals. Basal 
levels o f replication in normoxic cells (220+15 DPM) and in cells from chronically hypoxic 
animals (230+20 DPM) were not significantly different (p>0.05). lOpM 5-HT with the 
addition of 0.2% serum gave rise to an 4-fold increase in proliferation in the normoxic cells 
and a further increase (6.2-fold) in the cells from chronically hypoxic animals (p<0.005). 
The addition o f IpM  SB203580 (a specific p38 inhibitor) abolished this enhanced 5-HT 
growth response observed in the cells from chronically hypoxic animals (923+42 DPM). In 
the presence o f this compound the increase in [^H]thymidine uptake in cells from hypoxic 
rats was not significantly different to that from normoxic animals (793+102 DPM) 
(p>0.05). The addition of 0.1 pM of the MEK inhibitor U0126 completely abolished the 
proliferative response o f normoxic cells (312+28 DPM) and those from chronically hypoxic 
animals (331+38 DPM) which was not significantly different from control levels (p>0.05). 
The effect o f 5-HT antagonists were also investigated (Figure 8.4). The addition o f the 5- 
HT2A antagonist Ketanserin (0.1 pM) abolished the enhanced 5-HT growth response seen in 
the cells from clironically hypoxic animals (913+50 DPM). Like SB203580, the enhanced 
response was reduced to the level o f that observed for cells from normoxic animals 
(832+78 DPM) (p>0.05). In contrast, the 5 - H T i b - i d  antagonist GR55562 (IpM ) had no 
effect on the proliferation o f cells from either the normoxic or hypoxic animals.
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Figure 8.1 Effect of 5-HT and Sérum on [^H]Thymidine Uptake in RPAF ceils from Normoxic 
and Chronically Hypoxic Rats.
Uptake o f [^Hjthymidine from normoxic (□ ) and chronically hypoxic (■ ) rats. RPAF cells were 
grown to 60% confluency in 24-well plates and then quiesced in serum-free medium. The cells were 
stimulated with either 3pM or lOpM 5-HT alone or in conjunction with 0.2% serum as indicated in 
the graph. Cells were then allowed to grow in normoxic conditions for a period o f 24h. The 
experiment was repeated with cells from 8 different animals and the results shown are typical o f those 
obtained.
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Figure 8.2 Effects of lOpiM 5-HT and Serum on the Uptake of [^H]Thymidine in 
Pulmonary Artery Fibroblasts from Control and Chronically Hypoxic Animals.
Uptake o f [^H] thymidine from normoxic (□ ) and chronically hypoxic rats (■). RPAF cells 
were grown to 60% confluency in 24-well plates and then quiesced in serum-free medium. 
The cells were stimulated with a range o f serum concentrations either alone or in 
conjunction with lOpM 5-HT as indicated in the graph. Cells were then allowed to grow in 
normoxic conditions for a period o f 24h. The experiment was repeated with cells from 8 
different animals and the results shown are typical o f those obtained.
2 1 8
Figure 8.3
0>
03
Q .
1
>1.
J =I—
Xco
3 0 0 0
2 7 0 0
2 4 0 0
2100
1 8 0 0
1 5 0 0
1200
9 0 0
6 0 0
3 0 0
0
2 3 6 8 9 104 5 71
1“  C o n t r o l  
2 ”  0 . 2 %  S e r u m  
3 -  lOuM 5 - H T
4 “  0 . 2 %  S e r u m + I O u M  5 - H T  (A)
5 -  0 . 2 %  S e r u m + a i p h a  m e t h y l  5 - H T  
6 “  0 . 2 %  S e r u m + B W 7 2 3 C 8 6  
7 -  0 . 2 %  S e r u m + M K 2 1 2
8 “  ( A ) + K e t a n s e r i n  
9 -  ( A ) + S D Z S E R 0 8 2  
10=  ( A ) + R S 1 0 2 2 2 1
Figure 8.3 Effects of Specific 5-HT Agonists and Antagonists on the Replication of Pulmonary 
Artery Fibroblasts from Control and Chronically Hypoxic Animals.
Uptake o f [^HJthymidine from normoxic (□ ) and chronically hypoxic rats (■). RPAF cells were 
grown to 60% confluency in 24-well plates and then quiesced in serum-free medium. The cells were 
stimulated with serum (0.2%) either alone or in conjunction with 5-HT (lOpM) in the presence or 
absence o f a-methyl-5-HT (lOpM), BW723C86 (lOpM), MK212 (lOpM), Ketanserin (0.1 pM), 
SDZSER082 (IpM ) and R S I02221 (IpM ) as indicated in the graph. Cells were then allowed to grow 
in normoxic conditions for a period o f 24h. The experiment was repeated with cells from 8 different 
animals and the results shown are typical o f  those obtained.
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Figure 8.4 Effects of specific 5-HT and MAP kinase inhibitors on 5-HT-induced [^H]thymidine 
uptake of pulmonary artery fibroblasts from control and chronically hypoxic animals.
Uptake o f [^H] thymidine from normoxic (□ ) and chronically hypoxic rats (■). RPAF cells were 
grown to 60% confluency in 24-well plates and then quiesced in serum-free medium. The cells were 
stimulated with lOpM 5-HT (lOpM) in the presence o f 0.2% serum (S) in the presence and absence o f 
0.1 pM SB203580 (SB), IpM  U0126, 0.1 pM  Ketanserin (Ketan) or IpM  GR55562 (GR) as indicated 
in the graph. Cells were then allowed to grow in normoxic conditions for a period o f 24h. The 
experiment was repeated with cells from 8 different animals and the results shown are typical o f  those 
obtained.
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8.3.2 Effect of 5-HT and 5-HT Antagonists on p38 phosphorylation in Fibroblast 
cells from normoxic and chronically hypoxic rats.
Watts (1998) have shown that 5-HT can lead to the phosphorylation of MAP kinase. We 
were interested to see if 5-HT could further enhance p38 MAP kinase phosphorylation 
already observed (Chapter 7.32, Figure 7.3) in pulmonary artery fibroblasts from hypoxic 
rats.
Figure 8.5 shows the effect of increasing doses of 5-HT on phosphorylated p38 M /iP 
kinase (pp38) in pulmonary artery fibroblast cells from control and chronically hypoxic 
animals. In the unstimulated control cells from chronically hypoxic rats, a clear increase in 
pp38 can be seen which is not apparent in the cells from normoxic animals (Figure 8.5 
compare upper panel, lane 1 with lane 7). In the cells from chronically hypoxic animals 
pp38 MAP kinase was increased in a 5-HT do se-dependent manner with maximum 
phosphorylation occurring at lOpM 5-HT. In contrast, no increase was seen in the cells 
from normoxic animals. The total amount of p38 MAP kinase was examined (lower panel) 
to ensure equal loading of protein on the polyacrylamide gel.
Figure 8.6 shows the effect o f 5-HT on pp38 MAP kinase in pulmonary artery fibroblast 
cells from control and chronically hypoxic animals. The upper panel shows that, 3pM and 
lOpM 5-HT gave rise to a substantial increase in pp38 MAP kinase in the cells from 
chronically hypoxic animals in comparison to control untreated cell extracts. There was no 
increase in pp38 MAP kinase in extracts from normoxic cells. The increase in pp38 MAP 
kinase in the cells from chi’onically hypoxic animals could be abrogated with the addition 
ofO .lpM  Ketanserin, a specific 5-HTiA antagonist. In contrast, addition o f IpM  GR55562,
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a 5“HT ib-id antagonist had much less o f an effect. The total amount o f p38 was examined 
(lower panel) to ensure equal loading o f protein on the polyacrylamide gel.
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Figure 8.5 Effect of Increasing Concentration of 5-HT on p38 Activity in Pulmonary 
Artery Fibroblast Cells from Control and Chronically Hypoxic Rats
BPAF cells were grown to 90% confluency in 6-well plates and then quiesced for 24h in serum- 
free medium. The cells were then stimulated for 24h with a range o f 5-HT concentrations as 
indicated. Assessment o f phosphorylation was by SDS-PAGE gel electrophoresis and western 
blot analysis (Chapter 2.8). The experiment shown is one o f 4 replicate experiments and is typical 
o f those obtained. Band density is used as a measure o f protein level.
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Figure 8.6 Effect of 5-HT on p38 Activity in Pulmonary Artery Fibroblast Cells from Control 
and Chronically Hypoxic Rats.
BPAF cells were grown to 90% confluency in 6-well plates and then quiesced for 24h in serum-free 
medium. The cells were then pre-incubated with 0.1 pM ketanserin (K; a specific 5-HTzA antagonist) 
or IpM GR55562 (GR; a specific 5-H T ib /id  antagonist) for 2h prior to stimulated with 3 or lOpM 5- 
HT for 24h. The experiment shown is one o f 4 replicate experiments and is typical o f those obtained. 
Band density is used as a measure o f protein level.
2 2 3
8.3,3 Effect of 5-HT and 5-HT Antagonists on p42/p44 MAP Kinase
Phosphorylation
We wanted to see o f 5-HT could further enhance p42/p44 MAP kinase phosphorylation 
already observed in pulmonary artery fibroblasts from hypoxic rats. Figure 8.7 shows the 
effect o f increased doses of 5-HT on phosphorylated p42/44 MAP kinase activity in 
pulmonary artery fibroblast cells from control and chronically hypoxic animals. Again, in 
the unstimulated control cells f  om chronically hypoxic rats, a clear increase of p42/44 
MAP kinase activity can be seen which is not apparent in the cells from normoxic animals. 
Neither cell type responded to 5-HT under any of the concentrations used with respect to 
increases in p42/p44 MAP kinase phosphorylation. The total amount o f p42/p44 MAP 
kinase was examined (lower panel) to ensure equal loading of protein on the
polyacrylamide gel.
Figure 8.8 shows the effects o f 5-HT on phosphorylated p42/44 MAP kinase activity in 
pulmonary artery fibroblast cells from control and chronically hypoxic animals in the 
presence o f 0.2% serum. In the unstimulated control cells from chronically hypoxic rats, a 
clear increase o f p42/44 MAP kinase phosphorylation was observed in comparison to 
extracts from untreated normoxic rats. 3pM and lOpM 5-HT alone did not increase 
p42/p44 phosphorylation in either cell types as in Figure 8.7. In the presence of 0.2% 
serum, however, an increase in p42/p44 MAP kinase phosphorylation by 5-HT occurred in 
a dose-dependent fashion in the cells from chronically hypoxic animals. The total amount 
o f p42/44 MAP kinase was examined to ensure equal loading of protein on the 
polyacrylamide gel.
Figure 8.9 shows the effect of 5-HT on phosphorylation o f p42/44 MAP kinase in
pulmonary artery fibroblast cells from control and chronically hypoxic animals.
Unstimulated cells from clironically hypoxic animals displayed increased levels o f p42/44
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MAP kinase activity compared with normoxic cells. There was a further increase in 
p42/p44 MAP kinase phosphorylation with the addition o f 5% serum, in RPAF from 
hypoxic animals. Neither 3pM nor lOpM 5-FIT gave rise to increased p42/p44 MAP kinase 
phosphorylation in cells from chronically hypoxic animals or in the normoxic cells, over 
control levels. The addition o f Ketanserin, a specific 5-HT2a antagonist, and GR55562, a 5- 
FITiB-iD antagonist had no effect on phosphorylation of p42/p44 MAP kinase. The total 
amount of p42/p44 MAP kinase was examined (lower panel) to ensure equal loading of 
protein on the polyacrylamide gel.
Figure 8.7
2 2 5
Phospho Erk- {
Total Erk-
Normoxic Hypoxic
mimm mmm «mmw mmm- _ w'#* ■
'
C S 10 3  1 0.1 C S 10 3 1 0.1
Normoxic Hypoxic
‘
c s 10 3 1 0:1 C S  10 3 1 0.1
C = Coxdiol 
S = 5% Som i il 5-HTuM
Figure 8.7 Effect o f Increasing Concentration of 5-HT on p42/44 MAP Kinase Activity in 
Pulmonary Artery Fibroblast Cells fromControl and Chronically Hypoxic Animals
BPAF cells were grown to 90% confluency in 6-well plates and then quiesced for 24h in serum- 
free medium. The cells were then stimulated with a range o f 5-HT concentrations as outlined in 
the figure for 24h. Assessment o f kinase activity was by SDS PAGE gel electrophoresis and 
western blot analysis (See section 2.8). The experiment shown is one o f 4 replicate experiments 
and is typical o f  those obtained. Band density is used as a measure o f protein level.
Figure 8.8
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Figure 8.8 Effect o f 5-HT and Serum on p42/44 MAP Kinase Activity in Pulmonary Artery 
Fibroblast Cells from Control and Chronically Hypoxic Rats.
BPAF cells were grown to 90% confluency in 6-well plates and then quiesced for 24h in serum-free 
medium. The cells were stimulated with 5% serum (S), 3 or lOpM 5-HT with or without 0.2% serum 
(+S) for 24h as indicated in the figure. Assessment o f kinase activity was by SDS-PAGE gel 
electrophoresis and western blot analysis (See Chapter 2.8). The experiment shown is one o f 4 
replicate experiments and is typical o f those obtained. Band density is used as a measure o f protein 
level.
Figure 8.9
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Figure 8.9 Effect o f 5-HT on p42/44 MAP Kinase activity in Pulmonary Artery Fibroblast cells 
from Control and Chronically Hypoxic Rats.
BPAF cells were grown to 90% confluency in 6-well plates and then quiesced for 24h in serum-free 
medium. The cells were then pre-incubated with 0.1 pM ketanserin (a specific 5-HTiA antagonist) or 
IpM GR55562 (a  specific 5-H T ib /id  antagonist) for 2h prior to stimulated with 3 or lOpM 5-HT for 
24h. Assessment o f kinase activity was by SDS PAGE gel electrophoresis and western blot analysis 
(See Chapter 2.8). The experiment shown is one o f 4 replicate experiments and is typical o f  those 
obtained. Band density is used as a measure o f protein level.
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8.4 DISCUSSION
This chapter focused on the effects of 5-HT on the proliferation and cell signalling of 
RPAF cells from normoxic and chronic hypoxic rats. 5-HT alone did not produce a 
mitogenic response in pulmonary artery fibroblast cells from either control or chronically 
hypoxic animals. These results are in keeping with the work o f others (Pitt et al, 1994; 
Seuwen and Pouyssegur, 1990) who studied 5-HT induced proliferation o f bovine and rat 
pulmonary vascular smooth muscle cells in culture. In those studies, 5-HT had a co- 
mitogenic effect on the cells, requiring incubation with other growth factors such as PDGF 
and EGF. This is similar to the present work. The addition o f a low concentration o f serum 
(which in itself does not increase proliferation) in conjunction with 5-HT resulted in an 
increase o f proliferation in both the normoxic and especially in the chronically hypoxic 
cells. This effect may requii'c either binding o f 5-HT to cell membrane receptors or active 
transport of 5-HT into the cell via the 5-HT transporter (5-HTT) (Eddahibi et al, 2000). 
One hypothesis could be that other co-mitogens change the structural conformity of the 5- 
HT receptor allowing 5-HT to bind, or that it opens up the 5-HTT allowing 5-HT to enter 
the cell. Previous work has demonstrated that the proliferative effect o f 5-HT on 
[^HJthymidine incorporation in bovine pulmonary artery smooth muscle cells was 
abolished after inhibition of the 5-HT transporter into the cell (Lee et al, 1991; Lee et al, 
1994a).
Our previous work (Chapter 7) has demonstrated that cells from chronically hypoxic 
animals display increased basal levels o f p38 and p42/p44 MAP kinase phosphorylation in 
comparison to those from normoxic cells, and further induced that phosphorylation which 
occurred in response to serum. In this present study, 5-HT increased pp38 above that of 
basal levels and in a dose-dependent manner to 5-HT. This occurred in the absence o f any
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co-mitogens. In contrast, 5-HT was unable to further increase p42/p44 MAP kinase 
phosphorylation above basal levels. However, in the presence of low levels o f serum, there 
was a further enhancement of p42/p44 MAP kinase activation. Other work has 
demonstrated that 5-HT mediates its response by phosphorylating p42/44 MAP kinase 
(Florian and Watts, 1998; Watts, 1996). The mechanisms for this activation are unclear, 
however, signalling pathways for 5-HT have classically included activation o f PLC and 
plasma membrane calcium channels that are sensitive to inhibition by dihydropyridines 
(Watts 1996). In our work, p42/p44 MAP kinase activation was activated by 5-HT only in 
the presence o f co-mitogens. To date, this is the first study to show that pp38 is activated by 
5-HT and also that the specific p38 MAP kinase inhibitor, SB203580, can block the 
enhanced hypoxia-associated proliferation with 5-HT.
Previous work has indicated that the 5-HTi receptor is involved in contraction and the 5- 
HTz receptor is involved in proliferation o f cells (Frishman et al 1996). We were therefore 
particularly interested in the effects o f 5-HTi and S-HTz receptor antagonists on 
proliferation o f RPAF cells and MAP kinase activation in these cells. Studies by other 
groups in rat aortic smooth muscle cells indicate that it is the 5-HT2a receptor that mediates 
5-HT stimulated phosphorylation and activation of the p42/p44 MAPKs (Kelleher et al,
1995). This may not be the case for RPAF cells since 5-HT alone does not increase p42/p44 
phosphorylation. Other work has shown that the mitogenic effect o f 5-HT on rat pulmonary 
vascular smooth muscle cells was attenuated by the 5-HTi receptor antagonist, ketanserin 
(Pitt et al, 1994). This would agree with our findings since the use o f ketanserin blocked 
the increased proliferation in the cells from chronically hypoxic animals associated with 
hypoxia.
230
To be certain of which receptor was important in the proliferation and MAP kinase 
activation in chronically hypoxic animals with respect to 5-HT, further inhibitor studies in 
conjunction with specific agonist studies were undertaken. To date the 5 -HT2 receptor has 3 
sub-types identified, 5 -HT2A, 5-HT2b and 5 -HT2C. Unfortunately, there are no specific 5- 
HT2A agonists commercially available at this time, however, there are specific 5 -HT2B 
(BW72386) and 5 -HT2C (MK212) agonists and a specific 5 -HT2 agonist (a-methyl 5-HT). 
Use o f these compounds allowed us to determine the specificity o f the sub-types involved 
in proliferation o f RPAF cells. There are also specific antagonists available naamely, 5- 
HT2A (ketanserin), 5-HT2c (RSI02221) and a specific 5-HT2b/c antagonist (SDZ SER 082) 
which allowed us to determine further the action o f the individual receptor sub-types.
The results demonstrated that, neither the actions o f the 5 -HT2B nor 5 -HT2C agonists in the 
presence o f low serum could produce a proliferative effect on either cell type. However, the 
selective 5 -HT2 agonist gave rise to a proliferative response in both cells types, which 
equalled the response in terms of magnitude o f 5-HT itself. This suggests that the 5 -HT2A 
receptor may be responsible for proliferation o f these cells. Inhibitor studies were then used 
to corroborate these results.
Again, the use o f specific 5-HTiB/c inhibitors could not inhibit the replicative responses o f 
these cells to 5-HT. The hypoxic-associated growth o f these cells however, could be 
successfully abrogated by the use o f ketanserin (S-HT] inhibitor). These findings agreed 
with the agonist studies and firmly pointed towards the 5-HT2a receptor as being the 
receptor responsible for hypoxic-associated growth of pulmonary artery fibroblast cells 
from chronically hypoxic animals. The 5 -HT2A receptor also appears to signal via p38 
MAP kinase because, by blocking the actions of this receptor we also blocked pp38 
activation. pp38 has been shown previously in this thesis (Chapter 7) to be essential for 
hypoxic growth o f pulmonary artery fibroblasts.
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C hapter 9
General Discussion
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9.1 Summary of Results
The data presented in this thesis shows that hypoxia has a marked effect on 
proliferation and cell signalling in pulmonary artery fibroblast cells. Cell models have 
been established to study the effects of acute and chronic hypoxia on fibroblast cells 
derived from the pulmonary and systemic circulations.
We have shown that in response to acute hypoxia:
• Acute hypoxia can stimulate pulmonary artery fibroblast cells to proliferate and 
can also increase the effect o f mitogens. In contrast, acute exposure to hypoxia 
has no effect on proliferation o f cells derived from the systemic circulation.
• This increase in proliferation also coincides with an increase in the second 
messenger IP3 in pulmonary artery fibroblasts. Mitogens that caused increased 
proliferation to hypoxia in the pulmonary artery fibroblasts also gave rise to 
increases in IP3 mass.
• Acute hypoxia also led to increased phosphorylation of members o f the MAP 
kinase family o f  proteins that are known to be involved in cell growth and 
development.
We have also shown that in cells derived from chronically hypoxic rats but 
maintained in normoxia:
• Pulmonary artery fibroblast cells from clironically hypoxic animals ha\c 
undergone a phenotypic switch whereby these cells proliferate to a level similar 
to those made acutely hypoxic.
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• These cells also display increased MAP kinase phosphoiylation when compared 
to those of control cells.
• Increased sensitivity to proliferation by 5-HT, a potent vasoconstrictor known to 
be released in vivo to hypoxia, was also apparent in the pulmonary artery 
fibroblasts from chronic hypoxic rats. This was again related to increased MAP 
kinase phosphorylation.
• The specific 5-HT receptor sub-type responsible for proliferation in the 
pulmonary artery fibroblasts from control and chronically hypoxic rats was also 
elucidated,
9.2 Species Difference
Closer examination o f the results indicates that the effects o f hypoxia on pulmonary 
artery fibroblasts are not always consistent between different species. The most 
notable example is in the p42/p44 MAP kinase responses o f pulmonary artery 
fibroblasts. Acute hypoxia caused only a small increase in p42/p44 MAP kinase 
activity in cells derived from the bovine model whereas the rat cells that had been 
exposed to chronic hypoxia showed high levels of p42/p44 MAP kinase 
phosphorylation. This was also true o f other MAP kinase isoforms, for example, in 
the bovine model, JNK was activated in the face o f hypoxia which was unlike the rat 
model. This was also the case when cells from different species were subjected to 
hypoxia in cell proliferation studies. In the bovine cells, acute hypoxia alone increased 
proliferation, whilst in rat cells hypoxia increased proliferation only in the presence of 
mitogens. This apparent conflict in results may be due to an underlying difference in 
the pharmacology or biochemistry o f the pulmonary artery fibroblasts o f the various
234
species. ît must also be pointed out that bovine cells were exposed to low O2 levels 
(~30mmHg) for a relatively short time (24h) whereas rat cells had been exposed (m 
vivo) to less severe hypoxic exposure for a longer time period (~330mmHg for 14 
days). It is possible that the effect o f hypoxia on cell proliferation is dependent on 
both the intensity and the duration of the hypoxic stimulus, but this remains to be 
addressed by further scientific investigation.
Alternatively, the difference may be due to the different order o f pulmonary artery 
used from species to species. In both animals, we used the main branch o f the 
pulmonary artery. However, in the bovine cells the piece o f tissue was isolated from 
well down the main branch near to the tip o f the lobe. In the rat, the tissue was 
isolated just as the artery entered into the lungs. As stated in chapter 1, the response of 
pulmonary arteries to hypoxia may differ between proximal and distal regions o f the 
vessel. This may account for the experimental differences between the species. It 
would have been interesting to conduct a study comparing various regions o f the 
pulmonary artery from each species. This would have been possible in the bovine 
lung where the vessels were large. However, the rat pulmonary artery rapidly 
decreases in size and explanting become increasingly difficult.
Whilst the effect o f hypoxia differed between species, there was also differences in 
proliferation responses to various agonists. In pulmonary artery fibroblasts from the 
cow, endothelin-1 did not induce proliferation whereas in the rat, ET-1 was a good 
mitogen (Peacock and Aidulis, 1994). Also, in the bovine model, 5-HT acted as a 
mitogen on its own whilst in the rat model it only acted as a co-mitogen. It is possible 
that this may be due to changes in receptor abundance and conformity in fibroblasts 
from different species.
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9,3 Role of Stress-Activated Protein Kinases
It is clear from the results that there are factors in both the pulmonary arteries from 
cow and rat that are important to the hypoxia-associated increases in fibroblast 
proliferation. The stress-activated protein p38 MAP kinase was activated in the face 
o f acute hypoxia in the bovine model, and also in the cells from chronically hypoxic 
rats. The ability o f a specific pharmacological inhibitor of this protein (SB203580) to 
attenuate hypoxic-stimulated DNA synthesis in growth-arrested cells implies that its 
biological function is to relay signals important for cells to re-enter the cell cycle. 
That hypoxia evokes the activation o f multiple signalling pathways emphasises the 
intricate levels of control imposed on crucial cellular decisions such as those made 
prior to cell division. Ultimately, a complex process such as re-entry into the cell 
cycle will depend on the specific transcription factors that become activated by the 
terminal protein kinase o f the pathways to which a receptor o f a particular mitogen or 
stress is coupled. How these transcription factors combine in the nucleus to induce the 
co-ordinated expression o f specific early genes is critical for cell cycle progression. 
Research efforts in the past few years have been successfril in identifying some o f the 
transcription factors regulated by these kinases. For example, p62^^^/Elk-l is a 
common nuclear target for both the p42/44 and p38 MAP kinases iso forms which 
were shown in the cells from chronically hypoxic animals to be in abundance when 
compared with control cells (Marais et al, 1993, Raingeaud et al, 1996). While ATF-2 
is a substrate for p38 MAP kinase in vitro and in transfected cells (Raingeaud et al,
1996). In addition, specific nuclear targets for pVO®*"*^, MAPKAP kinase-2 and p90^^ 
are also coming to light (de Groot et al, 1994). While all o f these factors would be 
predicted to become activated on exposure o f pulmonary artery fibroblasts to hypoxia.
236
the full array of genes that they control, and the contribution that products o f these 
genes make to the genetic program regulating the cell cycle still has to be 
investigated. A better understanding o f the transcriptional control of genes will be 
necessary to provide information concerning how various signalling inputs impinging 
upon the nucleus are co-ordinated to initiate complex genetic responses. In the 
meantime, compounds such as Ketanserin and SB203580 used in this study will serve 
as valuable tools for identifying the specific nuclear apparatus by which transcription 
events are regulated by allowing researchers to dissect pathways involved in 
transcriptional control.
9.4 Hypoxia causing a Phenotypic Switch
The findings in this thesis that pulmonary artery fibroblasts from chronically hypoxic 
animals would appear to have undergone some form of phenotypic switch whereby 
signals associated with hypoxia are always switched on may help in the understanding 
o f which genes are important in the response. It would be logical to assume that if the 
products o f the gene were constantly available, then the genes that control their 
regulation would also be constantly in production. This would allow for comparisons 
o f gene amount and presence to be easily ascertained.
Despite outlining some o f the protein cascades involved in hypoxic-stimulated 
mitogenesis, a number of points remain unsolved regarding upstream events involved 
in their activation, the possible interplay between these pathways, and the nature of 
the hypoxic “receptor/s" that they are coupled to. While signal transduction by 
hypoxia is far from understood and it is unknown whether hypoxia signals via G- 
protein interactions or receptor tyrosine kinases, an observation in the BP A fibroblasts
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was the resemblance of hypoxic mediated events to signalling characteristics of 
growth factors that activate receptor tyrosine kinases, such as PDGF. Thus, for 
example, activation of MAP kinase by hypoxia followed a slow and gradual time 
course rather than the rapid kinetics reported in other cell types that are often maximal 
within 2-5 minutes. The relative importance o f G-protein-coupled receptor and 
tyrosine kinase receptor-mediated signalling events triggered by stresses and growth 
factors is currently a topic o f considerable interest. Research within the past few years 
has provided novel paradigms to support the concept o f physiologically relevant cross 
talk between G-protein-coupled receptors, and tyrosine kinase receptor-linked routes 
for communication within the cell (Daub et al, 1996).
9.5 Pulm onary vs. Systemic arteries
This thesis has demonstrated for the first time, to our knowledge, a fundamental 
difference in response to hypoxia between systemic and pulmonary artery cells. 
Unlike pulmonary artery fibroblasts, fibroblast cells from the systemic circulation in 
both the bovine and rat models do not proliferate to hypoxia, or indeed give rise to the 
phosphorylation o f the proteins which we consider important. This finding is 
fundamental to this thesis as it mimics the known physiological response where 
hypoxia in vivo does not result in vasoconstriction or in remodelled vessels in the 
systemic arteries. It also supports the results fi’om the pulmonary artery fibroblasts 
with respect to increased generation of signals resulting in proliferation, which are not 
seen in the systemic artery cells.
Despite questions that still need to be resolved, these studies have outlined a number 
of novel cellular consequences o f hypoxia on cells, further defining the possible
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mechanisms by which it is able to influence their behaviour. In particular, the studies 
highlight pathways that are likely to operate during vascular disease states like 
pulmonary hypertension and other hypoxic forms of lung disease where proliferation 
of these cell types contribute to blood vessel wall remodelling. A more conclusive 
role for these pathways will become apparent in future literature.
9,6 Future W ork
The work of this thesis shows quite clearly that hypoxia is an important regulator of 
the pulmonary vasculature and the mechanisms by which hypoxia regulates 
remodelling during pulmonary hypertension may help us identify potential therapeutic 
targets.
Wliile our picture o f acute and chronic stimulation of cell signalling in our cell models 
o f pulmonary hypertension is incomplete, it is clear that specific MAP kinase 
signalling pathways are being activated in cells from the pulmonaiy circulation. 
Furthermore, these pathways induce HIF-1 (Minet et al, 2000) which can lead to the 
upregulation o f several genes such as the mitogen VEGF. This raises the possibility o f 
exploiting differences between pathways as seen in this thesis in order to specifically 
inhibit hypoxia-induced signalling pathways in cardiopulmonary diseases. Achieving 
this goal requires a detailed biochemical and molecular understanding o f the 
signalling pathways activated in pulmonary fibroblasts in response to hypoxia and a 
study o f the regulatory events that these control.
Defining exactly how MAP kinase activation is involved in pulmonary hypertension 
is essential if we are to identify potential sites for therapeutic intervention. Although 
we have established that hypoxia causes an increase in proliferation o f FAF cells
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derived from the pulmonary artery of rats and cows, the effects of this on progression 
of these cells through the cell cycle is unknown. Recent work has shown that MAP 
kinase pathways converge to regulate cyclin D1 during hypoxic exposure of PC 12 
cells (Conrad et al 1999). Since hypoxia increases proliferation in our cell model, the 
role o f cyclin D1 in hypoxia-induced proliferation of PAF cells and the regulation of 
its expression by p38 MAPK. and ERK pathways is unclear and would be an attractive 
addition to this research.
We have shown that intracellular processes are specifically altered by decreased O2 in 
pulmonary artery but not systemic fibroblasts. Now we should take the investigation 
one step further and look at which transcription factors are turned on by hypoxia and 
which genes are thus activated.
Along with the increase in proliferation o f fibroblasts seen in pulmonary vascular 
remodelling, fibroblasts have an important role to play in laying dovm matrix proteins 
such as collagen, which render the vessels indistensible. Future work should include 
the examination o f extracellular matrix protein production fi'om normoxic and 
hypoxic pulmonary artery fibroblasts and compare such protein generation to those o f 
systemic vascular cells. Studying how the intracellular signalling changes seen in 
fibroblast cells due to hypoxic exposure may effect extracellular matrix production 
could also ultimately hold a clue for future treatments o f  pulmonary vascular 
remodelling during pulmonary hypertension.
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